Affordability; Telehealth, Mental Health; Maternal Health; Fair Hospital Billing; Site Neutrality/Site neutral payment reform; Prior Authorization; Health Equity; Affordable Care Act; Transparency in coverage.
S.1869 - SITE Act
To amend title XVIII of the Social Security Act and title XXVII of the Public Health Service Act to ensure fair billing practice for items and services furnished by off-campus hospital locations, to amend such title XVIII to provide for payments for graduate nursing education costs, and for other purposes.
Sponsor: Sen. Braun, Mike [R-IN] (Introduced 06/07/2023)
H.R.3417 - FAIR Act
To ensure fair billing practices for items and services furnished by off-campus outpatient departments of a provider.
Sponsor: Rep. Hern, Kevin [R-OK-1] (Introduced 05/17/2023)
H.R.5378 - Lower Costs, More Transparency Act
A bill requiring health care providers and insurers to disclose certain information about health care costs. It also establishes requirements for certain payment methodologies under Medicare and Medicaid and extends several public health programs.
Sponsor: Rep. McMorris Rodgers, Cathy [R-WA-5] (Introduced 09/08/2023)
H.R.3838 - Preventing Maternal Deaths Reauthorization Act of 2023
To amend title III of the Public Health Service Act to reauthorize Federal support of States in their work to save and sustain the health of mothers during pregnancy, childbirth, and the postpartum period, to eliminate disparities in maternal health outcomes for pregnancy-related and pregnancy-associated deaths, to identify solutions to improve health care quality and health outcomes for mothers, and for other purposes.
Sponsor: Rep. Burgess, Michael C. [R-TX-26] (Introduced 06/06/2023)
Medicaid; Medicaid Redeterminations; Medicare Advantage; Prior Authorization
H.R.5385 - Medicare PBM Accountability Act
To amend title XVIII of the Social Security Act to establish pharmacy benefit manager reporting requirements with respect to prescription drug plans and MA-PD plans under Medicare part D.
Sponsor: Rep. Landsman, Greg [D-OH-1] (Introduced 09/12/2023)
Duration: February 21, 2006
to
present
General Issues: Health Issues , Medicare/Medicaid , Pharmacy , Taxation/Internal Revenue Code , Government Issues , Budget/Appropriations , Insurance
Spending: about $1,550,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2006: House of Representatives, U.S. Senate, U.S. Senate,, Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY had in-house lobbyists. The report was filed on April 21.
Original Filing: 301569572.xml
Lobbying Issues
Affordability; Telehealth, Mental Health; Maternal Health; Fair Hospital Billing; Site Neutrality/Site neutral payment reform; Prior Authorization; Health Equity; Affordable Care Act; Transparency in coverage.
S.1869 - SITE Act
To amend title XVIII of the Social Security Act and title XXVII of the Public Health Service Act to ensure fair billing practice for items and services furnished by off-campus hospital locations, to amend such title XVIII to provide for payments for graduate nursing education costs, and for other purposes.
Sponsor: Sen. Braun, Mike [R-IN] (Introduced 06/07/2023)
H.R.3417 - FAIR Act
To ensure fair billing practices for items and services furnished by off-campus outpatient departments of a provider.
Sponsor: Rep. Hern, Kevin [R-OK-1] (Introduced 05/17/2023)
H.R.5378 - Lower Costs, More Transparency Act
A bill requiring health care providers and insurers to disclose certain information about health care costs. It also establishes requirements for certain payment methodologies under Medicare and Medicaid and extends several public health programs.
Sponsor: Rep. McMorris Rodgers, Cathy [R-WA-5] (Introduced 09/08/2023)
H.R.3838 - Preventing Maternal Deaths Reauthorization Act of 2023
To amend title III of the Public Health Service Act to reauthorize Federal support of States in their work to save and sustain the health of mothers during pregnancy, childbirth, and the postpartum period, to eliminate disparities in maternal health outcomes for pregnancy-related and pregnancy-associated deaths, to identify solutions to improve health care quality and health outcomes for mothers, and for other purposes.
Sponsor: Rep. Burgess, Michael C. [R-TX-26] (Introduced 06/06/2023)
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Medicaid; Medicaid Redeterminations; Medicare Advantage; Prior Authorization
H.R.5385 - Medicare PBM Accountability Act
To amend title XVIII of the Social Security Act to establish pharmacy benefit manager reporting requirements with respect to prescription drug plans and MA-PD plans under Medicare part D.
Sponsor: Rep. Landsman, Greg [D-OH-1] (Introduced 09/12/2023)
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2023
In Q4, HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY had in-house lobbyists. The report was filed on Jan. 20.
Original Filing: 301533712.xml
Lobbying Issues
Affordability; Telehealth, Mental Health; Maternal Health; Fair Hospital Billing; Site Neutrality/Site neutral payment reform; Prior Authorization; Health Equity; Affordable Care Act; Transparency in coverage.
S.1869 - SITE Act
To amend title XVIII of the Social Security Act and title XXVII of the Public Health Service Act to ensure fair billing practice for items and services furnished by off-campus hospital locations, to amend such title XVIII to provide for payments for graduate nursing education costs, and for other purposes.
Sponsor: Sen. Braun, Mike [R-IN] (Introduced 06/07/2023)
H.R.3417 - FAIR Act
To ensure fair billing practices for items and services furnished by off-campus outpatient departments of a provider.
Sponsor: Rep. Hern, Kevin [R-OK-1] (Introduced 05/17/2023)
H.R.5378 - Lower Costs, More Transparency Act
A bill requiring health care providers and insurers to disclose certain information about health care costs. It also establishes requirements for certain payment methodologies under Medicare and Medicaid and extends several public health programs.
Sponsor: Rep. McMorris Rodgers, Cathy [R-WA-5] (Introduced 09/08/2023)
H.R.3838 - Preventing Maternal Deaths Reauthorization Act of 2023
To amend title III of the Public Health Service Act to reauthorize Federal support of States in their work to save and sustain the health of mothers during pregnancy, childbirth, and the postpartum period, to eliminate disparities in maternal health outcomes for pregnancy-related and pregnancy-associated deaths, to identify solutions to improve health care quality and health outcomes for mothers, and for other purposes.
Sponsor: Rep. Burgess, Michael C. [R-TX-26] (Introduced 06/06/2023)
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Medicaid; Medicaid Redeterminations; Medicare Advantage; Prior Authorization; Site Neutral Payments and Payment Accuracy.
S1038/H.R. 1613 Drug Price Transparency in Medicaid Act of 2023
A bill requiring pass-through pricing models, and prohibits spread-pricing, for payment arrangements with pharmacy benefit managers under Medicaid.
Sponsor: Sen. Welch, Peter [D-VT] (Introduced 03/29/2023)
H.R.5385 - Medicare PBM Accountability Act
To amend title XVIII of the Social Security Act to establish pharmacy benefit manager reporting requirements with respect to prescription drug plans and MA-PD plans under Medicare part D.
Sponsor: Rep. Landsman, Greg [D-OH-1] (Introduced 09/12/2023)
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
COVID testing and therapeutics; Pharmacy Benefits
S127-Pharmacy Benefit Manager Transparency Act of 2023
A bill to prevent unfair and deceptive acts or practices and the dissemination of false information related to pharmacy benefit management services for prescription drugs, and for other purposes.
Sponsor: Sen. Cantwell, Maria [D-WA] (Introduced 01/26/2023)
S.1339 - Pharmacy Benefit Manager Reform Act
To provide for increased oversight of entities that provide pharmacy benefit management services on behalf of group health plans and health insurance coverage.
Sponsor: Sen. Sanders, Bernard [I-VT] (Introduced 04/27/2023)
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2023
In Q3, HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY had in-house lobbyists. The report was filed on Oct. 20, 2023.
Original Filing: 301509542.xml
Lobbying Issues
Affordability; Telehealth, Mental Health; Maternal Health; Prior Authorization; Health Equity; Surprise Billing; Transparency in coverage.
H.R. 3561, The Patient Act of 2023
To promote hospital and insurer price transparency, and for other purposes.
Sponsor:Rep. McMorris Rodgers, Cathy [R-WA-5] (Introduced 05/22/2023)
H.R. 4822, Health Care Price Transparency Act of 2023
To improve price transparency with respect to certain health care services, and for other purposes.
Sponsor: Rep. Smith, Jason [R-MO-8] (Introduced 07/24/2023)
H.R. 4507, Transparency in Coverage Act of 2023
To amend the Employee Retirement Income Security Act of 1974 to promote transparency in health coverage and reform pharmacy benefit management services with respect to group health plans, and for other purposes.
Sponsor: Rep. Good, Bob [R-VA-5] (Introduced 07/10/2023)
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Medicaid; Medicaid Redeterminations; Medicare Advantage, Prior Authorization.
S1038/H.R. 1613 Drug Price Transparency in Medicaid Act of 2023
A bill requiring pass-through pricing models, and prohibits spread-pricing, for payment arrangements with pharmacy benefit managers under Medicaid.
Sponsor: Sen. Welch, Peter [D-VT] (Introduced 03/29/2023)
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Affordability, COVID-19 Vaccines; Finance PBM Framework; Health Equity.
S127, Pharmacy Benefit Manager Transparency Act of 2023
A bill to prevent unfair and deceptive acts or practices and the dissemination of false information related to pharmacy benefit management services for prescription drugs, and for other purposes.
Sponsor: Sen. Cantwell, Maria [D-WA] (Introduced 01/26/2023)
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2023
In Q2, HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY had in-house lobbyists. The report was filed on July 19, 2023.
Original Filing: 301483574.xml
Lobbying Issues
Affordability; Telehealth, Mental Health; Maternal Health; Prior Authorization; Health Equity; Surprise Billing; Transparency in coverage.
S 1001 Telehealth expansion Act 2023
To amend the Internal Revenue Code of 1986 to permanently extend the exemption for telehealth services from certain high deductible health plan rules.
Sen. Daines, Steve [R-MT] (Introduced 03/28/2023)
H.R. 3561, The Patient Act of 2023
To promote hospital and insurer price transparency, and for other purposes.
Rep. McMorris Rodgers, Cathy [R-WA-5] (Introduced 05/22/2023)
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Medicaid; Medicaid Redeterminations; Medicaid work requirements; Medicare Advantage, Prior Authorization.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2023
In Q1, HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY had in-house lobbyists. The report was filed on April 20, 2023.
Original Filing: 301462111.xml
Lobbying Issues
Mental Health; Maternal Health; Health Equity.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Medicare Advantage Advance Rate Notice; Medicare Advantage, Prior Authorization.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2022
In Q4, HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY had in-house lobbyists. The report was filed on Jan. 20, 2023.
Original Filing: 301437749.xml
Lobbying Issues
Prescription drugs; Insulin
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
COVID-19; COVID-19 Transition/PHE; Telehealth; Health disparities; Social Determinants of Health; Maternal Health Mental Health; Funding for mental health programs; Affordability.
H.R. 7780-Mental Health Matters Act
A bill to increase access to mental and behavioral health care for students. The bill creates various grants to increase the number of school-based mental health services providers.
Sponsor: Rep. Mark DeSaulnier (D-CA-11) (Introduced 05/16/2022)
H.R. 7666-Restoring Hope for Mental Health and Well-Being Act of 2022
To amend to the Public Health Services Act to reauthorize center programs relating to mental health and substance use disorders, and for other purposes.
Sponsor: Rep. Frank Pallone (D-NJ-06) (Introduced 05/06/2022)
S. 346-Black Maternal Health Momnibus Act of 2021
A bill to end preventable maternal mortality and severe maternal morbidity in the United Stated and close disparities in maternal health outcomes, and for other purposes.
Sponsor: Sen. Cory Booker (D-NJ) (Introduced 02/22/2021)
H.R. 959-Black Maternal Health Momnibus Act of 2021
A bill to end preventable maternal mortality and severe maternal morbidity in the United Stated and close disparities in maternal health outcomes, and for other purposes.
Sponsor: Rep. Lauren Underwood (D-IL-14) (Introduced 02/08/2021)
H.R. 8876 Jackie Walorski Maternal and Child Home Visiting Reauthorization Act of 2022
To reauthorize through FY2027, increases funding for, and modifies the Maternal, Infant, and Early Childhood Home Visiting Program, and for other purposes.
Sponsor: Rep. Danny Davis, (D-IL-7) (Introduced 09/19/2022)
H.R. 432-Mentel Health Access Improvement Act of 2021
This bill provides for coverage of marriage and family therapist services and mental health counselor services under Medicare. It also excludes such services from the skilled nursing facility prospective payment system, and authorizes marriage and family therapists and mental health counselors to develop discharge plans for post-hospital services.
Sponsor: Rep. Mike Thompson (D-CA-5) (Introduced 01/21/2021)
H.R. 925 Data to Save Moms Act
The bill expands data collection and research on maternal morbidity and mortality among minority populations. The bill authorizes funding for maternal mortality review committees to promotes community engagement and for other purposes.
Sponsor: Rep. Sharice Davids (D-KS-3) (Introduced 02/08/2021)
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Medicare; Medicare Advantage; Medicare Advantage Prior Authorization; Medicaid; Social Determinants of Health.
H.R. 8594 Restore Protections for Dialysis Patients Act
A bill requiring private health insurers may not limit, restrict, or condition benefits for renal dialysis services for individuals with end-stage renal disease as compared to other types of benefits for other medical conditions under Medicare secondary payer rules.
Sponsor: Rep. Yvette D. Clarke (D-NY-9) (Introduced 07/29/2022)
H.R. 3173 Improving Seniors' Timely Access to Care Act of 2022
A bill that establishes several requirements and standards relating to prior authorization processes under Medicare Advantage (MA) plans.
Sponsor: Rep. Suzan DelBene (D-WA-1) (Introduced 05/13/2021)
S.4750 - Restore Protections for Dialysis Patients Act
A bill that specifies private health insurers may not limit, restrict, or condition benefits for renal dialysis services for individuals with end-stage renal disease as compared to other types of benefits for other medical conditions under Medicare secondary payer rules.
Sponsor: Sen. Robert Menendez, [D-NJ] (Introduced 08/03/2022)
Agencies Lobbied
U.S. House of Representatives
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Public Law 117-328 (H.R. 2617) -Fiscal 2023 omnibus spending package
Consolidated Appropriations Act, 2023
The bill provides appropriations to federal agencies for the remainder of FY2023, provides supplemental appropriations for disaster relief and to support Ukraine, extends several expiring authorities, and modifies or establishes various programs that address a wide range of policy areas.
Sponsor: Rep. Gerald E. Connolly, (D-VA-11) (Introduced 04/16/2021)
Agencies Lobbied
U.S. Senate
3rd Quarter, 2022
In Q3, HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY had in-house lobbyists. The report was filed on Oct. 20, 2022.
Original Filing: 301415922.xml
Lobbying Issues
COVID-19 Testing; Rx reform; Insulin; Prescription drugs.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Affordable Care Act; Extending ARPA Subsidies; COVID-19 Testing; Telehealth/Audio Only; Health disparities; Social Determinants of Health; Maternal Health Mental Health; Affordability.
H.R. 7780-Mental Health Matters Act
A bill to increase access to mental and behavioral health care for students. The bill creates various grants to increase the number of school-based mental health services providers.
Sponsor: Rep. Mark DeSaulnier (D-CA-11) (Introduced 05/16/2022)
H.R. 7666-Restoring Hope for Mental Health and Well-Being Act of 2022
Sponsor: Rep. Frank Pallone (D-NJ-06) (Introduced 05/06/2022)
S. 346-Black Maternal Health Momnibus Act of 2021
A bill to end preventable maternal mortality and severe maternal morbidity in the United Stated and close disparities in maternal health outcomes, and for other purposes.
Sponsor: Sen. Cory Booker (D-NJ) (Introduced 02/22/2021)
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Medicare; Prior Authorization; Medicare Advantage Reform; Medicaid;
H.R. 2166-Ensuring Parity in MA and PACE for Audio-Only Telehealth Act of 2021
Sponsor: Rep. Terri Sewell (D-AL-01)(Introduced 03/23/2021)
H.R. 3173 Improving Seniors' Timely Access to Care Act of 2022
A bill that establishes several requirements and standards relating to prior authorization processes under Medicare Advantage (MA) plans.
Sponsor: Rep. Suzan DelBene (D-WA-1) (Introduced 05/13/2021)
Agencies Lobbied
U.S. House of Representatives
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
2nd Quarter, 2022
In Q2, HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY had in-house lobbyists. The report was filed on July 20, 2022.
Original Filing: 301394530.xml
Lobbying Issues
COVID-19 Testing; Rx reform; Insulin; Prescription drugs.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Extending ARPA Subsidies; COVID-19 Testing; Telehealth/Audio Only; Health disparities; Social Determinants of Health; Mental Health; Affordability.
H.R. 5376-Build Back Better Act
Sponsor: Rep. John Yarmuth (D-KY-03)(Introduced 09/27/2021)
H.R. 7666-Restoring Hope for Mental Health and well-Being Act of 2022
Sponsor: Rep. Frank Pallone (D-NJ-06) (Introduced 05/06/2022)
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Medicare; Medicare Advantage Reform; Medicaid;
H.R. 2166-Ensuring Parity in MA and PACE for Audio-Only Telehealth Act of 2021
Sponsor: rep. Terri Sewell (D-AL-01)(Introduced 03/23/2021)
Agencies Lobbied
U.S. House of Representatives
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
1st Quarter, 2022
In Q1, HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY had in-house lobbyists. The report was filed on April 20, 2022.
Original Filing: 301366815.xml
Lobbying Issues
COVID-19 Testing; Rx reform; Prescription drugs; OTC COVID Tests.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Affordable Care Act (ACA); Health Reform; COVID-19; Telehealth/Audio Only; Health disparities; Extending Exchange Subsidies; Extending ARPA Subsidies; Health Equity Issues; Health Care spending; Social Determinants of Health; Pandemic preparedness; OTC COVID Testing; Affordability.
H.R. 5376-Build Back Better Act
Sponsor: Rep. John Yarmuth (D-KY-03)(Introduced 09/27/2021)
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Medicare; Medicare Advantage Reform; Medicaid.
Agencies Lobbied
U.S. House of Representatives
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
4th Quarter, 2021
In Q4, HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY did no lobbying for itself. The report was filed on Jan. 20, 2022.
Original Filing: 301331558.xml
3rd Quarter, 2021
In Q3, HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY had in-house lobbyists. The report was filed on Oct. 19, 2021.
Original Filing: 301306681.xml
Lobbying Issues
COVID-19 Testing; COVID-19 Vaccine Strategy and Treatment; Prescription Drugs; Prescription Drug Reform.
H.R. 3 -117th Congress (2021-2022)
Lower Drug Costs Act
Sponsor: Frank Pallone Jr. [D-NJ-6] (Introduced 04/22/2021)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Affordable Care Act (ACA); ACA Reform; ACA Coverage Improvement; Health Reform; Lower Health Care Costs; Transparency; Surprise Billing, Maternal Health; Black Maternal Health; COVID-19 Response/Relief Packages, COBRA subsidies; Telehealth/Audio-Only; Health Disparities; Health Equities; Cost and Affordability.
H.R. 4026 -Social Determinants of Health Data Analysis Act of 2021
Rep. Burgess, Michael C. [R-TX-26] (Introduced 06/22/2021)
H.R. 4387 -Maternal Health Quality Improvement Act of 2021
Rep. Kelly, Robin L. [D-IL-2] (Introduced 07/09/2021)
H.R. 959 - Black Maternal Health Momnibus Act of 2021
Rep. Underwood, Lauren [D-IL-14] (Introduced 02/08/2021)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicare; Medicare Advantage Reform; Medicaid; Part D Reform;
H.R. 2166 -117th Congress (2021-2022)
To amend title XVIII of the Social Security Act to require the inclusion of certain audio-only diagnoses in the determination of risk adjustment for Medicare Advantage plans and PACE programs, and for other purposes.
Sponsor: Rep. Terri Sewell (D-AL-07) (Introduced 03/23/2021)
Agencies Lobbied
U.S. Senate
Lobbying Issues
ACA Tax Credits.
H.R. 1868 -To prevent across-the-board direct spending cuts, and for other purposes.
Sponsor: Rep. John Yarmuth (D-KY-03) (Introduced 03/12/2021)
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
2nd Quarter, 2021
In Q2, HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY had in-house lobbyists. The report was filed on July 20, 2021.
Original Filing: 301288857.xml
Lobbying Issues
COVID-19 Testing; COVID-19 Vaccine Strategy and Treatment; Rx reform;
H.R. 3 -117th Congress (2021-2022)
Lower Drug Costs Act
Sponsor: Frank Pallone Jr. [D-NJ-6] (Introduced 04/22/2021)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Affordable Care Act (ACA); ACA Reform; ACA Coverage Improvement; Health Reform; Lower Health Care Costs; Transparency; Surprise Billing, Maternal Health; Black Maternal Health; COVID-19 Response/Relief Packages, COBRA subsidies; Telehealth/Audio-Only; COVID-19 Disaster Relief; Health Disparities; Health Equities; Cost and Affordability; SEP.
Public Law 117-2 (H.R. 1319)-117th Congress (2021-2022)
American Rescue Plan Act of 2021
Sponsor: Rep. John Yarmuth (D-KY-03)
H.R. 2503-117th Congress (2021-2022)
Social Determinants Accelerator Act of 2021
Sponsor: Rep. Cheri Bustos [D-IL-7] (Introduced 04/14/2021)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicaid Maternal Health; Medicare Advantage Audio Only; Medicaid FMAP; Medicare; Medicare Advantage.
S.150 -117th Congress (2021-2022)
Ensuring Parity in MA for Audio-Only Telehealth Act of 2021
Sponsor: Sen. Catherine Cortez Masto (D-NV) (Introduced 02/02/2021)
H.R. 2166 -117th Congress (2021-2022)
To amend title XVIII of the Social Security Act to require the inclusion of certain audio-only diagnoses in the determination of risk adjustment for Medicare Advantage plans and PACE programs, and for other purposes.
Sponsor: Rep. Terri Sewell (D-AL-07) (Introduced 03/23/2021)
Agencies Lobbied
U.S. Senate
Lobbying Issues
ACA Tax Credits; APTC;
H.R. 1868 -117th Congress (2021-2022)
To prevent across-the-board direct spending cuts, and for other purposes.
Sponsor: Rep. John Yarmuth (D-KY-03) (Introduced 03/12/2021)
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
1st Quarter, 2021
In Q1, HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY had in-house lobbyists. The report was filed on April 20, 2021.
Original Filing: 301265863.xml
Lobbying Issues
COVID-19 Testing; COVID-19 Vaccine Strategy and Treatment; Rx reform;
Agencies Lobbied
U.S. Senate
Lobbying Issues
Affordable Care Act (ACA); ACA Reform; ACA Coverage Improvement; Health Reform; Lower Health Care Costs; Transparency; Surprise Billing, Maternal Health; Black Maternal Health; COVID-19 Response/Relief Packages, COBRA subsidies; Telehealth/Audio-Only; COVID-19 Disaster Relief; Health Disparities; Health Equities; Cost and Affordability; SEP.
Public Law 117-2 (H.R. 1319)-117th Congress (2021-2022)
American Rescue Plan Act of 2021
Sponsor: Rep. John Yarmuth (D-KY-03)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicaid Maternal Health; Medicare Advantage Audio Only; Medicaid FMAP; Medicare; Medicare Advantage.
S.150 -117th Congress (2021-2022)
Ensuring Parity in MA for Audio-Only Telehealth Act of 2021
Sponsor: Sen. Catherine Cortez Masto (D-NV) (Introduced 02/02/2021)
H.R. 2166 -117th Congress (2021-2022)
To amend title XVIII of the Social Security Act to require the inclusion of certain audio-only diagnoses in the determination of risk adjustment for Medicare Advantage plans and PACE programs, and for other purposes.
Sponsor: Rep. Terri Sewell (D-AL-07) (Introduced 03/23/2021)
Agencies Lobbied
U.S. Senate
Lobbying Issues
ACA Tax Credits;
H.R. 1868 -117th Congress (2021-2022)
To prevent across-the-board direct spending cuts, and for other purposes.
Sponsor: Rep. John Yarmuth (D-KY-03) (Introduced 03/12/2021)
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
4th Quarter, 2020
In Q4, HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY had in-house lobbyists. The report was filed on Jan. 20, 2021.
Original Filing: 301239133.xml
Lobbying Issues
COVID-19 Testing; COVID-19 Vaccine Strategy and Treatment
Agencies Lobbied
U.S. Senate
Lobbying Issues
Affordable Care Act (ACA); ACA Regulations; ACA Stabilization; Health Reform; Rural Healthcare; Individual Market Reform; Individual Health Care Costs; Mental Health; Transparency; Interoperability; Surprise billing, State Based Exchange; ACA Outreach, Education, and Enrollment; Prior Authorization; Black Maternal health; Seniors health care; social determinants of health; Healthcare access/privacy; Telehealth/Audio Only; CDC Guidance Testing Funding Level/Plan requirements; COVID-19 Response/Relief Packages; change in corporate form/mutual holding company; COBRA subsidies; Premium Credits; ACA Tax Credits; Maternal Health.
H.R.3630 - 116th Congress (2019-2020)
No Surprises Act
Sponsor: Rep. Pallone, Frank, Jr. [D-NJ-6] (Introduced 07/09/2019)
H.R. 6800 - 116th Congress (2019-2020)
HEROES Act
Making emergency supplemental appropriations for the fiscal year ending September 30, 2020, and for other purposes.
Sponsor: Rep. Lowey, Nita [D-NY-17] (Introduced 05/12/2020)
Public Law 116-136 (H.R. 748) - 116th Congress (2019-2020)
Third Coronavirus Stimulus Package
Sponsor: Rep. Courtney, Joe [D-CT-02]
Public Law 116-260 (H.R. 133) - 116th Congress (2019-2020)
COVID-19 Relief and Fiscal Omnibus
Sponsor: Rep. Cuella, Henry [D-TX-28]
S.1895 - 116th Congress (2019-2020)
Lower Health Care Costs Act
Sponsor: Sen. Alexander, Lamar [R-TN]
Public Law 116-123 (H.R. 6074) - 116th Congress (2019-2020)
Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020
Sponsor: Rep. Lowey, Nita [D-NY-17]
H.R. 5826- - 116th Congress (2019-2020)-Second Session
Consumer Protection Against Surprise Medical Bills Act of 2020
Sponsor: Rep. Neal, Richard [D-MA-01] (Introduced 02/10/2020)
H.R. 6810-116th Congress-Second Session
Health Care Protection Act
Rep. Davis, Rodney [R-IL-13] (Introduced 05/12/2020)
H.R. 6545 - 116th Congress-Second Session
Health Insurance Marketplace Affordability Act of 2020
Sponsor: Rep. Murphy, Stephanie [D-FL-07] (Introduced 04/17/2020)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicare Advantage Audio Only; Medicaid Maternal Coverage; Medicaid FMAP Increase; Coronavirus Medicaid Response.
H.R. 7659- 116th Congress
Ensuring Parity in MA for Audio-Only Telehealth Act of 2020
To amend Title XVIII of the Social Security Act to require the inclusion of certain audio-only diagnoses in the determination of risk adjustment for Medicare Advantage plans, and for other purposes.
Sponsor: Rep. Sewell, Terri [D-AL-07] (Introduced 07/16/2020)
S. 4840- 116th Congress
Ensuring Parity in MA for Audio-Only Telehealth Act of 2020
Sponsor: Sen. Roberts, Pat [R-KS] (Introduced 10/21/2020)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Tax Extenders; ACA Tax credits;
H.R. 748 - 116th Congress (2019-2020)
CARES Act Third Coronavirus Package
Sponsor: Rep. Courtney, Joe [D-CT-02] (Introduced 01/24/2019)
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
3rd Quarter, 2020
In Q3, HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY had in-house lobbyists. The report was filed on Oct. 20, 2020.
Original Filing: 301222230.xml
Lobbying Issues
Opioids; Drug Pricing; COVID-19 Testing
Agencies Lobbied
U.S. Senate
Lobbying Issues
Affordable Care Act (ACA); ACA Regulations; ACA Stabilization; Health Reform; Rural Healthcare; Risk Adjustment; State Flexibility; Opioids; Marketplace Stability; Individual Market Reform; Health Care Costs; Mental Health; Transparency; Interoperability; Surprise billing, State Based Exchange; ACA Outreach, Education, and Enrollment; Prior Authorization; All-payer claims database; Negotiated rate disclosure; Medicare for All; Maternal health; Seniors health care; social determinants of health; Community health, Healthcare access/privacy; Risk Corridors; COBRA; Telehealth/Audio Only; CDC Guidance Testing; COVID-19; Premium Credits; ACA Tax Credits; Black Maternal Health.
H.R.3630 - 116th Congress (2019-2020)
No Surprises Act
Sponsor: Rep. Pallone, Frank, Jr. [D-NJ-6] (Introduced 07/09/2019)
H.R. 6800 - 116th Congress (2019-2020)
HEROES Act
Making emergency supplemental appropriations for the fiscal year ending September 30, 2020, and for other purposes.
Sponsor: Rep. Lowey, Nita [D-NY-17] (Introduced 05/12/2020)
H.R. 5826- - 116th Congress (2019-2020)-Second Session
Consumer Protection Against Surprise Medical Bills Act of 2020
Sponsor: Rep. Neal, Richard [D-MA-01] (Introduced 02/10/2020)
S. 3548 - 116th Congress -Second Session
Coronavirus Aid, Relief, and Economic Security Act
Sponsor: Sen. McConnell, Mitch [R-KY] (Introduced 03/19/2020)
H.R. 6201 - 116th Congress-Second Session
First Coronavirus Response Act
Sponsor: Rep. Lowey, Nita [D-NY-17] (Introduced 03/11/2020)
H.R. 6810-116th Congress-Second Session
Health Care Protection Act
Rep. Davis, Rodney [R-IL-13] (Introduced 05/12/2020)
H.R. 6545 - 116th Congress-Second Session
Health Insurance Marketplace Affordability Act of 2020
Sponsor: Rep. Murphy, Stephanie [D-FL-07] (Introduced 04/17/2020)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicare Advantage; Medicare Prior Authorization; Medicaid Rebates; Medicaid Expansion; Medicaid General; Provider funding; Medicaid FMAP Increase; Coronavirus Medicaid Response.
H.R. 3107 - 116th Congress (2019-2020)
Improving Seniors Timely Access to Care Act of 2019
Rep. DelBene, Suzan [D-WA-01] (Introduced 06/05/2019)
H.R. 7659- 116th Congress (2019-2020)
Ensuring Parity in MA for Audio-Only Telehealth Act of 2020
To amend Title XVIII of the Social Security Act to require the inclusion of certain audio-only diagnoses in the determination of risk adjustment for Medicare Advantage plans, and for other purposes.
Sponsor: Rep. Sewell, Terri [D-AL-07] (Introduced 07/16/2020)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Tax Extenders; ACA Tax credits;
H.R. 748 - 116th Congress (2019-2020)
CARES Act Third Coronavirus Package
Sponsor: Rep. Courtney, Joe [D-CT-02] (Introduced 01/24/2019)
H.R. 3107 - 116th Congress (2019-2020)- First Session
Improving Seniors Timely Access to Care Act of 2019
Rep. Delbene, Suzan [D-WA-01] (Introduced 06/05/2019)
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
2nd Quarter, 2020
In Q2, HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY had in-house lobbyists. The report was filed on July 20, 2020.
Original Filing: 301200105.xml
Lobbying Issues
Opioid; CREATES Act; Drug Pricing; generic drugs; Civica Rx.
H.R.6193 - 116th Congress (2019-2020)-Second Session
Medication Access in Emergencies Act of 2020
Sponsor: Rep. Pappas, Chris [R-NH-1] (Introduced 03/11/2020)
H.R. 5749- 116th Congress-Second Session
Affordable Insulin for All Act
Sponsor: Rep. Christ, Charlie [D-FL-13] (Introduced 02/04/2020)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Affordable Care Act (ACA); ACA Regulations; ACA Stabilization; Health Reform; Rural Healthcare; Risk Adjustment; State Flexibility; Point of Sale; Opioids; Marketplace Stability; Individual Market Reform; Health Care Costs; Mental Health; CREATES Act; Sec. 1332 Waivers; Value-based Care; Health Care Costs; Mental Health; Small Business Plans; Single Payer; Reinsurance; CSRs; SNPs; FEHBP Issues; 42 CFR Part 2; Transparency; Silver-loading; Health IT; Interoperability; Surprise billing, Transparency, Small Business, State Flexibility; Provider Directories; Postal Reform; Health Reimbursement Arrangements (HRAs), State Based Exchange; ACA Outreach, Education, and Enrollment; Prior Authorization; All-payer claims database; Negotiated rate disclosure; Consumer-facing app disclosure; Medicare for All; Medicare Buy-in; Maternal health; Seniors health care; social determinants of health; Community health, Healthcare access/privacy.
H.R.1384 - 116th Congress (2019-2020)
Medicare for All Act of 2019
Sponsor: Rep. Jayapal, Pramila [D-WA-7] (Introduced 02/27/2019)
S.1895 - 116th Congress (2019-2020)
Lower Health Care Costs Act
Sponsor: Sen. Alexander, Lamar [R-TN] (Introduced 06/19/2019)
H.R.2902 - 116th Congress (2019-2020)
Maternal CARE Act
Sponsor: Rep. Adams, Alma S. [D-NC-12] (Introduced 05/22/2019)
H.R.3630 - 116th Congress (2019-2020)
No Surprises Act
Sponsor: Rep. Pallone, Frank, Jr. [D-NJ-6] (Introduced 07/09/2019)
H.R.3439 - 116th Congress (2019-2020)
PATIENT Act
Sponsor: Rep. Beyer, Donald S., Jr. [D-VA-8] (Introduced 06/24/2019)
H.R.2279 - 116th Congress (2019-2020)
Safe Step Act
Sponsor: Rep. Ruiz, Raul [D-CA-36] (Introduced 04/10/2019)
H.R. 2774 - 116th Congress - First Session
Primary Care Patient Protection Act of 2019
Rep. Brad Schneider [D-IL-10] (Introduced 05/15/2019)
H.R. 5826- - 116th Congress (2019-2020)-Second Session
Consumer Protection Against Surprise Medical Bills Act of 2020
Sponsor: Rep. Richard Neal [D-MA-01] (Introduced 02/10/2020)
S. 3548 - 116th Congress -Second Session
Coronavirus Aid, Relief, and Economic Security Act
Sponsor: Sen. Mitch McConnell [R-KY] (Introduced 03/19/2020)
H.R. 6201 - 116th Congress-Second Session
First Coronavirus Response Act
Sponsor: Rep. Nita Lowey [D-NY-17] (Introduced 03/11/2020)
H.R. 6132 - 116th Congress-Second Session
Social Determinants for Moms Act of 2020
Sponsor: Rep. Lucy McBath [D-GA-06] (Introduced 03/09/2020)
H.R. 5800 - 116th Congress-Second Session
Ban Surprise Billing Act
Sponsor: Rep. Scott, Bobby [D-VA-03] (Introduced 02/07/2020)
H.R. 6311-11th Congress- Second Session
Care for COVID-19 Act
Sponsor: Rep. Ruiz, Raul [D-CA-36] (Introduced 03/19/2020)
H.R. 6231-116th Congress- Second Session
Ensuring Access to COVID-19 Preventive Care Act of 2020
Sponsor: Rep. Bucshon, Larry [R-IN-8] (Introduced 03/12/2020)
H.R. 6810-116th Congress-Second Session
Health Care Protection Act
Rep. Davis, Rodney [R-IL-13] (Introduced 05/12/2020)
H.R. 6426-116h Congress-Second Session
To direct the Secretary of Health and Human Services to establish a program under which loans shall be made to certain health care organizations to assist such organization with anticipated revenue loss or higher operating costs as a result of the COVID-19 emergency, and for other purposes.
Sponsor: Rep. Rose, Max [D-NY-11] (Introduced 03/31/2020)
H.R. 6644-116th-Second Session
To require group health plans and health insurance issuers offering group or individual health insurance coverage to provide coverage for services furnished via telehealth if such services would be covered if furnished in-person during the COVID-19 emergency.
Sponsor: Rep. Schrier, Kim [D-WA-8] (Introduced 04/28/2020)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicare Advantage; Medicare Prior Authorization; Medicaid Rebates; Medicaid Expansion; Medicaid General; CHIP Reform; MACRA; Medicare Part D; Medicaid Alignment; Part D Donut Hole, Rx Rebates; Medicare Data Sharing; Privacy; Medicare Prescription drug prices.
H.R. 3107 - 116th Congress (2019-2020)
Improving Seniors Timely Access to Care Act of 2019
Rep. DelBene, Suzan [D-WA-01] (Introduced 06/05/2019)
H.R.4996 - 116th Congress - First Session
Helping MOMS Act of 2019
Rep. Kelly, Robin [D-IL-02] (Introduced 11/08/2019)
H.R. 6583-116th Congress Second Session
To amend title XVIII of the Social Security Act to establish a risk corridor program for Medicare Advantage plans during COVID-19 emergency and for other purposes.
Sponsor: Rep. Houlahan, Chrissy [D-PA-06] (Introduced 04/21/2020)
H.R. 6486 - 116th Congress- Second Session
Care for COVID-19 Act 2.0
Sponsor: Rep. Ruiz, Raul [D-CA-36] (Introduced 04/10/2020)
H.R. 6273-116th Congress-Second Session
Protecting Vulnerable American in Times of Crisis Act of 2020
Sponsor: Rep. Butterfield, G.K. [D-NC-01] (Introduced 03/13/2020)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Health Insurance Tax (HIT Tax); Tax Extenders; ACA Tax Extenders;
H.R. 748 - 116th Congress (2019-2020)
CARES Act Third Coronavirus Package
Sponsor: Rep. Courtney, Joe [D-CT-02] (Introduced 01/24/2019)
H.R. 3107 - 116th Congress (2019-2020)- First Session
Improving Seniors Timely Access to Care Act of 2019
Rep. Suzan Delbene (D-WA-01] (Introduced 06/05/2019)
H.R.6440 - 116th Congress- Second Session
Pandemic Rapid Response Act
Sponsor: Rep. Davis, Rodney [R-IL-13] (Introduced 4/3/2020)
H.R. 6396- 116th Congress-Second Session
Responsible Relief for Americans Act
Sponsor: Rep. Biggs, Andy [R-AZ-05] (Introduced 03/26/2020)
H.R. 6800-116th Congress-Second Session
HEROES Act
Sponsor Rep. Lowey, Nita [D-NY-17] (Introduced 05/12/2020)
H.R. 6514-116th Congress-Second Session
Worker Health Coverage Protection Act
Sponsor: Rep. Scott, Bobby [D-VA-03] (Introduced 04/14/2020)
H.R. 6918-116th Congress-Second Session
Paycheck Recovery Act of 2020
Sponsor: Rep. Jayapal, Pramila [D-WA-07] (Introduced 05/19/2020)
H.R. 6545-116th Congress-Second Session
Health Insurance Marketplace Affordability Act of 2020
Sponsor: Rep. Murphy, Stephanie [D-FL-07] (Introduced 04/17/2020)
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
1st Quarter, 2020
In Q1, HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY had in-house lobbyists. The report was filed on April 20, 2020.
Original Filing: 301176688.xml
Lobbying Issues
Opioids (Epidemic, Deterrence, Treatment); CREATES Act; Drug Pricing; PBM/Prescription Drug Costs; Rx Rebates; Rx Rebates; Biosimilars; Part D Reform; Drug Patents; generic drugs; Drug approval; Civica Rx.
H.R.1781 - 116th Congress (2019-2020)
Payment Commission Data Act of 2019
Sponsor: Rep. Carter, Earl L. "Buddy" [R-GA-1] (Introduced 03/14/2019)
H.R.938 - 116th Congress (2019-2020)
BLOCKING Act of 2019
Sponsor: Rep. Schrader, Kurt [D-OR-5] (Introduced 01/31/2019)
H.R.1499 - 116th Congress (2019-2020)
Protecting Consumer Access to Generic Drugs Act of 2019
Sponsor: Rep. Rush, Bobby L. [D-IL-1] (Introduced 03/05/2019)
H.R.1520 - 116th Congress (2019-2020)
Purple Book Continuity Act of 2019
Sponsor: Rep. Eshoo, Anna G. [D-CA-18](Introduced 3/05/2019)
H.R.1503 - 116th Congress (2019-2020)
Orange Book Transparency Act of 2019
Sponsor: Rep. Kelly, Robin L. [D-IL-2](Introduced 3/5/2019)
H.R.965 - 116th Congress (2019-2020)
CREATES Act of 2019
Sponsor: Rep. Cicilline, David N. [D-RI-1] (Introduced 02/05/2019)
H.R.3 - 116th Congress (2019-2020)
Lower Drug Costs Now Act of 2019
Sponsor: Rep. Pallone, Frank, Jr. [D-NJ-6] (Introduced 09/19/2019)
H.R.275 - 116th Congress (2019-2020)
Medicare Prescription Drug Price Negotiation Act of 2019
Sponsor: Rep. Welch, Peter [D-VT-At Large] (Introduced 01/08/2019)
H.R.448 - 116th Congress (2019-2020)
Medicare Drug Price Negotiation Act
Sponsor: Rep. Cummings, Elijah E. [D-MD-7] (Introduced 01/10/2019)
H.R.1046 - 116th Congress (2019-2020)
Medicare Negotiation and Competitive Licensing Act of 2019
Sponsor: Rep. Doggett, Lloyd [D-TX-35] (Introduced 02/07/2019)
S.3092 - 116th Congress (2019-2020)
Expanding Access to Low-Cost Generics Act of 2019
Sponsor: Sen. Tina Smith (D-MN) (Introduced 12/18/2019)
S.2546 - 116th Congress (2019-2020)
Safe Step Act
Sen. Lisa Murkowski [R-AK] (Introduced 09/25/2019)
S.3374 - 116th Congress - Second Session
Protecting Jessica Grubbs Legacy Act
Sen. Joe Manchin [D-WV] (Introduced 03/03/2020)
H.R. 19 - 116th Congress -First Session
Lower Costs, More Cures Act of 2019
Rep. Greg Walden [R-OR-02] (Introduced 12/09/2019)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Affordable Care Act (ACA); ACA Regulations; ACA Stabilization; Health Reform; Rural Healthcare; Risk Adjustment; State Flexibility; Point of Sale; Opioids; Marketplace Stability; Individual Market Reform; Health Care Costs; Mental Health; CREATES Act; Sec. 1332 Waivers; Value-based Care; Health Care Costs; Mental Health; Small Business Plans; Single Payer; Reinsurance; CSRs; SNPs; FEHBP Issues; 42 CFR Part 2; Transparency; Silverloading; Health IT; Interoperability; Surprise billing, Transparency, Small Business, State Flexibility; Provider Directories; Postal Reform; Health Reimbursement Arrangements (HRAs), State Based Exchange; ACA Outreach, Education, and Enrollment; Prior Authorization; All-payer claims database; Negotiated rate disclosure; Consumer-facing app disclosure; Medicare for All; Medicare Buy-in; Maternal health; Seniors health care; social determinants of health; Community health, Healthcare access/privacy.
H.R.1384 - 116th Congress (2019-2020)
Medicare for All Act of 2019
Sponsor: Rep. Jayapal, Pramila [D-WA-7] (Introduced 02/27/2019)
H.R.3502 - 116th Congress (2019-2020)
Protecting People From Surprise Medical Bills Act
Sponsor: Rep. Ruiz, Raul [D-CA-36] (Introduced 06/26/2019)
S.1895 - 116th Congress (2019-2020)
Lower Health Care Costs Act
Sponsor: Sen. Alexander, Lamar [R-TN] (Introduced 06/19/2019)
H.R.1046 - 116th Congress (2019-2020)
Medicare Negotiation and Competitive Licensing Act of 2019
Sponsor: Rep. Doggett, Lloyd [D-TX-35] (Introduced 02/07/2019)
H.R.2902 - 116th Congress (2019-2020)
Maternal CARE Act
Sponsor: Rep. Adams, Alma S. [D-NC-12] (Introduced 05/22/2019)
H.R.3630 - 116th Congress (2019-2020)
No Surprises Act
Sponsor: Rep. Pallone, Frank, Jr. [D-NJ-6] (Introduced 07/09/2019)
H.R.3439 - 116th Congress (2019-2020)
PATIENT Act
Sponsor: Rep. Beyer, Donald S., Jr. [D-VA-8] (Introduced 06/24/2019)
H.R.3107 - 116th Congress (2019-2020)
Improving Seniors' Timely Access to Care Act of 2019
Sponsor: Rep. DelBene, Suzan K. [D-WA-1] (Introduced 06/05/2019)
H.R.4004 - 116th Congress (2019-2020)
Social Determinants Accelerator Act of 2019
Sponsor: Rep. Bustos, Cheri [D-IL-17] (Introduced 07/25/2019)
H.R.2279 - 116th Congress (2019-2020)
Safe Step Act
Sponsor: Rep. Ruiz, Raul [D-CA-36] (Introduced 04/10/2019)
S. 1895 - 116th Congress (2019-2020)
Lower Health Care Costs Act
Sponsor: Sen. Alexander, Lamar [R-TN](Introduced 06/19/2019)
S2897 - 116th Congress (2019-2020)
Patient-Centered Outcomes Research Institute Reauthorization Act
Sponsor: Sen. Warner, Mark (D-VA) (Introduced 11/19/2019)
H.R. 2774 - 116th Congress - First Session
Primary Care Patient Protection Act of 2019
Rep. Brad Schneider [D-IL-10] (Introduced 05/15/2019)
H.R. 5826- - 116th Congress (2019-2020)-Second Session
Consumer Protection Against Surprise Medical Bills Act of 2020
Sponsor: Rep. Richard Neal [D-MA-01] (Introduced 02/10/2020)
S. 3548 - 116th Congress -Second Session
Coronavirus Aid, Relief, and Economic Security Act
Sponsor: Sen. Mitch McConnell [R-KY] (Introduced 03/19/2020)
H.R. 6201 - 116th Congress-Second Session
First Coronavirus Response Act
Sponsor: Rep. Nita Lowey [D-NY-17] (Introduced 03/11/2020)
H.R. 6005 - 116th Congress (2019-2020)- Second Session
Know the Price Act
Sponsor: Rep. Lucy McBath [D-GA-06] (Introduced 02/27/2020)
H.R. 6132 - 116th Congress-Second Session
Social Determinants for Moms Act of 2020
Sponsor: Rep. Lucy McBath [D-GA-06] (Introduced 03/09/2020)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicare Advantage; Medicare Prior Authorization; Medicaid Rebates; Medicaid Expansion; Medicaid General; CHIP Reform; MACRA; Medicare Part D; Medicaid Alignment; Part D Donut Hole, Rx Rebates; Medicare Data Sharing; Privacy; Medicare Prescription drug prices.
H.R.1781 - 116th Congress (2019-2020)
Payment Commission Data Act of 2019
Sponsor: Rep. Carter, Earl L. "Buddy" [R-GA-1] (Introduced 03/14/2019)
H.R.3 - 116th Congress (2019-2020)
Lower Drug Costs Now Act of 2019
Sponsor: Rep. Pallone, Frank, Jr. [D-NJ-6](Introduced 09/19/2019)
H.R.275 - 116th Congress (2019-2020)
Medicare Prescription Drug Price Negotiation Act of 2019
Sponsor: Rep. Welch, Peter [D-VT-At Large] (Introduced 01/08/2019)
H.R.448 - 116th Congress (2019-2020)
Medicare Drug Price Negotiation Act
Sponsor: Rep. Cummings, Elijah E. [D-MD-7](Introduced 01/10/2019)
H.R.1046 - 116th Congress (2019-2020)
Medicare Negotiation and Competitive Licensing Act of 2019
Sponsor: Rep. Doggett, Lloyd [D-TX-35](Introduced 02/07/2019)
H.R.4629 - 116th Congress (2019-2020)
Star Rating for Biosimilars Act
Sponsor: Rep. Tonko, Paul [D-NY-20](Introduced 10/08/2019)
H.R. 3107 - 116th Congress (2019-2020)
Improving Seniors Timely Access to Care Act of 2019
Rep. DelBene, Suzan [D-WA-01] (Introduced 06/05/2019)
H.R.4996 - 116th Congress - First Session
Helping MOMS Act of 2019
Rep. Kelly, Robin [D-IL-02] (Introduced 11/08/2019)
H.R.5534 - 116th Congress-First Session
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2019
Rep. Kind, Ron [D-WI-03] (Introduced 12/23/2019)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Health Insurance Tax (HIT Tax); Health Reimbursement Arrangements (HRAs); Tax Extenders
H.R. 748 - 116th Congress (2019-2020)
Third Coronavirus Package (CARES Act)
To amend the Internal Revenue Code of 1986 to repeal the exercise tax on high cost employer-sponsored health coverage.
H.R. 3107 - 116th Congress (2019-2020)- First Session
Improving Seniors Timely Access to Care Act of 2019
Rep. Suzan Delbene (D-WA-01] (Introduced 06/05/2019)
H.R.1398 - 116th Congress (2019-2020)
Health Insurance Tax Relief Act of 2019
Sponsor: Rep. Bera, Ami [D-CA-7] (Introduced 02/27/2019)
H.R. 2774 - 116th Congress- First Session
Primary Care Patient Protection Act of 2019
Rep. Brad Schneider [D-IL-10] (Introduced 05/15/2019)
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
4th Quarter, 2019
In Q4, HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY had in-house lobbyists. The report was filed on Jan. 20, 2020.
Original Filing: 301123752.xml
Lobbying Issues
Opioids (Epidemic, Deterrence, Treatment); CREATES Act; Drug Pricing; PBM/Prescription Drug Costs Rx Rebates; Direct-to-Consumer Rx Advertising; Rx Rebates; Biosimilars
H.R.1781 - 116th Congress (2019-2020)
Payment Commission Data Act of 2019
Sponsor: Rep. Carter, Earl L. "Buddy" [R-GA-1] (Introduced 03/14/2019)
H.R.938 - 116th Congress (2019-2020)
BLOCKING Act of 2019
Sponsor: Rep. Schrader, Kurt [D-OR-5] (Introduced 01/31/2019)
H.R.1499 - 116th Congress (2019-2020)
Protecting Consumer Access to Generic Drugs Act of 2019
Sponsor: Rep. Rush, Bobby L. [D-IL-1] (Introduced 03/05/2019)
H.R.1520 - 116th Congress (2019-2020)
Purple Book Continuity Act of 2019
Sponsor: Rep. Eshoo, Anna G. [D-CA-18](Introduced 3/05/2019)
H.R.1503 - 116th Congress (2019-2020)
Orange Book Transparency Act of 2019
Sponsor: Rep. Kelly, Robin L. [D-IL-2](Introduced 3/5/2019)
H.R.965 - 116th Congress (2019-2020)
CREATES Act of 2019
Sponsor: Rep. Cicilline, David N. [D-RI-1] (Introduced 02/05/2019)
H.R.3 - 116th Congress (2019-2020)
Lower Drug Costs Now Act of 2019
Sponsor: Rep. Pallone, Frank, Jr. [D-NJ-6] (Introduced 09/19/2019)
H.R.275 - 116th Congress (2019-2020)
Medicare Prescription Drug Price Negotiation Act of 2019
Sponsor: Rep. Welch, Peter [D-VT-At Large] (Introduced 01/08/2019)
H.R.448 - 116th Congress (2019-2020)
Medicare Drug Price Negotiation Act
Sponsor: Rep. Cummings, Elijah E. [D-MD-7] (Introduced 01/10/2019)
H.R.1046 - 116th Congress (2019-2020)
Medicare Negotiation and Competitive Licensing Act of 2019
Sponsor: Rep. Doggett, Lloyd [D-TX-35] (Introduced 02/07/2019)
S.3092- 116th Congress (2019-2020)
Expanding Access to Low-Cost Generics Act of 2019
Sponsor: Sen. Tina Smith (D-MN) (Introduced 12/18/2019)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Affordable Care Act (ACA); ACA Regulations; ACA Stabilization; Health Reform; Rural Healthcare; Risk Adjustment; State Flexibility; Point of Sale; Opioids; Marketplace Stability; Individual Market Reform; CREATES Act; Sec. 1332 Waivers; Short Term Limited Duration (STLD): AHPs; Value-based Care; Health Care Costs; Mental Health; Small Business Plans; Single Payer; Reinsurance; CSRs; SNPs; FEHBP Issues; 42 CFR Part 2; Transparency; Silverloading; Health IT; Interoperability; Texas lawsuit; Surprise billing, Transparency, Small Business, State Flexibility; Biosimilars; Provider Directories; Postal Reform; Health Reimbursement Arrangements (HRAs), Outreach, Education, and Enrollment; Prior Authorization; All-payer claims database; Negotiated rate disclosure; Consumer-facing app disclosure; Medicare for All; Medicare Buy-in; Maternal health; Seniors health care; social determinants of health; Community health, Cybersecurity.
H.R.1346 - 116th Congress (2019-2020)
Medicare Buy-In and Health Care Stabilization Act of 2019
Sponsor: Rep. Higgins, Brian [D-NY-26] (Introduced 02/25/2019)
H.R.1384 - 116th Congress (2019-2020)
Medicare for All Act of 2019
Sponsor: Rep. Jayapal, Pramila [D-WA-7] (Introduced 02/27/2019)
H.R.3502 - 116th Congress (2019-2020)
Protecting People From Surprise Medical Bills Act
Sponsor: Rep. Ruiz, Raul [D-CA-36] (Introduced 06/26/2019)
H.R.1385 - 116th Congress (2019-2020)
SAVE Act
Sponsor: Rep. Kim, Andy [D-NJ-3] (Introduced 02/27/2019)
H.R.1386 - 116th Congress (2019-2020)
ENROLL Act of 2019
Sponsor: Rep. Castor, Kathy [D-FL-14] (Introduced 02/27/2019)
H.R.987 - 116th Congress (2019-2020)
Strengthening Health Care and Lowering Prescription Drug Costs Act
Sponsor: Rep. Blunt Rochester, Lisa [D-DE- At Large] (Introduced 02/06/2019)
H.R.986 - 116th Congress (2019-2020)
Protecting Americans with Preexisting Conditions Act of 2019
Sponsor: Rep. Kuster, Ann M. [D-NH-2] (Introduced 02/06/2019)
H.R.1425 - 116th Congress (2019-2020)
State Health Care Premium Reduction Act
Sponsor: Rep. Craig, Angie [D-MN-2] (Introduced 02/28/2019)
H.R.1143 - 116th Congress (2019-2020)
Educating Consumers on the Risks of Short-Term Plans Act of 2019
Sponsor: Rep. Eshoo, Anna G. [D-CA-18] (Introduced 02/11/2019)
H.R.1520 - 116th Congress (2019-2020)
Purple Book Continuity Act of 2019
Sponsor: Rep. Eshoo, Anna G. [D-CA-18] (Introduced 03/05/2019)
S.1895 - 116th Congress (2019-2020)
Lower Health Care Costs Act
Sponsor: Sen. Alexander, Lamar [R-TN] (Introduced 06/19/2019)
H.R.1046 - 116th Congress (2019-2020)
Medicare Negotiation and Competitive Licensing Act of 2019
Sponsor: Rep. Doggett, Lloyd [D-TX-35] (Introduced 02/07/2019)
H.R.2902 - 116th Congress (2019-2020)
Maternal CARE Act
Sponsor: Rep. Adams, Alma S. [D-NC-12] (Introduced 05/22/2019)
H.R.3630 - 116th Congress (2019-2020)
No Surprises Act
Sponsor: Rep. Pallone, Frank, Jr. [D-NJ-6] (Introduced 07/09/2019)
H.R.4378 - 116th Congress (2019-2020)
Continuing Appropriations Act, 2020, and Health Extenders Act of 2019
Sponsor: Rep. Lowey, Nita M. [D-NY-17] (Introduced 09/18/2019)
H.R.2328 - 116th Congress (2019-2020)
Community Health Investment, Modernization, and Excellence Act of 2019
Sponsor: Rep. O'Halleran, Tom [D-AZ-1] (Introduced 04/15/2019)
H.R.3439 - 116th Congress (2019-2020)
PATIENT Act
Sponsor: Rep. Beyer, Donald S., Jr. [D-VA-8] (Introduced 06/24/2019)
H.R.3107 - 116th Congress (2019-2020)
Improving Seniors' Timely Access to Care Act of 2019
Sponsor: Rep. DelBene, Suzan K. [D-WA-1] (Introduced 06/05/2019)
H.R.4004 - 116th Congress (2019-2020)
Social Determinants Accelerator Act of 2019
Sponsor: Rep. Bustos, Cheri [D-IL-17] (Introduced 07/25/2019)
H.R.2279 - 116th Congress (2019-2020)
Safe Step Act
Sponsor: Rep. Ruiz, Raul [D-CA-36] (Introduced 04/10/2019)
S. 1895-116th Congress (2019-2020)
Lower Health Care Costs Act
Sponsor: Sen. Alexander, Lamar [R-TN](Introduced 06/19/2019)
S2897-116th Congress (2019-2020)
Patient-Centered Outcomes Research Institute Reauthorization Act
Sponsor: Sen. Warner, Mark (D-VA) (Introduced 11/19/2019)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicare Advantage; Medicare Prior Authorization; Medicaid Rebates; Medicaid Expansion; Medicaid General; CHIP Reform; MACRA; Medicare Part D; Medicaid Alignment; Part D Donut Hole, Rx Rebates; Medicare Data Sharing; Privacy; Medicare Prescription drug prices.
H.R.1781 - 116th Congress (2019-2020)
Payment Commission Data Act of 2019
Sponsor: Rep. Carter, Earl L. "Buddy" [R-GA-1] (Introduced 03/14/2019)
H.R.3 - 116th Congress (2019-2020)
Lower Drug Costs Now Act of 2019
Sponsor: Rep. Pallone, Frank, Jr. [D-NJ-6](Introduced 09/19/2019)
H.R.275 - 116th Congress (2019-2020)
Medicare Prescription Drug Price Negotiation Act of 2019
Sponsor: Rep. Welch, Peter [D-VT-At Large] (Introduced 01/08/2019)
H.R.448 - 116th Congress (2019-2020)
Medicare Drug Price Negotiation Act
Sponsor: Rep. Cummings, Elijah E. [D-MD-7](Introduced 01/10/2019)
H.R.1046 - 116th Congress (2019-2020)
Medicare Negotiation and Competitive Licensing Act of 2019
Sponsor: Rep. Doggett, Lloyd [D-TX-35](Introduced 02/07/2019)
H.R.4629 - 116th Congress (2019-2020)
Star Rating for Biosimilars Act
Sponsor: Rep. Tonko, Paul [D-NY-20](Introduced 10/08/2019)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Health Insurance Tax (HIT Tax); Tax credits; Cadillac Tax; Health Reimbursement Arrangements (HRAs); Sec. 833, Tax Extenders.
S.172 - 116th Congress (2019-2020)
Health Insurance Tax Relief Act of 2019
Sponsor: Sen. Gardner, Cory [R-CO] (Introduced 01/16/2019)
S.684 - 116th Congress (2019-2020)
Middle Class Health Benefits Tax Repeal Act of 2019
Sponsor: Sen. Heinrich, Martin [D-NM] (Introduced 03/06/2019)
H.R.748 - 116th Congress (2019-2020)
Middle Class Health Benefits Tax Repeal Act of 2019
Sponsor: Rep. Courtney, Joe [D-CT-2] (Introduced 01/24/2019)
H.R.1398 - 116th Congress (2019-2020)
Health Insurance Tax Relief Act of 2019
Sponsor: Rep. Bera, Ami [D-CA-7] (Introduced 02/27/2019)
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
3rd Quarter, 2019
In Q3, HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY had in-house lobbyists. The report was filed on Oct. 20, 2019.
Original Filing: 301072998.xml
Lobbying Issues
Opioids (Epidemic, Deterrence, Treatment); CREATES Act; Drug Pricing; PBM/Prescription Drug Costs Rx Rebates; Direct-to-Consumer Rx Advertising; Rx Rebates; Biosimilars
H.R.1781 - 116th Congress (2019-2020)
Payment Commission Data Act of 2019
Sponsor: Rep. Carter, Earl L. "Buddy" [R-GA-1] (Introduced 03/14/2019)
H.R.938 - 116th Congress (2019-2020)
BLOCKING Act of 2019
Sponsor: Rep. Schrader, Kurt [D-OR-5] (Introduced 01/31/2019)
H.R.1499 - 116th Congress (2019-2020)
Protecting Consumer Access to Generic Drugs Act of 2019
Sponsor: Rep. Rush, Bobby L. [D-IL-1] (Introduced 03/05/2019)
H.R.1520 - 116th Congress (2019-2020)
Purple Book Continuity Act of 2019
Sponsor: Rep. Eshoo, Anna G. [D-CA-18](Introduced 3/05/2019)
H.R.1503 - 116th Congress (2019-2020)
Orange Book Transparency Act of 2019
Sponsor: Rep. Kelly, Robin L. [D-IL-2](Introduced 3/5/2019)
H.R.965 - 116th Congress (2019-2020)
CREATES Act of 2019
Sponsor: Rep. Cicilline, David N. [D-RI-1] (Introduced 02/05/2019)
H.R.3 - 116th Congress (2019-2020)
Lower Drug Costs Now Act of 2019
Sponsor: Rep. Pallone, Frank, Jr. [D-NJ-6] (Introduced 09/19/2019)
H.R.275 - 116th Congress (2019-2020)
Medicare Prescription Drug Price Negotiation Act of 2019
Sponsor: Rep. Welch, Peter [D-VT-At Large] (Introduced 01/08/2019)
H.R.448 - 116th Congress (2019-2020)
Medicare Drug Price Negotiation Act
Sponsor: Rep. Cummings, Elijah E. [D-MD-7] (Introduced 01/10/2019)
H.R.1046 - 116th Congress (2019-2020)
Medicare Negotiation and Competitive Licensing Act of 2019
Sponsor: Rep. Doggett, Lloyd [D-TX-35] (Introduced 02/07/2019)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Affordable Care Act (ACA); ACA Regulations; ACA Stabilization; Health Reform; Rural Healthcare; Risk Adjustment; State Flexibility; Point of Sale; Opioids; Marketplace Stability; Individual Market Reform; CREATES Act; Sec. 1332 Waivers; Short Term Limited Duration (STLD): AHPs; Value-based Care; Health Care Costs; Mental Health; Small Business Plans; Single Payer; Reinsurance; CSRs; SNPs; FEHBP Issues; 42 CFR Part 2; Transparency; Silverloading; Health IT; Interoperability; Texas lawsuit; Surprise billing, Transparency, Small Business, State Flexibility; Biosimilars; Provider Directories; Postal Reform; Health Reimbursement Arrangements (HRAs), Outreach, Education, and Enrollment; Prior Authorization; All-payer claims database; Negotiated rate disclosure; Consumer-facing app disclosure; Medicare for All; Medicare Buy-in.
H.R.1346 - 116th Congress (2019-2020)
Medicare Buy-In and Health Care Stabilization Act of 2019
Sponsor: Rep. Higgins, Brian [D-NY-26] (Introduced 02/25/2019)
H.R.1384 - 116th Congress (2019-2020)
Medicare for All Act of 2019
Sponsor: Rep. Jayapal, Pramila [D-WA-7] (Introduced 02/27/2019)
H.R.3502 - 116th Congress (2019-2020)
Protecting People From Surprise Medical Bills Act
Sponsor: Rep. Ruiz, Raul [D-CA-36] (Introduced 06/26/2019)
H.R.2003 - 116th Congress (2019-2020)
Ensuring FEHBP Coverage During Shutdowns Act
Sponsor: Rep. Cummings, Elijah E. [D-MD-7] (Introduced 04/01/2019)
H.R.2004 - 116th Congress (2019-2020)
Ensuring FEDVIP and FLTCIP Coverage During Shutdowns Act
Sponsor: Rep. Cummings, Elijah E. [D-MD-7] (Introduced 04/01/2019)
S.971 - 116th Congress (2019-2020)
Ensuring FEHBP Coverage During Shutdowns Act
Sponsor: Sen. Smith, Tina [D-MN] (Introduced 04/01/2019)
H.R.1385 - 116th Congress (2019-2020)
SAVE Act
Sponsor: Rep. Kim, Andy [D-NJ-3] (Introduced 02/27/2019)
H.R.1386 - 116th Congress (2019-2020)
ENROLL Act of 2019
Sponsor: Rep. Castor, Kathy [D-FL-14] (Introduced 02/27/2019)
H.R.987 - 116th Congress (2019-2020)
Strengthening Health Care and Lowering Prescription Drug Costs Act
Sponsor: Rep. Blunt Rochester, Lisa [D-DE- At Large] (Introduced 02/06/2019)
H.R.986 - 116th Congress (2019-2020)
Protecting Americans with Preexisting Conditions Act of 2019
Sponsor: Rep. Kuster, Ann M. [D-NH-2] (Introduced 02/06/2019)
H.R.1425 - 116th Congress (2019-2020)
State Health Care Premium Reduction Act
Sponsor: Rep. Craig, Angie [D-MN-2] (Introduced 02/28/2019)
H.R.1143 - 116th Congress (2019-2020)
Educating Consumers on the Risks of Short-Term Plans Act of 2019
Sponsor: Rep. Eshoo, Anna G. [D-CA-18] (Introduced 02/11/2019)
H.R.1520 - 116th Congress (2019-2020)
Purple Book Continuity Act of 2019
Sponsor: Rep. Eshoo, Anna G. [D-CA-18] (Introduced 03/05/2019)
S.1895 - 116th Congress (2019-2020)
Lower Health Care Costs Act
Sponsor: Sen. Alexander, Lamar [R-TN] (Introduced 06/19/2019)
H.R.1046 - 116th Congress (2019-2020)
Medicare Negotiation and Competitive Licensing Act of 2019
Sponsor: Rep. Doggett, Lloyd [D-TX-35] (Introduced 02/07/2019)
H.R.1897 - 116th Congress (2019-2020)
MOMMA's Act
Sponsor: Rep. Kelly, Robin L. [D-IL-2] (Introduced 03/27/2019)
H.R.1551 - 116th Congress (2019-2020)
Quality Care for Moms and Babies Act
Sponsor: Rep. Engel, Eliot L. [D-NY-16] (Introduced 03/06/2019)
H.R.2902 - 116th Congress (2019-2020)
Maternal CARE Act
Sponsor: Rep. Adams, Alma S. [D-NC-12] (Introduced 05/22/2019)
H.R.3630 - 116th Congress (2019-2020)
No Surprises Act
Sponsor: Rep. Pallone, Frank, Jr. [D-NJ-6] (Introduced 07/09/2019)
H.R.4378 - 116th Congress (2019-2020)
Continuing Appropriations Act, 2020, and Health Extenders Act of 2019
Sponsor: Rep. Lowey, Nita M. [D-NY-17] (Introduced 09/18/2019)
H.R.2328 - 116th Congress (2019-2020)
Community Health Investment, Modernization, and Excellence Act of 2019
Sponsor: Rep. O'Halleran, Tom [D-AZ-1] (Introduced 04/15/2019)
H.R.3439 - 116th Congress (2019-2020)
PATIENT Act
Sponsor: Rep. Beyer, Donald S., Jr. [D-VA-8] (Introduced 06/24/2019)
H.R.3107 - 116th Congress (2019-2020)
Improving Seniors' Timely Access to Care Act of 2019
Sponsor: Rep. DelBene, Suzan K. [D-WA-1] (Introduced 06/05/2019)
H.R.4004 - 116th Congress (2019-2020)
Social Determinants Accelerator Act of 2019
Sponsor: Rep. Bustos, Cheri [D-IL-17] (Introduced 07/25/2019)
H.R.2279 - 116th Congress (2019-2020)
Safe Step Act
Sponsor: Rep. Ruiz, Raul [D-CA-36] (Introduced 04/10/2019)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicare Advantage; Medicare Prior Authorization; Medicaid Rebates; Medicaid Expansion; Medicaid General; CHIP Reform; MACRA; Medicare Part D; Medicaid Alignment; Part D Donut Hole, Rx Rebates; Medicare Data Sharing; Privacy; Medicare Prescription drug prices.
H.R.1781 - 116th Congress (2019-2020)
Payment Commission Data Act of 2019
Sponsor: Rep. Carter, Earl L. "Buddy" [R-GA-1] (Introduced 03/14/2019)
H.R.3 - 116th Congress (2019-2020)
Lower Drug Costs Now Act of 2019
Sponsor: Rep. Pallone, Frank, Jr. [D-NJ-6](Introduced 09/19/2019)
H.R.275 - 116th Congress (2019-2020)
Medicare Prescription Drug Price Negotiation Act of 2019
Sponsor: Rep. Welch, Peter [D-VT-At Large](Introduced 01/08/2019)
H.R.448 - 116th Congress (2019-2020)
Medicare Drug Price Negotiation Act
Sponsor: Rep. Cummings, Elijah E. [D-MD-7](Introduced 01/10/2019)
H.R.1046 - 116th Congress (2019-2020)
Medicare Negotiation and Competitive Licensing Act of 2019
Sponsor: Rep. Doggett, Lloyd [D-TX-35](Introduced 02/07/2019)
H.R.4629 - 116th Congress (2019-2020)
Star Rating for Biosimilars Act
Sponsor: Rep. Tonko, Paul [D-NY-20](Introduced 10/08/2019)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Health Insurance Tax (HIT Tax); Tax credits; Cadillac Tax; Health Reimbursement Arrangements (HRAs).
S.172 - 116th Congress (2019-2020)
Health Insurance Tax Relief Act of 2019
Sponsor: Sen. Gardner, Cory [R-CO] (Introduced 01/16/2019)
S.684 - 116th Congress (2019-2020)
Middle Class Health Benefits Tax Repeal Act of 2019
Sponsor: Sen. Heinrich, Martin [D-NM] (Introduced 03/06/2019)
H.R.748 - 116th Congress (2019-2020)
Middle Class Health Benefits Tax Repeal Act of 2019
Sponsor: Rep. Courtney, Joe [D-CT-2] (Introduced 01/24/2019)
H.R.1398 - 116th Congress (2019-2020)
Health Insurance Tax Relief Act of 2019
Sponsor: Rep. Bera, Ami [D-CA-7] (Introduced 02/27/2019)
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
2nd Quarter, 2019
In Q2, HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY had in-house lobbyists. The report was filed on July 19, 2019.
Original Filing: 301051733.xml
Lobbying Issues
Opioids (Epidemic, Deterrence, Treatment); CREATES Act; Drug Pricing; PBM/Prescription Drug Costs Rx Rebates; Direct-to-Consumer Rx Advertising; Rx Rebates; Biosimilars
H.R.1781 - 116th Congress (2019-2020)
Payment Commission Data Act of 2019
Sponsor: Rep. Carter, Earl L. "Buddy" [R-GA-1] (Introduced 03/14/2019)
H.R.938 - 116th Congress (2019-2020)
BLOCKING Act of 2019
Sponsor: Rep. Schrader, Kurt [D-OR-5] (Introduced 01/31/2019)
H.R.1499 - 116th Congress (2019-2020)
Protecting Consumer Access to Generic Drugs Act of 2019
Sponsor: Rep. Rush, Bobby L. [D-IL-1] (Introduced 03/05/2019)
H.R.1520 - 116th Congress (2019-2020)
Purple Book Continuity Act of 2019
Sponsor: Rep. Eshoo, Anna G. [D-CA-18](Introduced 3/05/2019)
H.R.1503 - 116th Congress (2019-2020)
Orange Book Transparency Act of 2019
Sponsor: Rep. Kelly, Robin L. [D-IL-2] (Introduced 3/5/2019)
H.R.965 - 116th Congress (2019-2020)
CREATES Act of 2019
Sponsor: Rep. Cicilline, David N. [D-RI-1] (Introduced 02/05/2019)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Affordable Care Act (ACA); ACA Regulations; ACA Stabilization; Health Reform; Rural Healthcare; Risk Adjustment; State Flexibility; Point of Sale; Opioids; Marketplace Stability; Individual Market Reform; CREATES Act; Sec. 1332 Waivers; Short Term Limited Duration (STLD): AHPs; Value-based Care; Health Care Costs; Mental Health; Small Business Plans; Single Payer; Reinsurance; CSRs; SNPs; FEHBP Issues; 42 CFR Part 2; Transparency; Silverloading; Health IT; Interoperability; Texas lawsuit; Surprise billing, Transparency, Small Business, State Flexibility; Biosimilars; Provider Directories; Postal Reform; Health Reimbursement Arrangements (HRAs), Outreach, Education, and Enrollment; Prior Authorization; All-payer claims database; Negotiated rate disclosure; Consumer-facing app disclosure; Medicare for All; Medicare Buy-in.
H.R.1346 - 116th Congress (2019-2020)
Medicare Buy-In and Health Care Stabilization Act of 2019
Sponsor: Rep. Higgins, Brian [D-NY-26] (Introduced 02/25/2019)
H.R.1384 - 116th Congress (2019-2020)
Medicare for All Act of 2019
Sponsor: Rep. Jayapal, Pramila [D-WA-7] (Introduced 02/27/2019)
H.R.3502 - 116th Congress (2019-2020)
Protecting People From Surprise Medical Bills Act
Sponsor: Rep. Ruiz, Raul [D-CA-36] (Introduced 06/26/2019)
H.R.2003 - 116th Congress (2019-2020)
Ensuring FEHBP Coverage During Shutdowns Act
Sponsor: Rep. Cummings, Elijah E. [D-MD-7] (Introduced 04/01/2019)
H.R.2004 - 116th Congress (2019-2020)
Ensuring FEDVIP and FLTCIP Coverage During Shutdowns Act
Sponsor: Rep. Cummings, Elijah E. [D-MD-7] (Introduced 04/01/2019)
S.971 - 116th Congress (2019-2020)
Ensuring FEHBP Coverage During Shutdowns Act
Sponsor: Sen. Smith, Tina [D-MN] (Introduced 04/01/2019)
H.R.1385 - 116th Congress (2019-2020)
SAVE Act
Sponsor: Rep. Kim, Andy [D-NJ-3] (Introduced 02/27/2019)
H.R.1386 - 116th Congress (2019-2020)
ENROLL Act of 2019
Sponsor: Rep. Castor, Kathy [D-FL-14] (Introduced 02/27/2019)
H.R.987 - 116th Congress (2019-2020)
Strengthening Health Care and Lowering Prescription Drug Costs Act
Sponsor: Rep. Blunt Rochester, Lisa [D-DE- At Large] (Introduced 02/06/2019)
H.R.986 - 116th Congress (2019-2020)
Protecting Americans with Preexisting Conditions Act of 2019
Sponsor: Rep. Kuster, Ann M. [D-NH-2] (Introduced 02/06/2019)
H.R.1425 - 116th Congress (2019-2020)
State Health Care Premium Reduction Act
Sponsor: Rep. Craig, Angie [D-MN-2] (Introduced 02/28/2019)
H.R.1143 - 116th Congress (2019-2020)
Educating Consumers on the Risks of Short-Term Plans Act of 2019
Sponsor: Rep. Eshoo, Anna G. [D-CA-18] (Introduced 02/11/2019)
H.R.1520 - 116th Congress (2019-2020)
Purple Book Continuity Act of 2019
Sponsor: Rep. Eshoo, Anna G. [D-CA-18] (Introduced 03/05/2019)
S.1895 - 116th Congress (2019-2020)
Lower Health Care Costs Act
Sponsor: Sen. Alexander, Lamar [R-TN] (Introduced 06/19/2019)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicare Advantage; Medicare Prior Authorization; Medicaid Rebates; Medicaid Expansion; Medicaid General; CHIP Reform; MACRA; Medicare Part D; Medicaid Alignment; Part D Donut Hole, Rx Rebates; Medicare Data Sharing; Privacy.
H.R.1781 - 116th Congress (2019-2020)
Payment Commission Data Act of 2019
Sponsor: Rep. Carter, Earl L. "Buddy" [R-GA-1] (Introduced 03/14/2019)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Health Insurance Tax (HIT Tax); Tax credits; Cadillac Tax; Health Reimbursement Arrangements (HRAs).
S.172 - 116th Congress (2019-2020)
Health Insurance Tax Relief Act of 2019
Sponsor: Sen. Gardner, Cory [R-CO] (Introduced 01/16/2019)
S.684 - 116th Congress (2019-2020)
Middle Class Health Benefits Tax Repeal Act of 2019
Sponsor: Sen. Heinrich, Martin [D-NM] (Introduced 03/06/2019)
H.R.748 - 116th Congress (2019-2020)
Middle Class Health Benefits Tax Repeal Act of 2019
Sponsor: Rep. Courtney, Joe [D-CT-2] (Introduced 01/24/2019)
H.R.1398 - 116th Congress (2019-2020)
Health Insurance Tax Relief Act of 2019
Sponsor: Rep. Bera, Ami [D-CA-7] (Introduced 02/27/2019)
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
1st Quarter, 2019
In Q1, HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY had in-house lobbyists. The report was filed on April 21, 2019.
Original Filing: 301033082.xml
Lobbying Issues
Opioids (Epidemic, Deterrence, Treatment); CREATES Act; Drug Pricing; PBM/Prescription Drug Costs Rx Rebates; Direct-to-Consumer Rx Advertising; Rx Rebates; Biosimilars
H.R.1781 - 116th Congress (2019-2020)
Payment Commission Data Act of 2019
Sponsor: Rep. Carter, Earl L. "Buddy" [R-GA-1] (Introduced 03/14/2019)
H.R.938 - 116th Congress (2019-2020)
BLOCKING Act of 2019
Sponsor: Rep. Schrader, Kurt [D-OR-5] (Introduced 01/31/2019
H.R.1499 - 116th Congress (2019-2020)
Protecting Consumer Access to Generic Drugs Act of 2019
Sponsor: Rep. Rush, Bobby L. [D-IL-1] (Introduced 03/05/2019)
H.R.965 - 116th Congress (2019-2020)
CREATES Act of 2019
Sponsor: Rep. Cicilline, David N. [D-RI-1] (Introduced 02/05/2019)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Affordable Care Act (ACA); ACA Regulations; ACA Stabilization; Health Reform; Rural Healthcare; Risk Adjustment; State Flexibility; Point of Sale; Opioids; Marketplace Stability; Individual Market Reform; CREATES Act; Sec. 1332 Waivers; Short Term Limited Duration (STLD): AHPs; Value-based Care; Health Care Costs; Mental Health; Small Business Plans; Single Payer; Reinsurance; CSRs; SNPs; FEHBP Issues; 42 CFR Part 2; Transparency; Silverloading; Health IT; Interoperability; Texas lawsuit; Surprise billing, Transparency, Small Business, State Flexibility; Biosimilars; Provider Directories; Postal Reform; Health Reimbursement Arrangements (HRAs).
H.R.2003 - 116th Congress (2019-2020)
Ensuring FEHBP Coverage During Shutdowns Act
Sponsor: Rep. Cummings, Elijah E. [D-MD-7] (Introduced 04/01/2019)
H.R.2004 - 116th Congress (2019-2020)
Ensuring FEDVIP and FLTCIP Coverage During Shutdowns Act
Sponsor: Rep. Cummings, Elijah E. [D-MD-7] (Introduced 04/01/2019)
S.971 - 116th Congress (2019-2020)
Ensuring FEHBP Coverage During Shutdowns Act
Sponsor: Sen. Smith, Tina [D-MN] (Introduced 04/01/2019)
H.R.1385 - 116th Congress (2019-2020)
SAVE Act
Sponsor: Rep. Kim, Andy [D-NJ-3] (Introduced 02/27/2019)
H.R.1386 - 116th Congress (2019-2020)
ENROLL Act of 2019
Sponsor: Rep. Castor, Kathy [D-FL-14] (Introduced 02/27/2019)
H.R.987 - 116th Congress (2019-2020)
MORE Health Education Act
Sponsor: Rep. Blunt Rochester, Lisa [D-DE- At Large] (Introduced 02/06/2019)
H.R.986 - 116th Congress (2019-2020)
Protecting Americans with Preexisting Conditions Act of 2019
Sponsor: Rep. Kuster, Ann M. [D-NH-2] (Introduced 02/06/2019)
H.R.1425 - 116th Congress (2019-2020)
State Health Care Premium Reduction Act
Sponsor: Rep. Craig, Angie [D-MN-2] (Introduced 02/28/2019)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicare Advantage; Medicare Prior Authorization; Medicaid Rebates; Medicaid Expansion; Medicaid General; CHIP Reform; MACRA; Medicare Part D; Medicaid Alignment; Part D Donut Hole, Rx Rebates; Medicare Data Sharing; Privacy.
H.R.1781 - 116th Congress (2019-2020)
Payment Commission Data Act of 2019
Sponsor: Rep. Carter, Earl L. "Buddy" [R-GA-1] (Introduced 03/14/2019)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Health Insurance Tax (HIT Tax); Cadillac Tax; Health Reimbursement Arrangements (HRAs).
S.172 - 116th Congress (2019-2020)
Health Insurance Tax Relief Act of 2019
Sponsor: Sen. Gardner, Cory [R-CO] (Introduced 01/16/2019)
S.684 - 116th Congress (2019-2020)
Middle Class Health Benefits Tax Repeal Act of 2019
Sponsor: Sen. Heinrich, Martin [D-NM] (Introduced 03/06/2019)
H.R.748 - 116th Congress (2019-2020)
Middle Class Health Benefits Tax Repeal Act of 2019
Sponsor: Rep. Courtney, Joe [D-CT-2] (Introduced 01/24/2019)
H.R.1398 - 116th Congress (2019-2020)
Health Insurance Tax Relief Act of 2019
Sponsor: Rep. Bera, Ami [D-CA-7] (Introduced 02/27/2019)
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2018
In Q4, HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY had in-house lobbyists. The report was filed on Jan. 20, 2019.
Original Filing: 301011168.xml
Lobbying Issues
Opioids Epidemic; CREATES Act; Substance use disorders; Drug Pricing; PBM/Prescription Drug Costs. Rx Rebates.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Affordable Care Act (ACA); ACA Regulations; ACA Stabilization; Health Reform; Rural Healthcare; Risk Adjustment; State Flexibility; Point of Sale; Opioids; Sober Homes; Marketplace Stability; Individual Market Reform; FAA (Air Ambulance); CREATES Act; Sec. 1332 Waivers; Short Term Limited Duration (STLD): AHPs; Value-based Care; Health Care Costs; Mental Health; Small Business Plans; Single Payer; Reinsurance; CSRs; SNPs; Health Savings Accounts (HSAs); Postal Reform; 42 CFR Part 2; Transparency; Fall Priorities.
HR 6 SUPPORT for Patients and Communities Act Introduced June 13, 2018 by Greg Walden (R-OR) includes Medicaid, Medicare, and public health reforms to combat the opioid crisis by advancing treatment and recovery initiatives, improving prevention, protecting communities, and bolstering efforts to combat illicit synthetic drugs like fentanyl. The policies contained in the legislation were advanced through regular order by the House Energy and Commerce Committee and the Ways and Means Committee.
HR 2051 FAST Generics Act Introduced April 6, 2017 by David McKinley (R-WV) To amend the Federal Food, Drug, and Cosmetic Act to ensure that eligible product developers have competitive access to approved drugs and licensed biological products, so as to enable eligible product developers to develop and test new products, and for other purposes.
HR 2212 CREATES Act Introduced April 27, 2017 by Tom Marino (R-PA) To promote competition in the market for drugs and biological products by facilitating the timely entry of lower-cost generic and biosimilar versions of those drugs and biological products.
HR 3325 ACE Kids Act Introduced July 20, 2017 by Joe Barton (R-TX) To amend title XIX of the Social Security Act to provide States with the option of providing coordinated care for children with complex medical conditions through a health home, and for other purposes.
HR 6733 Know the Cost Act of 2018 Introduced September 7, 2018 by Buddy Carter (R-GA) To amend title XXVII of the Public Health Service Act and title XVIII of the Social Security Act to prohibit group health plans, health insurance issuers, prescription drug plan sponsors, and Medicare Advantage organizations from limiting certain information on drug prices.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicare Advantage; Medicare Prior Authorization; Medicaid Rebates; Medicaid Expansion; Medicaid General; CHIP Reform; Medicare Access & CHIP Reauthorization Act of 2015 (MACRA); Medicare Part D; Medicaid Alignment; Part D Donut Hole, Rx Rebates, Patients Act (Dialysis), ACE Kids Act.
HR 6 SUPPORT for Patients and Communities Act Introduced June 13, 2018 by Greg Walden (R-OR) includes Medicaid, Medicare, and public health reforms to combat the opioid crisis by advancing treatment and recovery initiatives, improving prevention, protecting communities, and bolstering efforts to combat illicit synthetic drugs like fentanyl. The policies contained in the legislation were advanced through regular order by the House Energy and Commerce Committee and the Ways and Means Committee.
HR 3325 ACE Kids Act Introduced July 20, 2017 by Joe Barton (R-TX) To amend title XIX of the Social Security Act to provide States with the options of providing coordinated care for children with complex medical conditions through a health home, and for other purposes.
HR 4143 Dialysis Patients Demonstration Act of 2017 Introduced October 26, 2017 by Jason Smith (R-MO) To establish a demonstration program to provide integrated care for Medicare beneficiaries with end-stage renal disease, and for other purposes.
HR 6478 Biosimilars Competition Act of 2018 Introduced July 23, 2018 by John Sarbanes (D-MD) To enhance competition for prescription drugs by increasing the ability of the Department of Justice and Federal Trade Commission to enforce existing antitrust laws regarding biologic and biosimilar products, and for other purposes.
S 2554 Patient Right to Know Drug Price Act of 2018 Introduced March 14, 2018 by Susan Collins (R-ME) Americans overspend by an estimated $135 million on prescriptions through their insurance, in cases when they would cost less out of pocket. Yet pharmacists are often under gag orders from telling customers about that discrepancy. A new bill introduced in the Senate would end this practice.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Health Insurance Tax (HIT Tax); Tax Credits; Cadillac Tax
HR 173 Middle Class Health Benefit Tax Repeal Act Introduced January 3, 2-17 by Mike Kelly (R-PA) To amend the Internal Revenue Code of 1986 to repeal the excise tax on high cost employer-sponsored health coverage.
HR 246 Introduced January 4, 2017 by Kristi Noem (R-SD) This bill repeals a provision of the Patient Protection and Affordable Care Act that imposes an annual fee on a health insurance provider based on its net premium income.
S 3063 Introduced June 13, 2018 by John Barrasso (R-WY) A bill to delay the reimposition of the annual fee on health insurance providers until after 2020.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
3rd Quarter, 2018
In Q3, HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY had in-house lobbyists. The report was filed on Oct. 22, 2018.
Original Filing: 300995318.xml
Lobbying Issues
Opioid Epidemic; CREATES Act; Substance abuse disorders; PBM/Prescription Drug pricing. Rx Rebates.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Affordable Care Act (ACA); ACA Regulations; ACA Stabilization; Health Reform; Rural Healthcare; Risk Adjustment; State Flexibility; Point of Sale; Opioids; Sober Homes; Marketplace Stability; Individual Market Reform; FAA (Air Ambulance); CREATES Act; Sec. 1332 Waivers; Short Term Limited Duration (STLD): AHPs; Value-based Care; Health Care Costs; Mental Health; Small Business Plans; Single Payer; Reinsurance; CSRs; SNPs; Health Savings Accounts (HSAs); Postal Reform; 42 CFR Part 2; Transparency.
HR 4 FAA Reauthorization Act of 2018 Introduced April 13, 2018 by Bill Shuster (R-PA) Air Ambulance issues.
HR 6 SUPPORT for Patients and Communities Act Introduced June 13, 2018 by Greg Walden (R-OR) includes Medicaid, Medicare, and public health reforms to combat the opioid crisis by advancing treatment and recovery initiatives, improving prevention, protecting communities, and bolstering efforts to combat illicit synthetic drugs like fentanyl. The policies contained in the legislation were advanced through regular order by the House Energy and Commerce Committee and the Ways and Means Committee.
HR 2051 FAST Generics Act Introduced April 6, 2017 by David McKinley (R-WV) To amend the Federal Food, Drug, and Cosmetic Act to ensure that eligible product developers have competitive access to approved drugs and licensed biological products, so as to enable eligible product developers to develop and test new products, and for other purposes.
HR 2212 CREATES Act Introduced April 27, 2017 by Tom Marino (R-PA) To promote competition in the market for drugs and biological products by facilitating the timely entry of lower-cost generic and biosimilar versions of those drugs and biological products.
HR 6082 Overdose Prevention and Patient Safety Act Introduced June 13, 2018 by Markwayne Mullin (R-OK) Amends the Public Health Service Act to permit substance use disorder (SUD) records to be shared among covered entities and Part 2 programs in accordance with the Health Insurance Portability and Accountability Act of 1996 (HIPAA), for the purposes of treatment, payment, and healthcare operations. In order to protect individuals seeking and receiving SUD treatment, the bill enhances the protections on the disclosure of SUD treatment records to non-covered entities and non-Part 2 programs by, except for authorization by court order or by consent of the patient, prohibiting the use of these records in any criminal, civil, or administrative investigations, actions, or proceedings. The legislation increases the penalties in the event of unlawful disclosure of SUD treatment records and establishes breach notification requirements in accordance with the Health Information Technology for Economic and Clinical Health (HITECH) Act. Finally, the bill requires the Secretary of Health and Human Services to issue regulations prohibiting discrimination based on data disclosed from such medical records, to issue regulations requiring covered entities to provide written notice of privacy practices, and to develop model training programs and materials for health care providers and patients and their families.
HR 6733 Know the Cost Act of 2018 Introduced September 7, 2018 by Buddy Carter (R-GA) To amend title XXVII of the Public Health Service Act and title XVIII of the Social Security Act to prohibit group health plans, health insurance issuers, prescription drug plan sponsors, and Medicare Advantage organizations from limiting certain information on drug prices.
S 974 Creating and Restoring Equal Access to Equivalent Samples Act of 2018 Introduced April 27, 2017 by Patrick Leahy (D-VT). A bill to promote competition in the market for drugs and biological products by facilitating the timely entry of lower-cost generic and biosimilar versions of those drugs and biological products.
S 1354 Individual Health Insurance Marketplace Improvement Act introduced June 14, 2017 by Thomas Carper (D-DE) A bill to establish an Individual Market Reinsurance fund to provide funding for State individual market stabilization reinsurance programs.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicare Advantage; Medicare Prior Authorization; Medicaid Rebates; Medicaid Expansion; CHIP Reform; Medicare Access & CHIP Reauthorization Act of 2015 (MACRA); Medicare Part D; Medicaid Alignment.
HR 6 SUPPORT for Patients and Communities Act Introduced June 13, 2018 by Greg Walden (R-OR) includes Medicaid, Medicare, and public health reforms to combat the opioid crisis by advancing treatment and recovery initiatives, improving prevention, protecting communities, and bolstering efforts to combat illicit synthetic drugs like fentanyl. The policies contained in the legislation were advanced through regular order by the House Energy and Commerce Committee and the Ways and Means Committee.
HR 4143 Dialysis Patients Demonstration Act of 2017 Introduced October 26, 2017 by Jason Smith (R-MO) To establish a demonstration program to provide integrated care for Medicare beneficiaries with end-stage renal disease, and for other purposes.
HR 6478 Biosimilars Competition Act of 2018 Introduced July 23, 2018 by John Sarbanes (D-MD) To enhance competition for prescription drugs by increasing the ability of the Department of Justice and Federal Trade Commission to enforce existing antitrust laws regarding biologic and biosimilar products, and for other purposes.
S 2554 Patient Right to Know Drug Price Act of 2018 Introduced March 14, 2018 by Susan Collins (R-ME) Americans overspend by an estimated $135 million on prescriptions through their insurance, in cases when they would cost less out of pocket. Yet pharmacists are often under gag orders from telling customers about that discrepancy. A new bill introduced in the Senate would end this practice.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Health Insurance Tax (HIT Tax); Tax Credits
HR 173 Middle Class Health Benefit Tax Repeal Act Introduced January 3, 2-17 by Mike Kelly (R-PA) To amend the Internal Revenue Code of 1986 to repeal the excise tax on high cost employer-sponsored health coverage.
HR 246 Introduced January 4, 2017 by Kristi Noem (R-SD) This bill repeals a provision of the Patient Protection and Affordable Care Act that imposes an annual fee on a health insurance provider based on its net premium income.
HR 5963 Introduced May 24, 2018 by Kristi Noem (R-SD)To delay the reimposition of the annual fee on health insurance providers until after 2020.
S 3063 Introduced June 13, 2018 by John Barrasso (R-WY) A bill to delay the reimposition of the annual fee on health insurance providers until after 2020.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
2nd Quarter, 2018
In Q2, HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY had in-house lobbyists. The report was filed on July 20, 2018.
Original Filing: 300977213.xml
Lobbying Issues
Opioid Epidemic; Substance abuse disorders; PBM/Prescription Drug pricing.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Affordable Care Act (ACA); ACA Regulations; ACA Stabilization; Health Savings Accounts (HSA); Small Group Market Reform; Short Term Limited Duration (STLD); Cost-sharing Reduction (CSR); Reinsurance; Risk Adjustment; Market Stability; Drug Pricing; Individual Market Reform; CREATES ACT; Health Insurance Tax (HIT); Affordability; Individual Market Rules; Small Group Market; Postal Reform; Association of Health Plans Opioid Epidemic; State Flexibility; Pay-fors; 42 CFR Part 2.
HR 246 Introduced January 4, 2017 by Kristi Noem (R-SD) This bill repeals a provision of the Patient Protection and Affordable Care Act that imposes an annual fee on a health insurance provider based on its net premium income.
HR 314 Introduced January 5, 2017 by Marsha Blackburn (R-TN) To repeal title I of the Patient Protection and Affordable Care Act and to amend the Public Health Service Act to provide for cooperative governing of individual health insurance coverage offered in interstate commerce.
HR 1703 Introduced March 23, 2017 by Morgan Griffith (R-VA) To amend the Federal Food, Drug, and Cosmetic Act with respect to determining the intended use of drugs and devices.
HR 2051 FAST Generics Act Introduced April 6, 2017 by David McKinley (R-WV) To amend the Federal Food, Drug, and Cosmetic Act to ensure that eligible product developers have competitive access to approved drugs and licensed biological products, so as to enable eligible product developers to develop and test new products, and for other purposes.
HR 2430 Introduced May 10, 2017 by Greg Walden (R-OR) To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs, medical devices, generic drugs, and biosimilar biological products, and for other purposes.
HR 1101 Small Business Health Fairness Act of 2017 Introduced February 16, 2017 by Sam Johnson (R-TX) To amend title I of the Employee Retirement Income Security Act of 1974 to improve access and choice for entrepreneurs with small businesses with respect to medical care for their employees.
HR 708 Introduced January 27, 2017 by Larry Bucshon (R-IN) This bill amends the Public Health Service Act to increase the permissible variation based on age for health insurance premiums for coverage offered in the individual or small group market from a factor of three to a factor of five, or to a factor determined by the state. This applies to plan years starting on or after January 1, 2018.
HR 3922 Championing Healthy Kids Act Introduced October 3, 2017 by Greg Walden (R-OR) Extends funding for the Childrens Health Insurance Program (CHIP) through Fiscal Year (FY) 2022, Federally Qualified Health Centers (FQHCs) through FY2019, and revises CHIP and Medicaid.
HR 2212 CREATES Act Introduced April 27, 2017 by Tom Marino (R-PA) To promote competition in the market for drugs and biological products by facilitating the timely entry of lower-cost generic and biosimilar versions of those drugs and biological products.
HR 1409 Cancer Drug Parity Act of 2017 Introduced March 7, 2017 by Leonard Lance (R-NJ) To amend the Public Health Service Act to require group and individual health insurance coverage and group health plans to provide for cost sharing for oral anticancer drugs on terms no less favorable than the cost sharing provided for anticancer medications administered by a health care provider.
HR 749 Lower Drug Cost Through Competition Act Introduced January 30, 2017 by Kurt Schrader (D-OR) To increase competition in the pharmaceutical industry.
HR 4666 Premium Relief Act Introduced December 18, 2017 by Ryan Costello (R-PA) To amend the Public Health Service Act to provide for a Patient and State Stability Fund.
HR 3976 Access to Marketplace Insurance Act Introduced October 5, 2017 by Kevin Cramer (R-ND) To amend the Patient Protection and Affordable Care Act to allow for certain third-party payments.
HR 6 SUPPORT for Patients and Communities Act Introduced June 13, 2018 by Greg Walden (R-OR) includes Medicaid, Medicare, and public health reforms to combat the opioid crisis by advancing treatment and recovery initiatives, improving prevention, protecting communities, and bolstering efforts to combat illicit synthetic drugs like fentanyl. The policies contained in the legislation were advanced through regular order by the House Energy and Commerce Committee and the Ways and Means Committee.
HR 5806 21st Century Tools for Pain and Addiction Treatment Act Introduced May 15, 2018 by Michael Burgess(R-TX) To require the Secretary of Health and Human Services to issue guidance with respect to the expedited approval of certain drugs, and for other purposes.
HR 5808 Medicaid Pharmaceutical Home Act of 2018 Introduced May 15, 2018 by Gus Bilirakis (R-FL) To amend title XIX of the Social Security Act to require States to operate drug management programs for at-risk beneficiaries, and for other purposes.
HR 5810 Medicaid Health Homes for Opioid-Use-Disorder Medicaid Enrollees Encouraged Act Introduced May 15, 2018 by Leonard Lance (R-NJ) To amend title XIX of the Social Security Act to provide for an extension of the enhanced FMAP for certain Medicaid health homes for individuals with substance use disorders.
HR 5796 Responsible Education Achieves Care and Healthy Outcomes for Users Treatment Act of 2018 Introduced May 15, 2018 by Brian Fitzpatrick (R-PA) To require the Secretary of Health and Human Services to provide grants for eligible entities to provide technical assistance to outlier prescribers of opioids, and for other purposes.
HR 5590 Opioid Addiction Action Plan Act Introduced April 24, 2018 by Adam Kinzinger (R-IL) To require the Secretary of Health and Human Services to provide for an action plan on recommendations for changes under Medicare and Medicaid to prevent opioids addictions and enhance access to medication-assisted treatment, and for other purposes.
HR 4684 Ensuring Access to Quality Sober Living Act of 2018 Introduced December 19, 2017 by Judy Chu (D-CA) Authorizes the Substance Abuse and Mental Health Services Administration to develop, publish, and disseminate best practices for operating recovery housing that promotes a safe environment and sustained recovery from substance use disorders. Recovery housing is increasingly recognized as critical to recovery for many individuals, and includes activities and programs such as mediation, one-on one counseling, group sessions, peer recovery support, medication management, spiritual engagement, and others.
HR 5580 STOP Fentanyl Deaths Act of 2018 Introduced April 23, 2018 by Ann Kuster (D-NH) To authorize the Secretary of Health and Human Services to conduct programs to address the usage of illicit drugs, particularly fentanyl, and for other purposes.
HR 5587 Peer Support Communities of Recovery Act Introduced April 23, 2018 by Ben Lujan (D-NM) enhances the Comprehensive Addiction and Recovery Acts Building Communities of Recovery Program and authorizes the Department of Health and Human Services (HHS) to award grants to peer support specialist organizations for the development and expansion of recovery services. Grants shall be awarded to nonprofit organizations that support community-based, peer delivered support, including technical support for the establishment of recovery community organizations, independent, nonprofit groups led by people in recovery and their families.
HR 5795 Overdose Prevention and Patient Safety Act Introduced May 15, 2018 by Earl Blumenauer (D-OR) To amend the Public Health Service Act to protect the confidentiality of substance use disorder patient records.
HR 5812 Creating Opportunities that Necessitate New and Enhanced Connections That Improve Opioid Navigation Strategies Act of 2018 Introduced May 15, 2018 by Morgan Griffith (R-VA) Will authorize the Centers for Disease Control and Prevention to carry out certain controlled substances overdose prevention and surveillance activities in order to improve data collection and integration into physician clinical workflow so that timely, complete, and accurate information will get into the hands of providers and dispensers so that they can make the best clinical decisions for their patients.
HR 4284 INFO Act Introduced November 7, 2017 by Robert Latta (R-OH) directs the Department of Health and Human Services (HHS) to create a public and easily accessible electronic dashboard linking to all of the nationwide efforts to combat the opioid crisis. In addition, the legislation creates an Interagency Substance Use Disorder Coordinating Committee to review and coordinate opioid use disorder (OUD) and other substance use disorder (SUD) research, services, and prevention activities across all relevant Federal agencies, evaluate the effectiveness of these activities, and make specific recommendations for actions that agencies can take to better coordinates the administration of services for patients with OUD and SUD.
HR 5009 Jessies Law Introduced February 13, 2018 by Tim Walberg (R-MI) Ensures medical professionals have access to a consenting patients complete health information when making treatment decisions by requiring the Department of Health and Human Services (HHS) to develop and annually disseminate best practices regarding the prominent display of substance use disorder (SUD) history in records of patients who have previously provided this information to a health care provider.
HR 5197 ALTO Act Introduced March 7, 2018 by Bill Pascrell, Jr. (D-NJ) Directs the Secretary of Health and Human Services (HHS) to carry out a demonstration program to test alternative pain management protocols to limit the use of opioids in hospital emergency departments. Following the completion of the three-year demonstration, the Secretary of Health and Human Services will submit a report to Congress on the results of the program and issue recommendations for broader implementation. The legislation authorizes $10 million annually in grants for fiscal years 2019-2021.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicare Advantage; CHIP Reform; Medicare Access & CHIP Reauthorization Act of 2015 (MACRA); Rate Notice and Call Letter; Medicaid; Opioids; Medicare Part D.
HR 2575 Introduced May 19, 2017 by Raul Ruiz (R-CA) To amend title XVIII of the Social Security Act to establish a system to educate individuals approaching Medicare eligibility, to simplify and modernize the eligibility enrollment process, and for other purposes.
HR 3921 HEALTHY KIDS Act Introduced October 3, 2017 by Michael Burgess (R-TX) To extend funding for the Children's Health Insurance Program, and for other purposes.
HR 1148 FAST Act of 2017 Introduced February 16, 2017 by Morgan Griffith (R-VA) To amend title XVIII of the Social Security Act to expand access to telehealth-eligible stroke services under the Medicare program.
HR 3192 CHIP Mental Health Parity Act Introduced July 12, 2017 by Joseph Kennedy III (D-MA) To amend title XXI of the Social Security Act to ensure access to mental health services for children under the Children's Health Insurance Program, and for other purposes.
HR 6 SUPPORT for Patients and Communities Act Introduced June 13, 2018 by Greg Walden (R-OR) includes Medicaid, Medicare, and public health reforms to combat the opioid crisis by advancing treatment and recovery initiatives, improving prevention, protecting communities, and bolstering efforts to combat illicit synthetic drugs like fentanyl. The policies contained in the legislation were advanced through regular order by the House Energy and Commerce Committee and the Ways and Means Committee.
HR 5752 Stop Illicit Drug Importation Act of 2018 Introduced May 10, 2018 by Marsha Blackburn (R-TN) amends the Federal Food, Drug, and Cosmetic Act (FD&C) to strengthen the Food and Drug Administrations (FDA) seizure powers and enhance its authority to detain, refuse, seize, or destroy illegal products offered for import. The legislation would subject more people to debarment and civil penalties under the Act.
HR 5806 21st Century Tools for Pain and Addiction Treatment Act Introduced May 15, 2018 by Michael Burgess(R-TX) To require the Secretary of Health and Human Services to issue guidance with respect to the expedited approval of certain drugs, and for other purposes.
HR 3192 CHIP Mental Health Parity Act To amend title XXI of the Social Security Act to ensure access to mental health services for children under the Children's Health Insurance Program, and for other purposes.
HR 5796 Responsible Education Achieves Care and Healthy Outcomes for Users Treatment Act of 2018 Introduced May 15, 2018 by Brian Fitzpatrick (R-PA) To require the Secretary of Health and Human Services to provide grants for eligible entities to provide technical assistance to outlier prescribers of opioids, and for other purposes.
HR 5605 Advancing High Quality Treatment for Opioid Use Disorders in Medicare Act Introduced April 24, 2018 by Raul Ruiz (D-CA) establishes a four-year demonstration program to increase access to treatment for opioid use disorder. The demonstration would provide incentive payments and funding for care management services based on criteria such as patient engagement, use of evidence-based treatments, and treatment length and intensity. Under the bill, the Secretary of Health and Human Services would be directed to encourage other payers to coordinate payments for opioid use disorder treatments and to evaluate the extent to which the demonstration reduces hospitalizations, increases the use of medication-assisted treatments, and improves the health outcomes of individuals with opioid use disorders during and after the demonstration. This bill also incorporates H.R. 3528, Every Prescription Conveyed Securely Act, which would require e-prescribing, with exceptions, for coverage of prescribed controlled substances under the Medicare Part D program.
HR 5587 Peer Support Communities of Recovery Act Introduced April 23, 2018 by Ben Lujan (D-NM) enhances the Comprehensive Addiction and Recovery Acts Building Communities of Recovery Program and authorizes the Department of Health and Human Services (HHS) to award grants to peer support specialist organizations for the development and expansion of recovery services. Grants shall be awarded to nonprofit organizations that support community-based, peer delivered support, including technical support for the establishment of recovery community organizations, independent, nonprofit groups led by people in recovery and their families.
HR 5809 Postoperative Opioid Prevention Act of 2018 Introduced May 15, 2018 by Scott Peters (D-CA) To amend title XVIII of the Social Security Act to encourage the use of non-opioid analgesics for the management of post-surgical pain under the Medicare program, and for other purposes.
HR 4284 INFO Act Introduced November 7, 2017 by Robert Latta (R-OH) directs the Department of Health and Human Services (HHS) to create a public and easily accessible electronic dashboard linking to all of the nationwide efforts to combat the opioid crisis. In addition, the legislation creates an Interagency Substance Use Disorder Coordinating Committee to review and coordinate opioid use disorder (OUD) and other substance use disorder (SUD) research, services, and prevention activities across all relevant Federal agencies, evaluate the effectiveness of these activities, and make specific recommendations for actions that agencies can take to better coordinates the administration of services for patients with OUD and SUD.
HR 5009 Jessies Law Introduced February 13, 2018 by Tim Walberg (R-MI) Ensures medical professionals have access to a consenting patients complete health information when making treatment decisions by requiring the Department of Health and Human Services (HHS) to develop and annually disseminate best practices regarding the prominent display of substance use disorder (SUD) history in records of patients who have previously provided this information to a health care provider.
HR 5197 ALTO Act Introduced March 7, 2018 by Bill Pascrell, Jr. (D-NJ) Directs the Secretary of Health and Human Services (HHS) to carry out a demonstration program to test alternative pain management protocols to limit the use of opioids in hospital emergency departments. Following the completion of the three-year demonstration, the Secretary of Health and Human Services will submit a report to Congress on the results of the program and issue recommendations for broader implementation. The legislation authorizes $10 million annually in grants for fiscal years 2019-2021.
HR 5261 Treatment, Education, and Community Help to Combat Addiction Act of 2018 Introduced March 13, 2018 by Bill Johnson (R-OH) directs theSecretary of Health and Human Services (HHS) to designate regional Centers of Excellence to enhance and improve how health professional are educated in substance abuse disorder prevention, treatment, and recovery through development, evaluation, and distribution of evidence-based curricula for health profession schools. The bill authorizes $4 million annually for grants to those programs over the 2019-2023 period.
HR 5272 To provide additional guidance to grantees seeking funding to treat or prevent mental health or substance use disorders. Introduced March 14, 2018 by Steve Stivers (R-OH) Requires the newly established National Mental Health and Substance Use Policy Laboratory to issue guidance to applicants for Substance Abuse and Mental Health Services Administration (SAMHSA) grants that support evidence-based practices. The guidance shall include how best to articulate the rationale for a given program or activity; encourage the funding of evidence-based interventions; and encourage the replication of promising or effective practices.
HR 5327 Comprehensive Opioid Recovery Centers Act of 2018 Introduced March 19, 2018 by Brett Guthrie (R-KY) directs the Secretary of Health and Human Services (HHS) to award grants to at least 10 providers that offer treatment services for people with opioid use disorder. These Comprehensive Opioid Recovery Centers would serve as models for comprehensive treatment and recovery and would utilize the full range of Food and Drug Administration approved medications and evidence-based treatments, have strong linkages with the community, generate meaningful outcomes data, and dramatically improve the opportunities for individuals to establish and maintain long-term recovery. Either directly or through coordination with other entities, Centers must provide services including withdrawal management, counseling, recovery housing, community-based and peer recovery support services, job training and placement assistance, pharmacy and toxicology services, and a secure and confidential electronic health information system.
HR 3331 To amend title XI of the Social Security Act to promote testing of incentive payments for behavioral health providers for adoption and use of certified electronic health record technology Introduced July 20, 2017 by Lynn Jenkins (R-KY) authorizes the Center for Medicare and Medicaid Innovation to test a program offering incentive payments to behavioral health providers that adopt and use certified electronic health record technology. The U.S. government introduced the Meaningful Use program as part of the 2009 Health Information Technology for Economic and Clinical Health (HITECH) Act, to encourage health care providers to show "meaningful use" of a certified Electronic Health Record (EHR). In doing so, eligible providers who do so receive incentive payments, but behavioral health providers were not included in the definition of eligible providers. Individual physicians and other eligible health care professionals can each receive up to $44,000 through the Medicare Meaningful Use program or up to $63,750 through the Medicaid Meaningful Use program, depending upon when they begin attesting to the program's requirements.
HR 3528 Every Prescription Conveyed Securely Act Introduced July 28, 2017 by Katherine Clark (D-MA) To amend title XVIII of the Social Security Act to require e-prescribing for coverage under part D of the Medicare program of prescription drugs that are controlled substances.
HR 4841 Standardizing Electronic Prior Authorization for Safe Prescribing Act of 2018 Introduced January 18, 2018 by David Schweikert (R-AZ) To amend title XVIII of the Social Security Act to provide for electronic prior authorization under Medicare part D for covered part D drugs, and for other purposes.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Health Insurance Tax (HIT Tax); Tax Credits
HR 173 Middle Class Health Benefit Tax Repeal Act Introduced January 3, 2-17 by Mike Kelly (R-PA) To amend the Internal Revenue Code of 1986 to repeal the excise tax on high cost employer-sponsored health coverage.
HR 246 Introduced January 4, 2017 by Kristi Noem (R-SD) This bill repeals a provision of the Patient Protection and Affordable Care Act that imposes an annual fee on a health insurance provider based on its net premium income.
HR 5963 Introduced May 24, 2018 by Kristi Noem (R-SD)To delay the reimposition of the annual fee on health insurance providers until after 2020.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
1st Quarter, 2018
In Q1, HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY had in-house lobbyists. The report was filed on April 20, 2018.
Original Filing: 300956761.xml
Lobbying Issues
Opioid use/Substance abuse disorders; Prescription Drug pricing.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Affordable Care Act (ACA); ACA Regulations; Market Stability; Special Needs Plans (SNP); Special Enrollment Periods (SEPs); Waivers; Small Group Market Reform; Short Term Limited Duration (STLD); Cost-sharing Reduction (CSR); Reinsurance; Third Party Payment of Premiums (TPP); Grace Periods; Health Care Reform; Drug Pricing; Individual Market Reform; Exchanges; Age Bands; Health Insurance Tax (HIT); Tax Credits; Graham-Cassidy Legislation; Collins Nelson-legislation; Alexander-Murray legislation; Association of Health Plans; Small Group Market; Postal Reform; Association of Health Plans.
S. 1354- 115th Congress (2017-2018) Individual Health Insurance Marketplace Improvement Act. Sponsor: Sen. Carper, Thomas R. [D-DE] (Introduced June 14, 2017)
S. 221-115th Congress (2017-2018) Repeal Insurance Plans of the Multi-State Program Act of 2017. Sponsor: Sen. Johnson, Ron [R-WI] (Introduced December 12, 2017)
H.R. 173- 115th Congress (2017-2018) Middle Class Health Benefits Tax Repeal Act of 2017. Sponsor: Rep. Mike Kelly [R-PA-3] (Introduced January 3, 2017)
H.R. 246- 115th Congress (2017-2018) To repeal the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act. Sponsor: Rep. Kristi Noem, [R-SD] (Introduced January 4, 2017)
H.R. 2430- 115th Congress (2017-2018) FDA Reauthorization Act of 2017 Sponsor: Rep. Walden, Greg [R-OR] (Introduced May 16, 2017)
H.R. 314- 115th Congress (2017-2018) Health Care Choice Act 2017 Sponsor: Rep. Blackburn, Marsha [R-TN] (Introduced January 5, 2017)
H.R. 2051- 115thth Congress (2017-2018) Fast Generics Act of 2017 Rep. McKinley, David B. [R-WV] (Introduced April 6, 2017)
H.R.4666-115th Congress (2017-2018) Premium Relief Act of 2017 Sponsor: Rep. Costello, Ryan A. [R-PA] (Introduced December 18, 2017)
H.R.1101- 115th Congress (2017-2018) Small Business Health Fairness Act of 2017 Sponsor: Rep. Johnson, Sam [R-TX] (Introduced February 16, 2017)
H.R.708- 115th Congress (2017-2018) State Age Rating Flexibility Act 2017 Sponsor: Rep. Bucshon, Larry [R-IN] (Introduced January 27, 2017)
H.R. 3922- 115th Congress (2017-2018) CHAMPIONING HEALTHY KIDS Act. Sponsor: Rep. Walden, Greg [R-OR] (Introduced October 3, 2017)
H.R.2212- 115th Congress (2017-2018) CREATES Act of 2017 Rep. Marino, Tom [R-PA] (Introduced April 27, 2017)
H.R.749- 115th Congress (2017-2018) Lower Drug Costs through Competition Act Sponsor: Rep. Schrader, Kurt [D-OR] (Introduced January 30, 2017)
H.R.3976- 115th Congress (2017-2018) Access to Marketplace Insurance Act Sponsor: Rep. Cramer, Kevin [R-ND] (Introduced October 5, 2017)
Agencies Lobbied
U.S. Senate
Lobbying Issues
CHIP reform; Medicare Access & CHIP Reauthorization Act of 2015 (MACRA); Medicare Advantage, Postal Reform; Site Neutral Payments; Rate Notice and Call letter; Medicare Advantage; SNPs.
H.R. 1148- 115th Congress (2017-2018) FAST Act of 2017. Sponsor: Rep. Griffith, H. Morgan [R-VA] (Introduced February 16, 2017)
H.R. 4998- 115th Congress (2017-2018) Health Insurance for Former Foster Youth Act. Sponsor: Rep. Bass, Karen [D-CA] (Introduced February 13, 2018)
H.R. 4005- 115th Congress (2017-2018) Medicaid Reentry Act. Sponsor: Rep. Tonko, Paul [D-NY] (Introduced October 10, 2017)
H.R. 1925- 115th Congress (2017-2018) At-Risk Youth Medicaid Protection Act of 2017. Sponsor Rep. Cardenas, Tony [D-CA] (Introduced April 5, 2017)
H.R. 3331- 115th Congress (2017-2018) To amend title XI of the Social Security Act to promote testing of incentive payments for behavioral health providers for adoption and use of certified electronic health record technology. Sponsor Rep. Jenkins, Lynn [R-KS] (Introduced July 20, 2017)
Agencies Lobbied
U.S. Senate
Lobbying Issues
833; Health Insurance Tax (HIT TAX); Tax Credits; Tax Reform
H.R. 173 Middle Class Health Benefit Tax Repeal Act. To amend the Internal Revenue Code of 1986 to repeal the excise tax on high cost employer-sponsored health coverage. Sponsor: Rep. Kelly, Mike [R-PA] (Introduced January 3, 2017)
H.R. 1- An Act to provide reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018. Sponsor: Rep. Brady, Kevin [R-TX] (Introduced November 2, 2017)
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Cost-Sharing reductions; Reinsurance
Agencies Lobbied
U.S. Senate
4th Quarter, 2017
In Q4, HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY had in-house lobbyists. The report was filed on Jan. 20, 2018.
Original Filing: 300931764.xml
Lobbying Issues
Opioid education/Substance abuse disorders; Prescription Drug pricing.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Affordable Care Act (ACA); ACA Regulations; Market Stability; Special Needs Plans (SNP); Special Enrollment Periods (SEPs); Waivers; Small Group Market Reform; Short Term Limited Duration (STLD); Cost-sharing Reduction (CSR); Reinsurance; Third Party Payment of Premiums (TPP); Grace Periods; Health Care Reform; Drug Pricing; Individual Market Reform; Exchanges; Age Bands; Health Insurance Tax (HIT); Tax Credits; Graham-Cassidy Legislation; Collins Nelson-legislation; Alexander-Murray legislation; Postal Reform; Association of Health Plans.
H.R. 173- 115th Congress (2017-2018) Middle Class Health Benefits Tax Repeal Act of 2017. Sponsor: Rep. Mike Kelly [R-PA-3] Introduced January 3, 2017.
H.R. 246- 115th Congress (2017-2018) To repeal the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act. Sponsor: Rep. Kristi Noem, [R-SD] Introduced January 4, 2017.
H.R. 2430- 115th Congress (2017-2018) FDA Reauthorization Act of 2017
H.R. 314- 115th Congress (2017-2018) Health Care Choice Act 2017
H.R. 2051- 115thth Congress (2017-2018) Fast Generics Act of 2017
H.R.4666-115th Congress (2017-2018) Premium Relief Act of 2017
H.R.1101- 115th Congress (2017-2018) Small Business Health Fairness Act of 2017
H.R.708- 115th Congress (2017-2018) State Age Rating Flexibility Act 2017
H.R.3922- 115th Congress (2017-2018) Championing Healthy Kids Act
H.R.2212- 115th Congress (2017-2018) CREATES Act of 2017
H.R.749- 115th Congress (2017-2018) Lower Drug Costs through Competition Act
H.R.4666-115th Congress (2017-2018) Premium Relief Act of 2017
H.R.3976- 115th Congress (2017-2018) Access to Marketplace Insurance Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
CHIP reform; Medicare Access & CHIP Reauthorization Act of 2015 (MACRA); Medicare Advantage, Postal Reform; Rate Notice and Call letter; Medicare Advantage; SNPs;
H.R. 756- 115th Congress (2017-2018) Postal Service Reform Act of 2017. Sponsor: Rep. Jason Chaffetz [R-UT-3] Introduced January 31, 2017.
H.R. 3921- 115th Congress (2017-2018) Helping Ensure Access for Little Ones, Toddlers, and Hopeful Youth by Keeping Insurance Delivery Stable Act of 2017 or HEALTHY KIDS Act. Sponsor: Rep. Michael Burgess [R-TX-26] Introduced October 3, 2017.
Agencies Lobbied
U.S. Senate
Lobbying Issues
833; Health Insurance Tax (HIT TAX); Tax Credits; Tax Reform
H.R. 173 Middle Class Health Benefit Tax Repeal Act Introduced January 3, 2017 by Mike Kelly (R-PA) To amend the Internal Revenue Code of 1986 to repeal the excise tax on high cost employer-sponsored health coverage.
H.R. 1- An Act to provide reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Cost-Sharing reductions; Reinsurance
Agencies Lobbied
U.S. Senate
3rd Quarter, 2017
In Q3, HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY had in-house lobbyists. The report was filed on Oct. 19, 2017.
Original Filing: 300911049.xml
Lobbying Issues
Opioid Abuse; Opioid Education; Prescription Drug pricing.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Affordable Care Act (ACA); ACA Regulations, HCR Implementation; American Health Care Act (AHCA); Market Stability; Health Savings Accounts (HSAs); Special Needs Plans (SNP); Special Enrollment Periods (SEPs); Cost-sharing Reduction (CSR); Reinsurance; Third Party Payment of Premiums (TPP); Repeal/Replace; Grace Periods; Health Care Reform; Drug Pricing; Marketplace Certainty Act; Individual Market Reform; Exchanges; Age Bands; 2017 Notice of Benefits and Payment Parameters; Senate Health Reform Bill (AHCA); Association of Health Plans.
H.R. 173- 115th Congress (2017-2018) Middle Class Health Benefits Tax Repeal Act of 2017. Sponsor: Rep. Mike Kelly [R-PA-3] Introduced January 3, 2017.
H.R. 246- 115th Congress (2017-2018) To repeal the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act. Sponsor: Rep. Kristi Noem, [R-SD] Introduced January 4, 2017.
H.R. 2575- 115th Congress (2017-2018)Beneficiary Enrollment Notification and Eligibility Simplification Act of 2017 or BENES Act of 2017 Sponsor: Rep. Raul Ruiz [D-CA-36] Introduced May 19, 2017.
H.R. 1628- 115th Congress (2017-2018) American Health Care Act of 2017 Sponsor:Rep. Diane Black [R-TN-6] Introduced March 20, 2017.
S. 1354- 115th Congress (2017-2018) Individual Health Insurance Marketplace Improvement Act Sponsor: Rep. Thomas Carper [D-DE] Introduced June 14, 2017.
Agencies Lobbied
U.S. Senate
Lobbying Issues
CHIP reform; Medicare Access & CHIP Reauthorization Act of 2015 (MACRA); Medicare Advantage, Postal Reform;
H.R. 756- 115th Congress (2017-2018) Postal Service Reform Act of 2017. Sponsor: Rep. Jason Chaffetz [R-UT-3] Introduced January 31, 2017.
H.R. 2575- 115th Congress (2017-2018) Beneficiary Enrollment Notification and Eligibility Simplification Act of 2017 or BENES Act of 2017. Sponsor Raul Ruiz [D-CA-36] Introduced May 19, 2017.
H.R. 3921- 115th Congress (2017-2018) Helping Ensure Access for Little Ones, Toddlers, and Hopeful Youth by Keeping Insurance Delivery Stable Act of 2017 or HEALTHY KIDS Act. Sponsor: Rep. Michael Burgess [R-TX-26] Introduced October 3, 2017.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Health Insurance Tax (HIT TAX); Cadillac Tax; Tax Credits
HR 173 Middle Class Health Benefit Tax Repeal Act Introduced January 3, 2017 by Mike Kelly (R-PA) To amend the Internal Revenue Code of 1986 to repeal the excise tax on high cost employer-sponsored health coverage.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Agencies Lobbied
U.S. Senate
2nd Quarter, 2017
In Q2, HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY had in-house lobbyists. The report was filed on July 19, 2017.
Original Filing: 300890615.xml
Lobbying Issues
Opioid Abuse; Opioid Education; Prescription Drug pricing.
HR 2026 Pharmaceutical Information Exchange Act Introduced April 6, 2017 by Brett Guthrie (R-VA) To improve patient access to emerging medication therapies by clarifying the scope of permitted health care economic and scientific information communications between biopharmaceitoca; manufacturers and population health decision makers.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Affordable Care Act (ACA); ACA Regulations, HCR Implementation; American Health Care Act (AHCA); Market Stability; Health Savings Accounts (HSAs); Special Needs Plans (SNP); Special Enrollment Periods (SEPs); Cost-sharing Reduction (CSR); Re-insurance; Third Party Payment of Premiums (TPP); Repeal/Replace; Grace Periods; Health Care Reform; Drug Pricing; Market Certainty Act; Individual Market Reform; Exchanges; Age Bands; 2017 Notice of Benefits and Payment Parameters; Senate Health Reform Bill.
HR 246 Introduces January 4, 2017 by Kristi Noem (R-SD) This bill repeals a provision of the Patient Protection and Affordable Care Act that imposes an annual fee on a health insurance provider based on its net premium income.
HR 314 Introduced January 5, 2017 by Marsha Blackburn (R-TN) This bill repeals the health insurance and health coverage expansion requirements of the Patient Protection and Affordable Care Act and related provisions of the Health Care and Education Reconciliation Act of 2010.
HR 756 Postal Service Reform Act of 2017 Introduced January 31, 2017 by Jason Chaffetz (R-UT) To restore the financial solvency and improve the governance of the United States Postal Service to ensure the efficient and affordable nationwide delivery of mail, and for other purposes.
HR 1628 American Health Care Act Introduced March 20, 2017 by Diane Black (R-TN) The American Health Care Act of 2017 (AHCA), also known as the Better Care Reconcilliation Act f 2017 (BCRA), is the leading proposal to repeal and replace the Affordable Care Act and defund Planned Parenthood.
HR 1703 Introduced March 23, 2017 by Morgan Griffith (R-VA) To amend the Federal Food, Drug, and Cosmetic Act with respect to determining the intended use of the drugs and devices.
HR 2026 Pharmaceutical Information Exchange Act Introduced April 6, 2017 by Brett Guthrie (R-VA) To improve patient access to emerging medication therapies by clarifying the scope of permitted health care economic and scientific information communications between biopharmaceutical manufacturers and population health decision makers.
HR 2051 FAST Generics Act Introduced April 6, 2017 by David McKinley (R-WV) To amend the Federal Food, Drug, and Cosmetic Act to ensure that eligible product developers have competitive access to approved drugs and licensed biological products, so as to enable eligible product developers to develop and test new products, and for other purposes.
S 1354 Individual Health Insurance Marketplace Improvement Act introduced June 14, 2017 by Thomas Carper (D-DE) A bill to establish an Individual Market reinsurance fund to provide funding for State individual market stabilization reinsurance programs.
HR 1101 Small Business Health Fairness Act of 2017 Introduced February 16, 2017 by Sam Johnson (R-TX) to amend title I of the Employee Retirement Income Security Act of 1974 to improve access and choice for entrepreneurs with small businesses with respect to medical care for their employees.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Chip reform; Medicare Access & CHIP Reauthorization Act of 2015 (MACRA); Rate Notice and Call Letter; Postal Reform; Medigap; Site Neutral Payments;
HR 756 Postal Service Reform Act of 2017 Introduced January 31, 2017 by Jason Chaffetz (R-UT) To restore the financial solvency and improve the governance of the United States Postal Service to ensure the efficient and affordable nationwide delivery of mail, and for other purposes.
HR 2575 Introduced May 19, 2017 by Paul Ruiz (R-CA) To amend the XVII of the Social Security Act to establish a system to educate individuals approaching Medicare eligibility, to simplify and modernize the eligibility enrollment process, and for other purposes.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Health Insurance Tax (HIT TAX); Cadillac Tax; Tax Credits
HR 173 Middle Class Health Benefit Tax Repeal Act Introduced January 3, 2017 by Mike Kelly (R-PA) To amend the Internal Revenue Code of 1986 to repeal the excise tax on high cost employer-sponsored health coverage.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Agencies Lobbied
U.S. Senate
Agencies Lobbied
U.S. Senate
1st Quarter, 2017
In Q1, HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY had in-house lobbyists. The report was filed on April 19, 2017.
Original Filing: 300871765.xml
Lobbying Issues
Opioid Abuse; Opioid Education; Prescription Drugs
Agencies Lobbied
U.S. Senate
Lobbying Issues
Affordable Care Act (ACA); ACA Regulations, HCR Implementation; American Health Care Act (AHCA); Market Stability; Health Savings Accounts (HSAs); Special Enrollment Periods (SEPs); Cost-sharing Reduction (CSR); Re-insurance; Repeal/Replace; Grace Periods; Healthcare Reform; Individual Market Reform; Exchanges; Age Bands; Association Health Plans.
HR 246 Introduces January 4, 2017 by Kristi Noem (R-SD This bill repeals a provision of the Patient Protection and Affordable Care Act that imposes an annual fee on a health insurance provider based on its net premium income.
HR 633 Patient Fairness and Relief Act of 2017 Introduced January 24, 2017 by Gregg Harper (R-MS) To authorize health insurance issuers to continue to offer for sale health insurance coverage offered in the individual market before the enactment of the Patient Protection and Affordable Care Act in satisfaction of the minimum essential health insurance coverage requirement, and for other purposes.
HR 661 Employer Fairness and Relief Act of 2017 Introduced January 27, 2017 Introduced January 24, 2017 by Brett Guthrie (R-KY) To authorize health insurance issuers to offer for sale previously available health insurance coverage in the small group market in satisfaction of the minimum essential health insurance coverage requirement and for other purposes.
HR 708 State Age Rating Flexibility Act of 2017 Introduced by Larry Bucshon (R-IN) This bill amends the Public Health Service Act to increase the permissible variation based on age for health insurance premiums for coverage offered in the individual or small group market from a factor of three to a factor of five, or to a factor determined by the state. This applies to plan years starting on or after January 1, 2018.
HR 710 Health Coverage State Flexibility Act 2017 Introduced January 17, 2017 by Bill Flores (R-TX) This bill amends the Patient Protection and Affordable Care Act to revise the grace period that health insurers must provide to recipients of premium subsidies before discontinuing health coverage for nonpayment of premiums. The grace period is shortened from 3 months to 30 days unless state law includes an applicable grace period.
HR 706 Plan Verification and Fairness Act of 2017 Introduced January 27, 2017 by Marsha Blackburn (R-TN) This bill amends the Patient Protection and Affordable Care Act to require health insurance exchanges to verify an individual's eligibility for a special enrollment period before coverage is made effective. Individuals seeking coverage through an exchange during a special enrollment period must submit to the exchange the documents necessary to verify their eligibility for the special enrollment period.
HR 749 Lower Drug Costs Through Competition Act Introduced January 30, 2017 by Kurt Schrader (D-OR) To increase competition in the pharmaceutical industry.
HR 1101 Small Business Health Fairness Act of 2017 Introduced February 16, 2017 by Sam Johnson (R-TX) to amend title I of the Employee Retirement Income Security Act of 1974 to improve access and choice for entrepreneurs with small businesses with respect to medical care for their employees.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medigap; Medicare Advantage; CHIP Reform; Medicare Access & CHIP Reauthorization Act 2015 (MACRA); Site-neutral Payments; Rate Notice and Call letter.
HR 1290 Improving Access to Mental Health Act Introduced March 1, 2017 by Barbra Lee (D-CA) To amend title XVII of the Social Security Act to improve access to mental services under the Medicare program.
HR 1389 Increasing State Flexbility in Care Coordination for the Most Vulnerable Act of 2017 Introduced March 7, 2017 by Gus Bilirakis (R-FL) To amend title XIX of the Social Security Act to provide States with flexibility to provide care coordination under Medicaid for the most vulnerable through managed care.
HR 1395 MACPAC Improvement Act of 2017 Introduced March 7, 2017 by Michael Burgess (R-TX) To amend title XIX of the Social Security Act to improve the Medicaid and Chip Payment and Access Commission (MACPAC).
Agencies Lobbied
U.S. Senate
Lobbying Issues
Health Insurance Tax (HIT TAX); Cadillac Tax
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Cost-sharing Reduction Payments under the ACA; ACA Reinsurance.
Agencies Lobbied
U.S. Senate
Agencies Lobbied
U.S. Senate
4th Quarter, 2016
In Q4, HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY had in-house lobbyists. The report was filed on Jan. 19, 2017.
Original Filing: 300852200.xml
Lobbying Issues
Opioid Abuse; Opioid Education; Prescription Drugs.
HR 953 Introduced February 12, 2015 by James Sensenbrenner, Jr. (R-WI) Comprehensive Addiction and Recovery Act of 2015. The bill amends the Public Health Service Act to authorize the Center for Substance Abuse Treatment to award grants to enable state substance abuse agencies, local governments, nonprofit organizations, and Indian tribes or tribal organizations that have a high rate of, or have had a rapid increase in, the use of heroin or other opioids to expand activities, including medication assisted treatment, for the treatment of addiction in the geographical areas affected.
The Comprehensive Recovery Act, S. 524 was introduced by Sen. Sheldon Whitehouse (D-RI) and HR 953 to tackle the growing epidemic.
HR 2805 Heroin and Prescription Opioid Abuse Prevention, Education and Enforcement Act of 2015 Introduced June 17, 2015 by Susan Brooks (R-IN). This bill requires the Department of Health and Human Services (HHS), in cooperation with the Department of Veteran Affairs, the Department of Defense, and the Drug Enforcement Administration (DEA) to convene a Pain Management Best Practices Inter-Agency Task Force to develop and study best practice for pain management and prescription of pain medication.
HR 4499 Introduced February 9, 206 by Alex Mooney (R-VA) Promoting Responsible Opioid Prescribing Act of 2016. To amend title XVII of the Social Security Act to remove consideration of certain pain-related issues from calculations under the Medicare hospital value-based purchasing program, and for other purposes.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Affordable Care Act (ACA) Issues; ACA Regulations, HCR Implementation; Market Stability; Health Savings Accounts (HSAs); Notice of Benefits and Payment Parameters (NBPP); Special Enrollment Periods (SEPs); Cost-sharing Reduction (CSR); Re-insurance; Risk Corridors; Better Way; Repeal/Replace Modeling; ACA Reform; Risk Programs; Premium Education; Chronic Care; Individual Market Reform; Third Party Payments of Premiums; Exchanges; Age Bands.
HR 2488 Medicare Beneficiary Preservation of Choice Act of 2015 Introduced May 21, 2015 by Keith Rothfus (R-PA) This bill amends title XVIII (Medicare) of the Social Security Act to expand and modify enrollment and disenrollment options for Medicare Advantage (MA) eligible individuals. Specifically, the bill extends the annual period in which an individual enrolled in MA may elect to instead receive benefits under the original Medicare fee-for-service (FFS) program as well as elect to change qualified prescription drug coverage. Furthermore, any MA-eligible individual (whether or not enrolled in MA) may once per period change a previous election with respect to receiving benefits through MA or Medicare FFS, including changing from one MA plan to another. Unsolicited marketing during this period is prohibited.
HR 928 Introduced February 12, 2015 by Charles Boustany (R-LA). This bill repeals a provision of the ACA that imposes an annual fee on a health insurance provider based on its net premium income.
HR 2646 Helping Families in Mental Health Crisis Act of 2015 Introduced May 4, 2015 by Tim Murphy (R-PA) To make available needed psychiatric, psychological, and supportive services for individuals with mental illness and families in mental health crisis, and for other purposes.
HR 3742 Access to Marketplace Insurance Act Introduced October 9, 2015 by Kevin Cramer (R-ND) To amend the Patient Protection and Affordable Care Act to allow for certain third party payments.
HR 5410 Health Coverage State Flexibility Act of 2016, Introduced June 21, 2016 by Bill Flores (R-TX), Amends the Patient Protection and Affordable Care Act to revise the grace period that health insurers must provide to recipients of premium subsidies before discontinuing health coverage for nonpayment of premiums.
HR 5506 Introduced June 15, 2016 by Todd Young (R-IN) To amend title XVIII of the Social Security Act to establish a demonstration program to provide integrated care for Medicare beneficiaries with end-stage renal disease, and for other purposes.
HR 5547 Health Care Price Transparency Promotion Act of 2016 Introduced by Michael Burgess (R-IN) To amend title XIX of the Social Security Act to provide for increased price transparency of hospital information and to provide for additional research on consumer information on charges and out-of picket costs.
HR 5589 Plan Verification and Fairness Act of 2016 Introduced June 28, 2016 by Marsha Blackburn (R-TN) To amend title I of the Patient Protection and Affordable Care Act to require verification for eligibility for enrollment during special enrollment periods in PPACA insurance plans, and for other purposes.
HR 5904 Tax Payers Before Insurers Act Introduced July 14, 2016 by Mark Walker (R-NC) To require the Secretary of Health and Human Services to deposit certain funds into the general fund of the Treasury in accordance with provision of Federal law with regard to the Patient Protection and Affordable Care Acts Transitional reinsurance Program.
HR 5921 State Age Rating Flexibility Act Introduced July 21, 2016 by Larry Bucshon (R-IN) To amend title XXVII of the Public Health Services Act to change the permissible age variation in health insurance premium rates.
S. 524 Comprehensive Addition and Recovery Act of 2016 Introduced February 12, 2015 by Sheldon Whitehouse (D-RI) Overdoes from heroin, prescription drugs, and opioid pain relievers. Overdoses from heroin, prescription drugs, and opioid pain relievers last year surpassed car accidents as the leading cause of injury-related death in America, according to the Centers for Disease Control. Deaths have reached their highest levels of the 21st century in 2014, the most recent year for which data is available, according to the National Institute on Drug Abuse. The bill authorizes the Attorney General and Secretary of Health and Human Services to award grants to address the national epidemics of prescription opioid abuse and heroin use.
S. 1945 Mental Health Reform Act of 2015 Introduced August 5, 2015 by Bill Cassidy (R-LA) A bill to make available needed psychiatric, psychological and supportive services for individuals with mental illness and families in mental health crisis, and for other purposes.
Network Adequacy standards and tiered networks.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicare/Medicaid Issues; Medicare Advantage; CHIP Reform; Medicare Access & CHIP Reauthorization Act 2015 (MACRA); Chronic Care Reform; Exchanges; Site-neutral Payments; Rate Notice and Call Letter.
HR 2488 Medicare Beneficiary Preservation of Choice Act of 2015 Introduced May 21, 2015 by Keith Rothfus (R-PA) This bill amends title XVII (Medicare) of the Social Security Act to expand and modify enrollment and disenrollment options for Medicare Advantage (MA) eligible individuals. The Bill extends the annual period in which an individual enrolled in MA may elect to instead receive benefits under the original Medicare fee-for-service (FFS) program as well as elect to change qualified prescription drug coverage. Furthermore, any MA-eligible individual (whether or not enrolled in MA) may once per period change a previous election with respect to receiving benefits through MA or Medicare FFS, including changing from one MA plan to another. Unsolicited marketing during this period is prohibited.
HR 2895 Introduced June 25, 2015 by Mike Pompeo (R-KS) Medicare Patient Access to Cancer Treatment Act of 2015 To amend title XVIII of the Social Security Act to establish payment parity under the Medicare program for ambulatory cancer services furnished in the hospital outpatient department and the physician office setting.
HR 3716 Introduced October 8, 2015 by Larry Bucshon (R-IN) To amend title XIX of the Social Security Act to require States to provide to the Secretary of Health and Human Services certain information with respect to provider termination, and for other purposes.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Health Insurance Tax (HIT TAX);HIT Tax Delay; Cadillac Tax.
HR 928 Introduced February 12, 2015 by Charles Boustany (R-LA) This bill repeals a provision of the PPACA that imposes an annual fee on a health insurance provider based on its net premium income.
S 183 Jobs and Premium Protection Act Introduced January 16, 2015 by John Barrasso (R-WY) A bill to repeal the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Cost-sharing Reduction Payments under the ACA; ACA Reinsurance; Risk Corridors.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2016
In Q3, HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY had in-house lobbyists. The report was filed on Oct. 19, 2016.
Original Filing: 300834214.xml
Lobbying Issues
Opioid Abuse; Opioid Education; Prescription Drugs; Pharmaceutical Innovation
HR 953 Introduced February 12, 2015 by James Sensenbrenner, Jr. (R-WI) Comprehensive Addiction and Recovery Act of 2015. The bill amends the Public Health Service Act to authorize the Center for Substance Abuse Treatment to award grants to enable state substance abuse agencies, local governments, nonprofit organizations, and Indian tribes or tribal organizations that have a high rate of, or have had a rapid increase in, the use of heroin or other opioids to expand activities, including medication assisted treatment, for the treatment of addiction in the geographical areas affected.
The Comprehensive Recovery Act, S. 524 was introduced by Sen. Sheldon Whitehouse (D-RI) and HR 953 to tackle the growing epidemic.
HR 2805 Heroin and Prescription Opioid Abuse Prevention, Education and Enforcement Act of 2015 Introduced June 17, 2015 by Susan Brooks (R-IN). This bill requires the Department of Health and Human Services (HHS), in cooperation with the Department of Veteran Affairs, the Department of Defense, and the Drug Enforcement Administration (DEA) to convene a Pain Management Best Practices Inter-Agency Task Force to develop and study best practice for pain management and prescription of pain medication.
HR 4499 Introduced February 9, 206 by Alex Mooney (R-VA) Promoting Responsible Opioid Prescribing Act of 2016. To amend title XVII of the Social Security Act to remove consideration of certain pain-related issues from calculations under the Medicare hospital value-based purchasing program, and for other purposes.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Affordable Care Act - Chronic Care Innovations; Payment reform; CBPP; 2017 Notice of Benefit and Payment Parameters; ACA Regulations, Implementation; Open Enrollment; Market Stability; Special Enrollment Periods (SEPs); Reinsurance; Risk corridors; Risk Mitigation; Risk Programs; Premiums; Individual Market Reform; Third party payments; Exchanges; Age Bands.
Other Health Care Issues- Mental Health Reform; End Stage Renal Disease (ESRD); Health Savings Accounts; Opioid Education.
HR 2488 Medicare Beneficiary Preservation of Choice Act of 2015 Introduced May 21, 2015 by Keith Rothfus (R-PA) This bill amends title XVIII (Medicare) of the Social Security Act to expand and modify enrollment and disenrollment options for Medicare Advantage (MA) eligible individuals. Specifically, the bill extends the annual period in which an individual enrolled in MA may elect to instead receive benefits under the original Medicare fee-for-service (FFS) program as well as elect to change qualified prescription drug coverage. Furthermore, any MA-eligible individual (whether or not enrolled in MA) may once per period change a previous election with respect to receiving benefits through MA or Medicare FFS, including changing from one MA plan to another. Unsolicited marketing during this period is prohibited.
HR 928 Introduced February 12, 2015 by Charles Boustany (R-LA). This bill repeals a provision of the ACA that imposes an annual fee on a health insurance provider based on its net premium income.
HR 2646 Helping Families in Mental Health Crisis Act of 2015 Introduced May 4, 2015 by Tim Murphy (R-PA) To make available needed psychiatric, psychological, and supportive services for individuals with mental illness and families in mental health crisis, and for other purposes.
HR 3742 Access to Marketplace Insurance Act Introduced October 9, 2015 by Kevin Cramer (R-ND) To amend the Patient Protection and Affordable Care Act to allow for certain third party payments.
HR 5410 Health Coverage State Flexibility Act of 2016, Introduced June 21, 2016 by Bill Flores (R-TX), Amends the Patient Protection and Affordable Care Act to revise the grace period that health insurers must provide to recipients of premium subsidies before discontinuing health coverage for nonpayment of premiums.
HR 5506 Introduced June 15, 2016 by Todd Young (R-IN) To amend title XVIII of the Social Security Act to establish a demonstration program to provide integrated care for Medicare beneficiaries with end-stage renal disease, and for other purposes.
HR 5589 Plan Verification and Fairness Act of 2016 Introduced June 28, 2016 by Marsha Blackburn (R-TN) To amend title I of the Patient Protection and Affordable Care Act to require verification for eligibility for enrollment during special enrollment periods in PPACA insurance plans, and for other purposes.
HR 5904 Tax Payers Before Insurers Act Introduced July 14, 2016 by Mark Walker (R-NC) To require the Secretary of Health and Human Services to deposit certain funds into the general fund of the Treasury in accordance with provision of Federal law with regard to the Patient Protection and Affordable Care Acts Transitional reinsurance Program.
HR 5921 State Age Rating Flexibility Act Introduced July 21, 2016 by Larry Bucshon (R-IN) To amend title XXVII of the Public Health Services Act to change the permissible age variation in health insurance premium rates.
S. 524 Comprehensive Addition and Recovery Act of 2016 Introduced February 12, 2015 by Sheldon Whitehouse (D-RI) Overdoes from heroin, prescription drugs, and opioid pain relievers. Overdoses from heroin, prescription drugs, and opioid pain relievers last year surpassed car accidents as the leading cause of injury-related death in America, according to the Centers for Disease Control. Deaths have reached their highest levels of the 21st century in 2014, the most recent year for which data is available, according to the National Institute on Drug Abuse. The bill authorizes the Attorney General and Secretary of Health and Human Services to award grants to address the national epidemics of prescription opioid abuse and heroin use.
S. 1945 Mental Health Reform Act of 2015 Introduced August 5, 2015 by Bill Cassidy (R-LA) A bill to make available needed psychiatric, psychological and supportive services for individuals with mental illness and families in mental health crisis, and for other purposes.
S. 2713 Introduced March 17, 2016 by Lamar Alexander (R-TN) Advancing Precision Medicine Act of 2016 A bill to provide for the implementation of Precision Medicine Initiative.
Network Adequacy standards and network tiering.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicare/Medicaid Issues; Medicare Advantage; CHIP Reform; Medicare Access & CHIP Reauthorization Act 2015 (MACRA); Chronic Care Reform; Exchanges; Site-neutral Payments; Quality Improvement Strategy for QHPs; Rate Notice and Call Letter; QHP Quality Rating System (QRS); MHP.
HR 2488 Medicare Beneficiary Preservation of Choice Act of 2015 Introduced May 21, 2015 by Keith Rothfus (R-PA) This bill amends title XVII (Medicare) of the Social Security Act to expand and modify enrollment and disenrollment options for Medicare Advantage (MA) eligible individuals. The Bill extends the annual period in which an individual enrolled in MA may elect to instead receive benefits under the original Medicare fee-for-service (FFS) program as well as elect to change qualified prescription drug coverage. Furthermore, any MA-eligible individual (whether or not enrolled in MA) may once per period change a previous election with respect to receiving benefits through MA or Medicare FFS, including changing from one MA plan to another. Unsolicited marketing during this period is prohibited.
HR 2895 Introduced June 25, 2015 by Mike Pompeo (R-KS) Medicare Patient Access to Cancer Treatment Act of 2015 To amend title XVIII of the Social Security Act to establish payment parity under the Medicare program for ambulatory cancer services furnished in the hospital outpatient department and the physician office setting.
HR 3716 Introduced October 8, 2015 by Larry Bucshon (R-IN) To amend title XIX of the Social Security Act to require States to provide to the Secretary of Health and Human Services certain information with respect to provider termination, and for other purposes.
HR 4588 Introduced February 23, 2016 by Green (D-TX) To amend title XIX of the Social Security Act to provide the same level of Federal matching assistance for every State that chooses to expand Medicaid coverage to newly eligible individuals, regardless of when such expansion takes place.
Agencies Lobbied
U.S. Senate
Lobbying Issues
833; Health Insurance Tax (HIT TAX); Cadillac Tax
HR 928 Introduced February 12, 2015 by Charles Boustany (R-LA) This bill repeals a provision of the PPACA that imposes an annual fee on a health insurance provider based on its net premium income.
S 183 Jobs and Premium Protection Act Introduced January 16, 2015 by John Barrasso (R-WY) A bill to repeal the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Risk Corridors; Risk Corridor Funding; ACA Reinsurance
Agencies Lobbied
U.S. Senate
2nd Quarter, 2016
In Q2, HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY had in-house lobbyists. The report was filed on July 19, 2016.
Original Filing: 300815843.xml
Lobbying Issues
Affordable Care Act - Chronic Care Innovations; Payment reform; CBPP; 2017 Notice of Benefit and Payment Parameters; ACA Regulations, Implementation; Open Enrollment; Market Stability; Sepcial Enrollment Periods (SEPs); Reinsurance; Taskforce; Agency Health Research Quality (AHRQ)
Other Health Care Issues- Mental Health Parity; Opioid Education; Air Ambulances
Federal Employee Health Benefit Program (FEHBP) regarding proposals to allow additional types of carriers including regional PPOs to be included in the coverage options offered by OPM.
HR 928 Introduced February 12, 2015 by Charles Boustany (R-LA). This bill repeals a provision of the ACA that imposes an annual fee on a health insurance provider based on its net premium income.
HR 2646 Helping Families in Mental Health Crisis Act of 2015 Introduced May 4, 2015 by Tim Murphy (R-PA) To make available needed psychiatric, psychological, and supportive services for individuals with mental illness and families in mental health crisis, and for other purposes.
HR 3742 Access to Marketplace Insurance Act Introduced October 9, 2015 by Kevin Cramer (R-ND) To amend the Patient Protection and Affordable Care Act to allow for certain third party payments.
HR 5589 Plan Verification and Fairness Act of 2016 Introduced June 28, 2016 by Marsha Blackburn (R-TN) To amend title I of the Patient Protection and Affordable Care Act to require verification for eligibility for enrollment during special enrollment periods in PPACA insurance plans, and for other purposes.
S. 524 Comprehensive Addition and Recovery Act of 2016 Introduces February 12, 2015 by Sheldon Whitehouse (D-RI) Overdoes from heroin, perscription drugs, and opioid pain relievers. Overdoses from heroin, prescription drugs, and opioid pain relievers last year surpassed car accidents as the leading cause of injury-related death in America, according to the Centers for Disease Control. Deaths have reached their highest levels of the 21st century in 2014, the most recent year for which data is available, according to the National Institute on Drug Abuse. The bill authorizes the Attorney General and Secretary of Health and Human Services to award grants to address the national epidemics of prescription opioid abuse and heroin use.
S. 1945 Mental Health Reform Act of 2015 Introduced August 5, 2015 by Bill Cassidy (R-LA) A bill to make available needed psychiatric, psychological and supportive services for individuals with mental illness and families in mental health crisis, and for other purposes.
Network Adequacy standards and network tiering.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicare/Medicaid Issues; Medicare Advantage; Chronic Care Reform; Exchanges; Site-neutral Payments; Quality Improvement Strategy for QHPs; network adequacy standards.
HR 2488 Medicare Beneficiary Preservation of Choice Act of 2015 Introduced May 21, 2015 by Keith Rothfus (R-PA) This bill amends title XVII (Medicare) of the Social Security Act to expand and modify enrollment and disenrollment options for Medicare Advantage (MA) eligible individuals. The Bill extends the annual period in which an individual enrolled in MA may elect to instead recieve benefits under the original Medicare fee-for-service (FFS) program as well as elect to change qualified perscription drug coverage.
HR 2895 Introduced June 25, 2015 by Mike Pompeo (R-KS) Medicare Patient Access to Cancer Treatment Act of 2015 To amend title XVIII of the Social Security Act to estblish payment parity under the Medicare program for ambulatory cancer services furnished in the hospital outpatient department and the physician office setting.
HR 3716 Introduced October 8, 2015 by Larry Bucshon (R-IN) To amend title XIX of the Social Security Act to require States to provide to the Secretary of Health and Human Services certin information with respect to provider termination, and for other purposes.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Risk Corridors; Risk Corridor Funding; ACA Reinsurance; Federal Health Employee Health Benefits Plan Regional PPO language.
Agencies Lobbied
U.S. Senate
Lobbying Issues
833; Health Insurance Tax (HIT TAX); Cadillac Tax
HR 928 Introduced February 12, 2015 by Charles Boustany (R-LA) This bill repeals a provision of the PPACA that imposes an annual fee on a health insurance provider based on its net premium income.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Opioid Abuse; Opioid Education; Perscription Drugs; Pharmaceutical Innovation
HR 953 Introduced February 12, 2015 by James Sensenbrenner, Jr. (R-WI) Comprehensive Addiction and Recovery Act of 2015. The bill amends the Public Health Service Act to authorize the Center for Substance Abuse Treatment to award grants to enable state substance abuse agencies, local governments, nonprofit organizations, and Indian tribes or tribal organizations that have a high rate of, or have had a rapid increase in, the use of heroin or other opioids to expand activities, including medication assisted treatment, for the treatment of addiction in the geographical areas affected. The Comprehensive Recovery Act, S. 524 was introduced by Sen. Sheldon Whitehouse (D-RI) and HR 953 to tackle the growing epidemic.
HR 2805 Heroin and Prescription Opioid Abuse Prevention, Education and Enforcement Act of 2015 Introduced June 17, 2015 by Susan Brooks (R-IN). This bill requires the Department of Health and Human Services (HHS), in cooperation with the Department of Veteran Affairs, the Department of Defense, and the Drug Enforcement Administration (DEA) to convene a Pain Management Best Practices Inter-Agency Task Force to develop and study best pratice for pain management and perscription of pain medication.
Agencies Lobbied
U.S. Senate
1st Quarter, 2016
In Q1, HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY had in-house lobbyists. The report was filed on April 19, 2016.
Original Filing: 300797196.xml
Lobbying Issues
Affordable Care Act - Chronic Care Innovations; Small Group Expansion; Payment reform; CBPP; 2017 Notice of Benefit and Payment Parameters; ACA Regulations; Co-ops; Innovations for a Healthier Americans Act; Open Enrollment; Market Stability; Agency Health Research Quality (AHRQ)
Federal Employee Health Benefit Program (FEHBP) regarding proposals to allow additional types of carriers including regional PPOs to be included in the coverage options offered by OPM.
HR 928 Introduced February 12, 2015 by Charles Boustany (R-LA). This bill repeals a provision of the ACA that imposes an annual fee on a health insurance provider based on its net premium income.
HR 1624 Introduced March 25, 2015 by Brett Guthrie (R-KY) to amend title I of the PPACA and title XXVII of the Public Health Service Act to revise the definition of small employer.
HR 2646 Helping Families in Mental Health Crisis Act of 2015 Introduced May 4, 2015 by Tim Murphy (R-PA) To make available needed psychiatric, psychological, and supportive services for individuals with mental illness and families in mental health crisis, and for other purposes.
S. 1099 introduced April 27, 2015 by Tim Scott (R-SC) A bill to amend the PPACA to provide states with flexibility in determining size of employers in the small group market.
Network Adequacy standards; network tiering; network criteria; OMNIA
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicare/Medicaid Issues; Medicare Advantage; Chronic Care Reform; Exchanges; Site-neutral Payments; Quality Improvement Strategy for QHPs; network adequacy standards.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Risk Corridors; Reinsurance.
Agencies Lobbied
U.S. Senate
Lobbying Issues
833; Health Insurance Tax (HIT)
HR 928 Introduced February 12, 2015 by Charles Boustany (R-LA) This bill repeals a provision of the PPACA that imposes an annual fee on a health insurance provider based on its net premium income.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
4th Quarter, 2015
In Q4, HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY had in-house lobbyists. The report was filed on Jan. 21, 2016.
Original Filing: 300784546.xml
Lobbying Issues
Affordable Care Act - Chronic Care Innovations; Small Group Expansion; Payment reform; CBPP; 2017 Notice of Benefit and Payment Parameters; ACA Regulations; Co-ops; Innovations for a Healthier Americans Act; Cyber Security; Open Enrollment; Market Stability; Agency Health Research Quality (AHRQ)
Federal Employee Health Benefit Program (FEHBP) regarding proposals to allow additional types of carriers including regional PPOs to be included in the coverage options offered by OPM
HR 6 21st Century Cures Act introduced May 19, 2015 by Fred Upton (R-MI). This bill amends the Public Health Service Act to reauthorize the National Institutes of Health (NIH) through FY 2018. The NIH Innovation Fund is established to fund a strategic plan, early stage investigators, and high-risk, high-reward research.
HR 928 Introduced February 12, 2015 by Charles Boustany (R-LA). This bill repeals a provision of the ACA that imposes an annual fee on a health insurance provider based on its net premium income.
HR 1624 Introduced March 25, 2015 by Brett Guthrie (R-KY) to amend title I of the PPACA and title XXVII of the Public Health Service Act to revise the definition of small employer.
HR 2646 Helping Families in Mental Health Crisis Act of 2015 Introduced May 4, 2015 by Tim Murphy (R-PA) To make available needed psychiatric, psychological, and supportive services for individuals with mental illness and families in mental health crisis, and for other purposes.
S. 1099 introduced April 27, 2015 by Tim Scott (R-SC) A bill to amend the PPACA to provide states with flexibility in determining size of employers in the small group market.
Network Adequacy standards; network tiering; network criteria; OMNIA
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicare/Medicaid Issues; Medicare Advantage; CHIP reform; Chronic Care Reform; Exchanges; ICD-10; Site-neutral Payments; Quality Improvement Strategy for QHPs; network adequacy standards.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Risk Corridors; Reinsurance; Regional PPO Language
Agencies Lobbied
U.S. Senate
Lobbying Issues
833; Health Insurance Tax (HIT); Cadillac Tax IRA 2015-68 Notice
HR 928 Introduced February 12, 2015 by Charles Boustany (R-LA) This bill repeals a provision of the PPACA that imposes an annual fee on a health insurance provider based on its net premium income.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
3rd Quarter, 2015
In Q3, HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY had in-house lobbyists. The report was filed on Oct. 19, 2015.
Original Filing: 300757164.xml
Lobbying Issues
Pharmaceutical Innovation; Patent Reform; Senate HELP Cures Bill information
Lobbying Issues
Affordable Care Act: Small group expansion; Risk Corridors; Delivery system reform; Implementation issues; Regulations; Premiums; Exchanges; Opioid Abuse; Medical Loss Ratios; Payment Reform; Cybersecurity
Federal Employee Health Benefit Program (FEHBP) regarding proposals to allow additional types of carriers including regional PPOs to be included in the coverage options offered by OPM
HR 6 21st Century Cures Act Introduced May 19,2015 by Fred Upton (R-MI). This bill amends the Public Health Service Act to reauthorize the National Institutes of Health (NIH) through FY2018. The NIH Innovation Fund is established to fund a strategic plan, early stage investigators, and high-risk, high-reward research. The NIH may require scientific data to be shared if the research is fully funded by the NIH. The NIH and the Food and Drug Administration (FDA) must implement a sytem that allows further research on clinical trial data. The Centers for Disease Control and Prevention must expand surveillance of neurological diseases. The Council for 21st Century Cures is established to accelerate the discovery, development, and delivery of innovative cures, treatments, and preventive measures. The Department of Health and Human Services must monitor the use of antibacterial and antifungal drugs and resistance to these drugs.
S. 1099 Introduced April 27, 2015 by Tim Scott (R-SC) A bill to amend the Patient Protection and Affordable Care Act to provide States with flexibility in determining the size of employers in the small group market
HR 928 Introduced February 12, 2015 by Charles Boustany (R-LA) This bill repeals a provision of the Patient Protection and Affordable Care Act that imposes an annual fee on a health insurance provider based on its net premium income.
HR 1624 Introduced March 25, 2015 by Brett Guthrie (R-KY) To amend title I of the Patient Protection and Affordable Care Act and title XXVII of the Public Health Service Act to revise the definition of small employer.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicare/Medicaid Issues; Medigap; Medicare Advantage; CHIP Reform; Chronic Care Reform; MLTSS; D-SNIPs
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Health Insurance Tax; IRC section 833(b) tax provisions Medical Loss Ratio definition to qualify for 833(b) tax deduction; Cadillac tax
HR 928 Introduced February 12, 2015 by Charles Boustany (R-LA) To repeal the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act.
S 183 Introduced January 16, 2015 by John Barasso (R-WY) Jobs and Premium Protection Act. This bill repeals a provision of the Patient Protection and Affordable Care Act that imposes an annual fee on a health insurance provider based on its net premium income.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
2nd Quarter, 2015
In Q2, HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY had in-house lobbyists. The report was filed on July 16, 2015.
Original Filing: 300736786.xml
Lobbying Issues
21st Century Cures
HR 6 21st Century Cures Act Introduced May 19, 2015 by Fred Upton (R-MI) This bill amends the Public Health Service Act to reauthorize the National Institutes of Health (NIH) through FY2018. The NIH Innovation Fund is established to fund a strategic plan,
early stage investigators, and high-risk, high-reward research. The NIH may require scientific data to be shared if the research is fully funded by the NIH. The NIH and the Food and Drug Administration (FDA) must implement a system that allows further research on
clinical trial data. The Centers for Disease Control and Prevention must expand surveillance of neurological diseases. The Council for 21st Century Cures is established to accelerate the discovery, development, and delivery of innovative cures, treatments, and preventive measures. The Department of Health and Human Services must monitor the use of antibacterial and antifungal drugs and resistance to these drugs
Agencies Lobbied
U.S. Senate
Lobbying Issues
Affordable Care Act Issues: Small group expansion; Risk Corridors; Delivery system reform; Consumer experience; Back end issues; Implementation issues; Regulations; Premiums; Exchanges; Supreme Court decision implications
Other Major Health Care Related Issues: Cybersecurity; Medicare Advantage; Reinsurance; Health care quality issues; Community health management; Site-neutral Payments; Dialysis care funding mechanism; Patient reform; Payment reform; Opioid abuse; Medical Loss Ratios; Mental health parity implementation
Federal Employee Health Benefit Program (FEHBP) regarding proposals to allow additional types of carriers including regional PPOs to be included in the coverage options offered by OPM; Alternative structures for the FEHBM.
S 123 Introduced January 8, 2015 by Marco Rubio (R-FL) Obamacare Taxpayer Bailout Prevention Act Repeals the provision of the Patient Protection and Affordable Care Act that directs the Secretary of Health and Human Services to establish and administer a
program of risk corridors for calendar years 2014, 2015, and 2016 under which a qualified.
S. 1099 Introduced April 27, 2015 by Tim Scott (R-SC) A bill to amend the Patient Protection and Affordable Care Act to provide States with flexibility in determining the size of employers in the small group market
HR 221 Introduced January 8, 2015 by Andy Harris (R-MD) Taxpayer bailout of health insurers
HR 928 Introduced February 12, 2015 by Charles Boustany (R-LA) This bill repeals a provision of the Patient Protection and Affordable Care Act that imposes an annual fee on a health insurance provider based on its net premium income.
HR 1624 Introduced March 25, 2015 by Brett Guthrie (R-KY) To amend title I of the Patient Protection and Affordable Care Act and title XXVII of the Public Health Service Act to revise the definition of small employer.
Agencies Lobbied
U.S. Senate
1st Quarter, 2015
In Q1, HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY had in-house lobbyists. The report was filed on April 20, 2015.
Original Filing: 300721606.xml
Lobbying Issues
Affordable Care Act Issues: Risk corridors, back end issues, implementation issues, premiums, exchanges, CHIP reauthorization
Cybersecurity; Medicare Advantage; Small group expansion; reinsurance; health care quality issues; selling insurance across state lines
Medical loss ratios; level playing field for MLRs
Federal Employee Health Benefit Program (FEHBP) regarding proposals to allow additional types of carriers including regional PPOs to be included in coverage options offered by OPM
S 123 Marco Rubio (R-FL) Obamacare Taxpayer Bailout Prevention Act - repeals the provision in PPACA that directs the Secretary of Health and Human Services to establish and administer a program of risk corridors for calendar years 2014-2016
HR 221 Andy Harris (R-MD) Taxpayer bailout of health insurers
HR 1624 Brett Guthrie (R-KY) to amend Title I of PPACA and Title XXVII of the Public Health Service Act to revise the definition of small employer
HR 2 Michael Burgess (R-TX) Medicare Access and CHIP Reauthorization Act of 2015 - amends Title XVII (Medicare) of the Social Security Act to: (1) remove sustainable growth rate (SGR) methodology from the determination of annual conversion factors in the formula for payments to physicians' services, and (2) revise the update in the rates for 2015 and subsequent years. Directs the Secretary of Health and Human Services to establish Merit-based Incentive Payment (MIP) system under which eligible professionals (including physicians, physicians assistants, nurse practioners, clinical nurse specialists, and certified registered nurse anesthetists) shall receive annual payment or decreases based on performance. Requires specified incentive payments to eligible participants in an alternative payment model
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicare Reforms: Medicare A & B; Delivery System Reforms; Benefit Restructuring; Medigap first-dollar coverage; Summary of Benefits Rule
Quality Incentives/SGR Reform; HIPAA Code Adoption Process; Medicare Advantage Risk Delay; Community Health Management; Medicare fraud; Cybersecurity; ICD-10
HR 2 Michael Burgess (R-TX) Medicare Access and CHIP Reauthorization Act of 2015; Amends Title XVIII(Medicare) of the Social Security Act to: (1) remove sustainable growth rate (SGR) methodology from the determination of annual conversion factors in the formula for payment for physicians' services, and (2) revise the update in rates for 2015 and subsequent years. Directs the Secretary of Health and Human Services to establish a Merit-based Incentive Program (MIP) system under which eligible professionals (including physicians, physicians assistants, nurse practioners, clinical nurse specialists, and certified nurse anesthetists) shall receive annual payment increases or decreases based on their performance. Requires specified incentive payments to eligible participants in an alternative payment model.
Agencies Lobbied
U.S. Senate
Lobbying Issues
ACA Risk Corridors; Federal Employee Health Benefit Program (FEHBP) offerings; Government Contributions to FEHBP premiums; SHOP Employer Choice; Regional PPOs
Agencies Lobbied
U.S. Senate
Lobbying Issues
Health Insurance Taxl IRC section 833(b) tax provisions; Health Spending Accounts; Medical Loss Ratio definition to qualify for 833(b) tax deduction
HR 928 Charles Boustany (R-LA) To repeal the annual fee on health insurance providers enacted by the PPACA
S 183 John Barrasso (R-WY) Jobs and Premium Protection Act. This bill repeals a provision of the PPACA that imposes an annual fee on a health insurance provider based on its net premium income.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
4th Quarter, 2014
In Q4, HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY had in-house lobbyists. The report was filed on Jan. 20, 2015.
Original Filing: 300702245.xml
Lobbying Issues
Affordable Private Health Care: Effect of the Health Insurance Tax, defined Essential Health Benefits, and Age Rating on premiums;
Healthcare Delivery System Reforms
Medical Loss Ratios: Level Playing Field for MLRs; Consistent reporting requirements for all insurers; MLR Broker Fees:
Health Care Quality: Delivery System Incentives to Promote Better Care; Payment Reforms; Patient-centered Primary Care/Medical Home; Evidence Based Care; Wellness; Chronic Care Management
Federal Employee Health Benefit Program (FEHBP) regarding proposals to allow additional types of carriers including regional PPOs to be included in the coverage options offered by OPM
FEHBP Modernization Act circulation draft President's budget, regional PPOs, government contributions
Bailouts for Insurance Companies, S. 1726, H.R. 3541, 3812, 3851. 4406
HR 2328 Introduced in House June 12, 2013 Rep. Rogers, Mike J. (R-MI)
HR 3541 introduced by Tim Griffin November 19,2013 Obamacare Taxpayer Bailout Prevention Act - Repeals the provision of the Patient Protection and Affordable Care Act that directs the Secretary of Health and Human Services (HHS) to establish and administer a program of risk corridors for calendar years 2014, 2015, and 2016 under which a qualified health plan offered in the individual or small group market is required to participate in a payment adjustment system based on the ratio of the allowable costs of the plan to the plan's aggregate premiums.
Other general Affordable Care Act topics related to multiple parts of legislation: ACA Implementation and back-end issues;
Multi-State Plan Program Implementation; Risk Corridors and Risk Mitigation; Reinsurance;
Electronic Health Records (EHRs); Health IT Roadmap;
HR 1701 Introduced April 24, 2013 by Ted Poe (R-TX)
Cutting Costly Codes Act of 2013 - Prohibits the Secretary of Health and Human Services (HHS) from implementing,administering, or enforcing specified regulations insofar as they would replace International Classification of Diseases (ICD)-9 with ICD-10 as a standard for code sets for appropriate data elements for financial and administrative transactions involving the electronic exchange of health information.
HR 3750 Introduced December 12, 2013 by Donna Matsui (D-CA) Telehealth Modernization Act of 2013 - Calls for states to authorize health care professionals to deliver health care to individuals through telehealth and to consider adopting conditions under which such a professional should: have access to the individual's medical history.
Agencies Lobbied
U.S. Senate
Lobbying Issues
HR 2960 Introduced August 1, 2013 by Frank Pallone (D-NJ) Medicare Prescription Drug Integrity Act of 2013 - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act (SSA) to require a prescription drug plan (PDP) sponsor to have in place procedures designed to prevent fraud and abuse in PDPs.
HR 5558 Introduced September 18, 2014 by Diane Black (R-TN) To amend title XVIII of the Social Security Act to improve the Medicare accountable care organization (ACO) program, and for other purposes
Agencies Lobbied
U.S. Senate
Lobbying Issues
IRC section 833(b) tax provisions; Health Spending Accounts; Medical Loss Ratio definition to qualify for 833(b) tax deduction; Health Insurance Tax: Health Insurance Excise Tax, S. 603/HR 763, HR 3367,; Tax Extenders; HR 83 and HJ Res 124 Consolidated appropriations
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
ACA Risk Corridors, Omnibus, Federal Health Employee Benefit Program offerings; SHOP Employer Choice; Reinsurance; Regional PPO Language; HR 83 and HJ Res 124 Consolidated appropriations
Agencies Lobbied
U.S. Senate
3rd Quarter, 2014
In Q3, HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY had in-house lobbyists. The report was filed on Oct. 23, 2014.
Original Filing: 300689938.xml
Agencies Lobbied
U.S. Senate
Lobbying Issues
Affordable Private Health Care: Effect of the Health Insurance Tax, defined Essential Health Benefits, and Age Rating on premiums; Healthcare Delivery System Reforms
State-based regulation: State Oversight of Rates; Properly designed state based health insurance exchanges to improve competition and maximize choice; federal exchanges; Multi-State Health Plans; Centralized All-Payer Database
Medical Loss Ratios: Level Playing Field for MLRs; Consistent reporting requirements for all insurers; MLR Broker Fees:
Health Care Quality: Delivery System Incentives to Promote Better Care; Payment Reforms; Patient-centered Primary
Care/Medical Home; Evidence Based Care; Wellness; Chronic Care Management
HR 2667 Introduced by Griffin (R-AR) on July 11, 2013 Authority for Mandate Delay Act
HR 2668 Introduced by Young (R-IN) on July 17, 2013 Fairness for Families Act
Bailouts for Insurance Companies, S. 1726, H.R. 3541, 3812, 3851. 4406
HR 2328 Introduced in House June 12, 2013 Rep. Rogers, Mike J. (R-MI)
HR 3541 introduced by Tim Griffin November 19,2013 Obamacare Taxpayer Bailout Prevention Act - Repeals the provision of the Patient Protection and Affordable Care Act that directs the Secretary of Health and Human Services (HHS) to establish and administer a program of risk corridors for calendar years 2014, 2015, and 2016 under which a qualified health plan offered in the individual or small group market is required to participate in a payment adjustment system based on the ratio of the allowable costs of the plan to the plan's aggregate premiums.
Other general Affordable Care Act topics related to multiple parts of legislation: ACA Implementation and back-end issues;
Multi-State Plan Program Implementation; Risk Corridors and Risk Mitigation; Reinsurance; Small Business Health Options Program (SHOP) implementation; Third-party payment of premiums; Electronic Health Records (EHRs); Health IT Roadmap; Contraception Rule; Expatriate Legislation.
HR 3362 Introduced October 29, 2013 by Rep. Terry, Lee (R-NE)
Exchange Information Disclosure Act - Amends the Patient Protection and Affordable Care Act to expand reporting requirements related to health care exchanges. Requires the Secretary of Health and Human Services (HHS) to publish reports weekly through March 31, 2015, on: (1) consumer interactions with healthcare.gov or subsequent sites and any efforts
undertaken to remedy problems that impact taxpayers and consumers, (2) calls to the federal customer service call center,including the number of calls received by the call center, problems identified by users, and referrals of those calls; (3) all
navigators and certified application counselors that have been trained and certified by health care exchanges; and (4) all agents
and brokers who have been trained and certified by the federal health care exchange.
HR 762 Introduced in House February 15, 2013 by Rep. Blackburn, Marsha (R-TN)
Health Care Choice Act of 2013 - Repeals the health insurance and health coverage expansion requirements of the Patient Protection and Affordable Care Act and related requirements of the Health Care and Education Reconciliation Act of 2010. Restores provisions of law amended or repealed by such provisions.
HR 1701 Introduced April 24, 2013 by Ted Poe (R-TX)
Cutting Costly Codes Act of 2013 - Prohibits the Secretary of Health and Human Services (HHS) from implementing,administering, or enforcing specified regulations insofar as they would replace International Classification of Diseases (ICD)-9 with ICD-10 as a standard for code sets for appropriate data elements for financial and administrative transactions involving the electronic exchange of health information.
HR 4777 Introduced May 30, 2014 by Michael Burgess (R-TX) To amend the Internal Revenue Code of 1986 to modify rules relating to health savings accounts.
HR 3522 Introduced November 18, 2013 by Bill Cassidy (R-LA) To authorize health insurance issuers to continue to offer for sale current group health insurance coverage in satisfaction of the minimum essential health insurance coverage requirement,
and for other purposes.
HR 3750 Introduced December 12, 2013 by Donna Matsui (D-CA) Telehealth Modernization Act of 2013 - Calls for states to authorize health care professionals to deliver health care to individuals through telehealth and to consider adopting conditions under which such a professional should: have access to the individual's medical history.
HR 5453 Introduced September 11, 2014 by Bruce Braley (D-IA) To authorize health insurance issuers to continue to offer for sale current group health insurance coverage in satisfaction of the minimum essential health insurance coverage requirement,
and for other purposes.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicare Reforms: Medicare A & B; Delivery System Reforms, Benefit Restructuring ; Medigap first-dollar coverage; Quality Initiatives/SGR Reform, HIPAA Code Adoption Process, Medicare Advantage Risk Delay Part D Cuts, HR 2810 Introduced by Burgess (R-TX) on July 31, 2013
Addtional Medicare/Medicaid Issues:
HR 3392 Introduced October 13, 2013 by Gus Bilirakis (R-FL) To amend title XVIII of the Social Security Act to provide for a PDP safety program to prevent fraud and abuse in the dispensing of controlled substances under part D of the Medicare program, and for other purposes.
Multi-State Plan Programs, Medicare Patient Access and Quality Improvement Act of 2013, Medicare Prescription Drug Integrity. Medicare fraud; Provider terminations in Medicare Advantage; CHIP (Children's Health Insurance Program)reauthorization
HR 2960 Introduced August 1, 2013 by Frank Pallone (D-NJ) Medicare Prescription Drug Integrity Act of 2013 - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act (SSA) to require a prescription drug plan (PDP) sponsor to have in place procedures designed to prevent fraud and abuse in PDPs.
D-SNP Plan Changes
Agencies Lobbied
U.S. Senate
Lobbying Issues
IRC section 833(b) tax provisions; Health Spending Accounts; Medical Loss Ratio definition to qualify for 833(b) tax deduction; Health Insurance Tax: Health Insurance Excise Tax, S. 603/HR 763, HR 3367
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
2nd Quarter, 2014
In Q2, HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY had in-house lobbyists. The report was filed on July 16, 2014.
Original Filing: 300657756.xml
Lobbying Issues
See attached addendum for general issue area code: HCR - Health IssuesAffordable Private Health Care: Effect of the Health Insurance Tax, defined Essential Health Benefits, and Age Rating on
premiums; Healthcare Delivery System Reforms
State-based regulation: State Oversight of Rates; Properly designed state based health insurance exchanges to improve
competition and maximize choice; federal exchanges; Multi-State Health Plans; Centralized All-Payer Database
Medical Loss Ratios: Level Playing Field for MLRs; Consistent reporting requirements for all insurers; MLR Broker Fees:
Health Care Quality: Delivery System Incentives to Promote Better Care; Payment Reforms; Patient-centered Primary
Care/Medical Home; Evidence Based Care; Wellness; Chronic Care Management
Federal Employee Health Benefit Program (FEHBP) regarding proposals to allow additional types of carriers including regional
PPOs to be included in the coverage options offered by OPM
FEHBP Modernization Act circulation draft President's budget, regional PPOs, government contributions
HR 2667 Introduced by Griffin (R-AR) on July 11, 2013
Bailouts for Insurance Companies, S. 1726, H.R. 3541, 3812, 3851. 4406
HR 3541 introduced by Tim Griffin November 19,2013 Obamacare Taxpayer Bailout Prevention Act - Repeals the provision of
the Patient Protection and Affordable Care Act that directs the Secretary of Health and Human Services (HHS) to establish and
administer a program of risk corridors for calendar years 2014, 2015, and 2016 under which a qualified health plan offered in
the individual or small group market is required to participate in a payment adjustment system based on the ratio of the allowable
costs of the plan to the plan's aggregate premiums.
Other general Affordable Care Act topics related to multiple parts of legislation: ACA Implementation and back-end issues;
Multi-State Plan Program Implementation; Risk Corridors and Risk Mitigation; Reinsurance; Small Business Health Options
Program (SHOP) implementation; Third-party payment of premiums; Electronic Health Records (EHRs); Health IT Roadmap;
Contraception Rule
HR 762 Introduced in House February 15, 2013 by Rep. Blackburn, Marsha (R-TN)
Health Care Choice Act of 2013 - Repeals the health insurance and health coverage expansion requirements of the Patient
Protection and Affordable Care Act and related requirements of the Health Care and Education Reconciliation Act of 2010.
Restores provisions of law amended or repealed by such provisions.
HR 1701 Introduced April 24, 2013 by Ted Poe (R-TX)
Cutting Costly Codes Act of 2013 - Prohibits the Secretary of Health and Human Services (HHS) from implementing,
administering, or enforcing specified regulations insofar as they would replace International Classification of Diseases (ICD)-9
with ICD-10 as a standard for code sets for appropriate data elements for financial and administrative transactions involving the
electronic exchange of health information.
HR 3985 Introduced February 3, 2014 by Lynn Westmoreland (R-GA) Prohibits health insurance issuers and third-party
administrators, for any period after December 31, 2014, from being required to make payments under the Patient Protection and
Affordable Care Act (PPACA) for a transitional reinsurance program for the individual health insurance market in each state.
Allows payments to issuers, as limited by this Act, only to the extent of available funds. Limits to 2014 the applicability of the
program of risk corridors, under which a qualified health plan offered in the individual or small group market shall participate in
a payment adjustment system based on the ratio of the allowable costs of the plan to the plan's aggregate premiums .
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
See attached addendum for general issue area code: MMM - Medicare/MedicaidMedicare Reforms: Medicare A & B; Delivery System Reforms, Benefit Restructuring ; Medigap first-dollar coverage;
Quality Initiatives/SGR Reform, HIPAA Code Adoption Process, Medicare Advantage Risk Delay
Part D Cuts, HR 2810 Introduced by Burgess (R-TX) on July 31, 2013
HR 3392 Introduced October 13, 2013 by Gus Bilirakis (R-FL) To amend title XVIII of the Social Security Act to provide for a
PDP safety program to prevent fraud and abuse in the dispensing of controlled substances under part D of the Medicare program,
and for other purposes.
Multi-State Plan Programs, Medicare Patient Access and Quality Improvement Act of 2013, Medicare Prescription Drug
Integrity. Medicare fraud; Provider terminations in Medicare Advantage
HR 4160 Introduced March 6, 2014 by Renee Ellmers (R-NC) Keep the Promise to Seniors Act of 2014 - Prohibits the
Secretary of Health and Human Services (HHS) from taking any action (through promulgation of a final or interim final
regulation, issuance of regulatory or program guidance, use of federal payment audit procedures, or other enforcement or
administrative action, policy, or practice) to implement any provision of the proposed regulation (relating to policy and technical changes to the MedicareAdvantage and part D programs under Medicare) published in the Federal Register on January 10, 2014, insofar as that regulation relates to part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act (SSA), including its application to MedicareAdvantage- Prescription Drug (MA-PD) plans under part C
(Medicare+Choice Program).
HR 4930 Introduced June 20, 2014 by Joe Barton (R-TX) Advancing Care for Exceptional Kids Act of 2014 or the ACE Kids
Act of 2014 - Amends titles XIX (Medicaid) and XXI (Children's Health Insurance) (CHIP) of the Social Security Act to extend
medical assistance to payment for items and services furnished under a Medicaid Children's Care Coordination (MCCC)
Program which the state may elect to provide to eligible children with complex medical conditions
HR 4577 Introduced May 6, 2014 by H. Griffith (R-VA) Ensuring Seniors Access to Local Pharmacies Act of 2014 - Amends
part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act with respect to a
prescription drug plan that has, in its network of pharmacies, one or more pharmacies located in a health professional shortage
area, in a medically underserved area, or among a medically underserved population, and that provides a reduction in coinsurance
or copayments for covered part D drugs dispensed through them. Declares that such a plan shall extend to any pharmacy located
in that area or among that population the option to be an in-network pharmacy with respect to such plan under terms and
conditions comparable to those the plan has agreed upon with other in-network pharmacies located in the area or among that
population.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
IRC section 833(b) tax provisions; Health Spending Accounts; Medical Loss Ratio definition to qualify for 833(b) tax deduction;
Health Insurance Tax: Health Insurance Excise Tax, S. 603/HR 763, HR 3367
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
1st Quarter, 2014
In Q1, HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY had in-house lobbyists. The report was filed on April 21, 2014.
Original Filing: 300644104.xml
Lobbying Issues
Please see attached addendum for general issue area code: HCRS. 1486 Introduced August 1, 2013 by Sen. Carper, Thomas R. (D-DE)
Postal Reform Act of 2013 - Amends provisions of federal law relating to the funding of the U.S. Postal Service (USPS)
retirement and health care systems, operations, revenue, and governance.. Section 104 Substitute Amendment.
HR 3362 Introduced October 29,2013 by Rep. Terry, Lee (R-NE)
Exchange Information Disclosure Act - Amends the Patient Protection and Affordable Care Act to expand reporting
requirements related to health care exchanges. Requires the Secretary of Health and Human Services (HHS) to publish reports
weekly through March 31, 2015, on: (1) consumer interactions with healthcare.gov or subsequent sites and any efforts
undertaken to remedy problems that impact taxpayers and consumers, (2) calls to the federal customer service call center,
including the number of calls received by the call center, problems identified by users, and referrals of those calls; (3) all
navigators and certified application counselors that have been trained and certified by health care exchanges; and (4) all agents
and brokers who have been trained and certified by the federal health care exchange.
HR 762 Introduced in House February 15, 2013 by Rep. Blackburn, Marsha (R-TN)
Health Care Choice Act of 2013 - Repeals the health insurance and health coverage expansion requirements of the Patient
Protection and Affordable Care Act and related requirements of the Health Care and Education Reconciliation Act of 2010.
Restores provisions of law amended or repealed by such provisions.
HR 1701 Introduced April 24, 2013 by Ted Poe (R-TX)
Cutting Costly Codes Act of 2013 - Prohibits the Secretary of Health and Human Services (HHS) from implementing,
administering, or enforcing specified regulations insofar as they would replace International Classification of Diseases (ICD)-9
with ICD-10 as a standard for code sets for appropriate data elements for financial and administrative transactions involving the
electronic exchange of health information.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Medicare Reforms: Medicare A & B; Delivery System Reforms, Benefit Restructuring ; Medigap first-dollar coverage;
Quality Initiatives/SGR Reform, HIPAA Code Adoption Process, Medicare Advantage Risk Delay
Part D Cuts, HR 2810 Introduced by Burgess (R-TX) on July 31, 2013
Multi-State Plan Programs, Medicare Patient Access and Quality Improvement Act of 2013, Medicare Prescription Drug Integrity.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
IRC section 833(b) tax provisions; Health Spending Accounts; Medical Loss Ratio definition to qualify for 833(b) tax deduction;
Health Insurance Tax: Health Insurance Excise Tax, S. 603/HR 763, HR 3367
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
4th Quarter, 2013
In Q4, HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY had in-house lobbyists. The report was filed on Jan. 21, 2014.
Original Filing: 300623483.xml
Lobbying Issues
Please see attached addendum for General Issue Area: HCR - Health IssuesSuccessful Insurance Industry Implementation of Health Reforms: Reasonable regulatory implementation timeline for compliance with PL 111-148
Affordable Private Health Care: Effect of the Health Insurance Tax, defined Essential Health Benefits, and Age Rating on
premiums; Healthcare Delivery System Reforms
State-based regulation: State Oversight of Rates; Properly designed state based health insurance exchanges to improve
competition and maximize choice; federal exchanges; Multi-State Health Plans; Centralized All-Payer Database
Medical Loss Ratios: Level Playing Field for MLRs; Consistent reporting requirements for all insurers; MLR Broker Fees:
Health Care Quality: Delivery System Incentives to Promote Better Care; Payment Reforms; Patient-centered Primary
Care/Medical Home; Evidence Based Care; Wellness; Chronic Care Management
Insurance Market Reform; Individual Market Reform; Small Group Market Reform; Guaranteed Issue; Community Rating; Age
Rating; Health Savings Accounts
Federal Employee Health Benefit Program (FEHBP) regarding proposals to allow additional types of carriers including regional
PPOs to be included in the coverage options offered by OPM
S. 1488 Introduced in Senate September 9, 2013
Fairness for American Families Act - Amends the Internal Revenue Code, as amended by the Patient Protection and Affordable
Care Act (PPACA), to delay until 2015 the requirement that individuals maintain minimal essential health care coverage.
Authority for Mandate Delay Act - Amends PPACA to delay until 2015 enforcement of requirements that large employers offer
their full-time employees the opportunity to enroll in minimum essential coverage. Delays the effective date of related
reporting requirements for such employers and for providers of minimum essential coverage.
HR 3350 Passed House without amendment November 15, 2013
Keep Your Health Plan Act of 2013 - Permits a health insurance issuer that has in effect health insurance coverage in the
individual market as of January 1, 2013, to continue offering such coverage for sale during 2014 outside of a health care
exchange established under the Patient Protection and Affordable Care Act. Treats such coverage as a grandfathered health plan
for purposes of an individual meeting the requirement to maintain minimum essential health coverage.
HR 2328 Introduced in House June 12, 2013 Rep. Rogers, Mike J. (R-MI)
Access to Professional Health Insurance Advisors Act of 2013 - Amends the Public Health Service Act to exclude remuneration
paid for licensed independent insurance producers from administrative cost calculations for purposes of calculating the
medical-loss ratio of a health insurance plan.
HR 762 Introduced in House February 15, 2013 by Rep. Blackburn, Marsha (R-TN)
Health Care Choice Act of 2013 - Repeals the health insurance and health coverage expansion requirements of the Patient
Protection and Affordable Care Act and related requirements of the Health Care and Education Reconciliation Act of 2010.
Restores provisions of law amended or repealed by such provisions.
Grandfathering and Delay of Individual Mandate
ACA Implementation
Multi-state Plan Program Implementation
Risk Corridors
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Medicare Reforms: Medicare A & B; Delivery System Reforms, Benefit Restructuring ; Medigap first-dollar coverage;
Quality Initiatives/SGR Reform
HR 2810 Introduced by Burgess (R-TX) on July 31, 2013
Medicare Patient Access and Quality Improvement Act of 2013
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
IRC section 833(b) tax provisions; Health Spending Accounts; Medical Loss Ratio definition to qualify for 833(b) tax deduction;
Health Insurance Tax: Health Insurance Excise Tax, HR 763, HR 3367
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
3rd Quarter, 2013
In Q3, HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY had in-house lobbyists. The report was filed on Oct. 21, 2013.
Original Filing: 300605031.xml
Lobbying Issues
Please see attached addendum for general issue area code: HCRSuccessful Insurance Industry Implementation of Health Reforms: Reasonable regulatory implementation timeline for
compliance with PL 111-148
Affordable Private Health Care: Effect of the Health Insurance Tax, defined Essential Health Benefits, and Age Rating on
premiums; Healthcare Delivery System Reforms
State-based regulation: State Oversight of Rates; Properly designed state based health insurance exchanges to improve
competition and maximize choice; federal exchanges; Multi-State Health Plans; Centralized All-Payer Database
Medical Loss Ratios: Level Playing Field for MLRs; Consistent reporting requirements for all insurers; MLR Broker Fees:
Health Care Quality: Delivery System Incentives to Promote Better Care; Payment Reforms; Patient-centered Primary
Care/Medical Home; Evidence Based Care; Wellness; Chronic Care Management
Insurance Market Reform; Individual Market Reform; Small Group Market Reform; Guaranteed Issue; Community Rating; Age
Rating; Health Savings Accounts
Federal Employee Health Benefit Program (FEHBP) regarding proposals to allow additional types of carriers including regional
PPOs to be included in the coverage options offered by OPM
HR 2667 Introduced by Griffin (R-AR) on July 11, 2013
Authority for Mandate Delay Act
HR 2668 Introduced by Young (R-IN) on July 17, 2013
Fairness for Families Act
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Medicare Reforms: Medicare A & B; Delivery System Reforms, Benefit Restructuring ; Medigap first-dollar coverage;
Medicare Patient Access and Quality Improvement Act of 2013; H.R. 2960, Medicare Prescription Drug Integrity Act of 2013
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
IRC section 833(b) tax provisions; Health Spending Accounts; Medical Loss Ratio definition to qualify for 833(b) tax deduction;
Health Insurance Tax:
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
2nd Quarter, 2013
In Q2, HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY had in-house lobbyists. The report was filed on July 22, 2013.
Original Filing: 300584350.xml
Lobbying Issues
See attached addendum for general issue area: HCR.Successful Insurance Industry Implementation of Health Reforms: reasonable regulatory implementation timeline for
compliance with PL 111-148
Affordable Private Health Care: effect of the Health Insurance Tax, defined Essential Health Benefits, and Age Rating on
premiums; Healthcare Delivery System Reforms
State-based regulation: State Oversight of Rates; Properly designed state based health insurance exchanges to improve
competition and maximize choice; federal exchanges; Multi-State Health Plans; Centralized All-Payer Database
Medical Loss Ratios: Level Playing Field for MLRs; Consistent reporting requirements for all insurers; MLR Broker Fees:
Health Care Quality: Delivery System Incentives to Promote Better Care; Payment Reforms; Patient-centered Primary
Care/Medical Home; Evidence Based Care; Wellness; Chronic Care Management
Insurance Market Reform; Individual Market Reform; Small Group Market Reform; Guaranteed Issue; Community Rating; Age
Rating; Health Savings Accounts
Federal Employee Health Benefit Program (FEHBP) regarding proposals to allow additional types of carriers including regional
PPOs to be included in the coverage options offered by OPM
HR 2328 Introduced by Rogers (R-Mi.) on June 12, 2013
Access to Professional Health Insurance Advisors Act of 2013.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Medicare Reforms: Medicare A & B; Delivery System Reforms, Benefit Restructuring ; Medigap first-dollar coverage;
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
IRC section 833(b) tax provisions; Health Spending Accounts; Medical Loss Ratio definition to qualify for 833(b) tax deduction;
Health Insurance Tax:
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
1st Quarter, 2013
In Q1, HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY had in-house lobbyists. The report was filed on April 22, 2013.
Original Filing: 300559879.xml
Lobbying Issues
Please see attached addendum for general issue area: HCR - Health IssuesSuccessful Insurance Industry Implementation of Health Reforms: reasonable regulatory implementation timeline for
compliance with PL 111-148
Affordable Private Health Care: effect of the Health Insurance Tax, defined Essential Health Benefits, and Age Rating on
premiums; Healthcare Delivery System Reforms
State-based regulation: State Oversight of Rates; Properly designed state based health insurance exchanges to improve
competition and maximize choice; federal exchanges; Multi-State Health Plans; Centralized All-Payer Database
Medical Loss Ratios: Level Playing Field for MLRs; Consistent reporting requirements for all insurers; MLR Broker Fees:
Health Care Quality: Delivery System Incentives to Promote Better Care; Payment Reforms; Patient-centered Primary
Care/Medical Home; Evidence Based Care; Wellness; Chronic Care Management
Insurance Market Reform; Individual Market Reform; Small Group Market Reform; Guaranteed Issue; Community Rating; Age
Rating; Health Savings Accounts
HR 544 Introduced by Gingrey (R-Ga.) on February 6, 2013 - Letting Insurance Benefit Everyone Regardless of Their Youth (LIBERTY) Act
HR 763 Introduced by Boustany (R-La.) on February 15, 2013 - A bill to repeal the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act.
S 603 Introduced by Barrasso (R-Wyo.) on March 19, 2013 - A bill to repeal the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Medicare Reforms: Medicare A & B; Delivery System Reforms, Benefit Restructuring ; Medigap first-dollar coverage;
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
IRC section 833(b) tax provisions; ; Medical Loss Ratio definition to qualify for 833(b) tax deduction;
Health Insurance Tax: HR 763 Introduced by Boustany (R-La.) on February 15, 2013 - bill to repeal the annual fee on health
insurance providers enacted by the Patient Protection and Affordable Care Act.; S 603 Introduced by Barrasso (R-Wyo.) on March
19, 2013 - bill to repeal the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
4th Quarter, 2012
In Q4, HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY had in-house lobbyists. The report was filed on Jan. 22, 2013.
Original Filing: 300539272.xml
Lobbying Issues
Please see attached addendum for general issue area code: HCR - Health IssuesSuccessful Insurance Industry Implementation of Health Reforms: reasonable regulatory implementation timeline for
compliance with PL 111-148
Affordable Private Health Care: effect of the Health Insurance Tax, defined Essential Health Benefits, and Age Rating on
premiums; Healthcare Delivery System Reforms
State-based regulation: State Oversight of Rates; Properly designed state based health insurance exchanges to improve
competition and maximize choice; federal exchanges; Multi-State Health Plans; Centralized All-Payer Database
Medical Loss Ratios: Level Playing Field for MLRs; Consistent reporting requirements for all insurers; MLR Broker Fees:
HR1206 "Access to Professional Health Insurance Act of 2011", S 2068 "Access to Independent Health Insurance Advisors Act
of 2012"
Health Care Quality: Delivery System Incentives to Promote Better Care; Payment Reforms; Patient-centered Primary
Care/Medical Home; Evidence Based Care; Wellness; Chronic Care Management
Insurance Market Reform; Individual Market Reform; Small Group Market Reform; Guaranteed Issue; Community Rating; Age
Rating; Health Savings Accounts
Federal Employee Health Benefit Program (FEHBP) regarding proposals to allow additional types of carriers including regional
PPOs to be included in the coverage options offered by OPM; HR 2309 "Postal Reform Act of 2011" sections pertaining to
FEHBP; S1789 "21st Century Postal Service Act of 2012" sections pertaining to Postal Benefits carveout
Printed
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Medicare Reforms: Medicare A & B; Delivery System Reforms, Benefit Restructuring ; Medigap first-dollar coverage; HR 1063
"Strengthening Medicare And Repaying Taxpayers Act of 2011"; Fraud;; S1789 "21st Century Postal Service Act of 2012" sections
pertaining to wraparound plan for postal workers with Medicare Part A & B
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
IRC section 833(b) tax provisions; Health Savings Accounts; Medical Loss Ratio definition to qualify for 833(b) tax deduction;
Health Insurance Tax: HR1370 "To Repeal the annual fee on Health Insurance Providers Enacted by PPACA" and S1880 "Jobs and
Premium Protection Act"
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
3rd Quarter, 2012
In Q3, HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY had in-house lobbyists. The report was filed on Oct. 18, 2012.
Original Filing: 300510895.xml
Lobbying Issues
See attached addendum for General Issue Area: HCR - Health IssuesSuccessful Insurance Industry Implementation of Health Reforms: reasonable regulatory implementation timeline for
compliance with PL 111-148, Retail store
Affordable Private Health Care: Health Insurance Tax; Affordable Essential Health Benefits; Inextricable link between Individual
Mandate and Insurance Reforms; Healthcare Delivery System Reforms; BCBSA's proposal "Building Tomorrow's Healthcare
System: The Pathway to High-Quality, Affordable Care in America"
State-based regulation: State Oversight of Rates; Properly designed state based health insurance exchanges to improve
competition and maximize choice; federal exchanges; existing state regulatory functions; Selling Health Insurance across state
lines: HR371 "Health Care Choice Act of 2011"; Multi-State Health Plans
Medical Loss Ratios: MLR Broker Fee; State Innovation Waivers; Quality improvement definition; Consistent reporting
requirements for all insurers; Transition for smaller states and Plans; include benefits for individuals as well as populations;
MLR Broker Fees: HR1206 "Access to Professional Health Insurance Act of 2011", S 2068 "Access to Independent Health
Insurance Advisors Act of 2012"
Health Care Quality: Delivery System Incentives to Promote Better Care; Payment Reforms; Patient-centered Primary
Care/Medical Home; Comparative Effectiveness Research; Evidence Based Care; Health Disparities; Wellness; Chronic Care
Management; Telemedicine
Health Information Technology Standards; Health Information Privacy; Electronic Health Records; Administrative
Simplification; ICD10 implementation; Data Sharing; Data Aggregation; Centralized All-Payer Database
Insurance Market Reform; Individual Market Reform; Small Group Market Reform; Small Business Healthcare; Guaranteed
Issue; Community Rating; Age Rating; Health Status Rating; Health Savings Accounts: HR5858 "Health Savings Accounts
Improvement Act of 2012"; Individual Mandate; Association Health Plans
Federal Employee Health Benefit Program (FEHBP) regarding proposals to allow additional types of carriers including regional
PPOs to be included in the coverage options offered by OPM; HR 2309 "Postal Reform Act of 2011" sections pertaining to
FEHBP; S1789 "21st Century Postal Service Act of 2012" sections pertaining to Postal Benefits carveout; OMB Postal Benefit
Carveout
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Medigap first-dollar coverage; S1789 "21st Century Postal Service Act of 2012" sections pertaining to wraparound plan for postal
workers with Medicare Part A & B; Delivery System Reforms; Physician Payment Alternatives; Fee for Service Payment Reforms;
HR 1063 "Strengthening Medicare And Repaying Taxpayers Act of 2011," Medicaid PCA rates
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
IRC section 833(b) tax provisions; Health Savings Accounts; Medical Loss Ratio definition to qualify for 833(b) tax deduction;
Health Insurance Tax: HR1370 "To Repeal the annual fee on Health Insurance Providers Enacted by PPACA" and S1880 "Jobs and
Premium Protection Act"
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
2nd Quarter, 2012
In Q2, HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY had in-house lobbyists. The report was filed on July 19, 2012.
Original Filing: 300491946.xml
Lobbying Issues
See attached addendum on General Issue Area Code: HCR - HealthcareSuccessful Insurance Industry Implementation of Health Reforms: good faith compliance standard, reasonable regulatory
implementation timeline for compliance with PL 111-148
Affordable Private Health Care: Health Insurance Tax; Affordable Essential Health Benefits; Inextricable link between Individual
Mandate and Insurance Reforms; Healthcare Delivery System Reforms; BCBSA's proposal "Building Tomorrow's Healthcare
System: The Pathway to High-Quality, Affordable Care in America"
State-based regulation: State Oversight of Rates; Properly designed state based health insurance exchanges to improve
competition and maximize choice; federal exchanges; existing state regulatory functions; Selling Health Insurance across state
lines: HR371 "Health Care Choice Act of 2011"
Medical Loss Ratios: MLR Broker Fee; State Innovation Waivers; Quality improvement definition; Consistent reporting
requirements for all insurers; Transition for smaller states and Plans; include benefits for individuals as well as populations
Health Care Quality: Delivery System Incentives to Promote Better Care; Payment Reforms; Patient-centered Primary
Care/Medical Home; Comparative Effectiveness Research; Evidence Based Care; Health Disparities; Wellness; Chronic Care
Management; Telemedicine
Health Information Technology Standards; Health Information Privacy; Electronic Health Records; Administrative
Simplification; ICD10 implementation; Data Sharing; Data Aggregation; Centralized All-Payer Database
Insurance Market Reform; Individual Market Reform; Small Group Market Reform; Small Business Healthcare; Guaranteed
Issue; Community Rating; Health Status Rating; Health Savings Accounts: HR5858 "Health Savings Accounts Improvement Act
of 2012"; Individual Mandate; Association Health Plans
Federal Employee Health Benefit Program (FEHBP) regarding proposals to allow additional types of carriers including regional
PPOs to be included in the coverage options offered by OPM; HR 2309 "Postal Reform Act of 2011" sections pertaining to
FEHBP; S1789 "21st Century Postal Service Act of 2012" sections pertaining to Postal Benefits carveout; OMB Postal Benefit
Carveout; OPM IG's Statement on FEHBP audits
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Medigap first-dollar coverage; S1789 "21st Century Postal Service Act of 2012" sections pertaining to wraparound plan for postal
workers with medigap Part A & B; Delivery System Reforms; Physician Payment Alternatives
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
.IRC section 833(b) tax provisions; Health Savings Accounts; Medical Loss Ratio definition to qualify for 833(b) tax deduction;
MLR Broker Fees: HR1206 "Access to Professional Health Insurance Act of 2011"; Health Insurance Tax: HR1370 "To Repeal the
annual fee on Health Insurance Providers Enacted by PPACA" and S1880 "Jobs and Premium Protection Act"
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
1st Quarter, 2012
In Q1, HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY had in-house lobbyists. The report was filed on April 20, 2012.
Original Filing: 300475668.xml
Lobbying Issues
See attached addendum for General Lobbying Issue Area: HCR - HealthcareSuccessful Insurance Industry Implementation of Health Reforms: good faith compliance standard, reasonable regulatory
implementation timeline for compliance with PL 111-148
Affordable Private Health Care: Health Insurance Excise Tax; Realistic Essential Health Benefits; Effective Individual Mandate;
Healthcare Delivery System Reforms; Small Employer Tax Credits; BCBSA's proposal "Building Tomorrow's Healthcare
System: The Pathway to High-Quality, Affordable Care in America"
State-based regulation: State Oversight of Premium Increases; Properly designed state based health insurance exchanges to
improve competition and maximize choice; federal exchanges; federal rate review; existing state regulatory functions; Selling
Health Insurance across state lines: HR371 Health Care Choice Act of 2011; HR1213 "Repeal mandatory funding provided to
States in the PPACA to Establish Benefit Exchanges"; HR5 "HEALTH Act of 2011"
Medical Loss Ratios: MLR Broker Fee HR1206 Access to Professional Health Insurance Advisors Act of 2011; State
Innovation Waivers; Quality improvement definition; Consistent reporting requirements for all insurers; Transition for smaller
states and Plans; include benefits for individuals as well as populations
Health Care Quality: Delivery System Incentives to Promote Better Care; Payment Reforms; Patient-centered Primary
Care/Medical Home; Comparative Effectiveness Research; Evidence Based Care; Health Disparities; Wellness; Chronic Care
Management
Health Information Technology Standards; Health Information Privacy; Electronic Health Records; Administrative
Simplification; ICD10 implementation; Data Sharing; Data Aggregation; Centralized All-Payer Database
Insurance Market Reform; Individual Market Reform; Small Group Market Reform; Small Business Healthcare; Guaranteed
Issue; Community Rating; Health Status Rating; Health Savings Accounts/Medical Savings Accounts; Individual Mandate;
MEWAs
Federal Employee Health Benefit Program (FEHBP) regarding proposals to allow additional types of carriers including regional
PPOs to be included in the coverage options offered by OPM.
Comprehensive Primary Care Initiative grant proposal from CMMI.
HR4209 "Patient's Access to Treatments Act of 2012"
HR3630 "Middle Class Tax Relief and Job Creation Act of 2012"
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
IRC section 833(b) tax provisions; Small Employer Tax Credits; Health Savings Accounts; Medical Loss Ratio definition to qualify
for 833(b) tax deduction; MLR Broker Fees HR1206 "Access to Professional Health Insurance Act of 2011"; health insurer excise
tax; HR1370 "To Repeal the annual fee on Health Insurance Providers Enacted by PPACA"; S1880 "Jobs and Premium Protection
Act"
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Medigap first-dollar coverage; HR452 "Medicare Decisions Accountability Act of 2011"
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2011
In Q4, HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY had in-house lobbyists. The report was filed on Jan. 20, 2012.
Original Filing: 300446498.xml
Lobbying Issues
Medicare Advantage funding; deficit; BCBSA's proposal "Building Tomorrow's Healthcare System: The Pathway to High-Quality,
Affordable Care in America"; Consolidated Appropriations Act of 2012
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Medicare Advantage; HR1683 and S868 "State Flexibility Act"; Medigap first-dollar coverage
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
IRC section 833(b) tax provisions; annual insurer assessments, proposed excise tax on high-value health insurance plans, limitation
of tax deduction for health insurer's executive compensation; Small Employer Tax Credits; Health Savings Accounts; Medical Loss
Ratio definition to qualify for 833(b) tax deduction; MLR Broker Fees HR1206 "Access to Professional Health Insurance Act of
2011"; HR1370 "To Repeal the annual fee on Health Insurance Providers Enacted by PPACA"
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
See attached addendum for General Issue Area: HCR - Health IssuesSuccessful Insurance Industry Implementation of Health Reforms: good faith compliance standard, reasonable effective dates
for compliance with PL 111-148
Affordable Private Health Care: Insurer Fees; Realistic Essential Health Benefits; Effective Individual Mandate; Healthcare
Delivery System Reforms; Small Employer Tax Credits; Adequate Insurer Reserve Levels; Most Favored Nation clauses in
provider health contracts; Individual responsibility to obtain and maintain insurance coverage; Health Insurance Excise Tax
State-based regulation: State Oversight of Premium Increases; Creation of State-based Exchanges; Value of properly designed
state health insurance exchanges to improve competition and maximize choice; federal exchanges; federal rate review; existing
state regulatory functions; Selling Health Insurance across state lines: HR371 Health Care Choice Act of 2011; HR1213
"Repeal mandatory funding provided to States in the PPACA to Establish Benefit Exchanges"; HR5 "HEALTH Act of 2011"
Medical Loss Ratios: MLR Broker Fee HR1206 Access to Professional Health Insurance Advisors Act of 2011; State
Innovation Waivers; Quality improvement definition; Consistent reporting requirements for all insurers; Transition for smaller
states and Plans; include benefits for individuals as well as populations
Health Care Quality: Delivery System Incentives to Promote Better Care; Payment Reforms; Patient-centered Primary
Care/Medical Home; Comparative Effectiveness Research; Evidence Based Care; Health Disparities; Wellness; Chronic Care
Management; Childhood Obesity
Health Information Technology Standards; Health Information Privacy; Electronic Health Records; Administrative
Simplification; ICD10 Real time claims adjudication; Data Sharing; Data Aggregation; Centralized All-Payer Database
Insurance Market Reform; Individual Market Reform; Small Group Market Reform; Small Business Healthcare; Guaranteed
Issue; Community Rating; Health Status Rating; Health Savings Accounts/Medical Savings Accounts; Individual Mandate;
MEWAs
BCBSA's proposal "Building Tomorrow's Healthcare System: The Pathway to High-Quality, Affordable Care in America"
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2011
In Q3, HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY had in-house lobbyists. The report was filed on Oct. 18, 2011.
Original Filing: 300416600.xml
Lobbying Issues
See attached addendum on General Lobbying Issue Area: HCR - Health Issues Successful Insurance Industry Implementation of Health Reforms: good faith compliance standard, reasonable effective dates
for compliance with PL 111-148
Affordable Private Health Care: Insurer Fees; Realistic Essential Health Benefits; Effective Individual Mandate; Healthcare
Delivery System Reforms; Small Employer Tax Credits; Adequate Insurer Reserve Levels; Most Favored Nation clauses in
provider health contracts; Individual responsibility to obtain and maintain insurance coverage; Health Insurance Excise Tax
State-based regulation: State Oversight of Premium Increases; Creation of State-based Exchanges; Value of properly designed
state health insurance exchanges to improve competition and maximize choice; federal exchanges; federal rate review; existing
state regulatory functions; Selling Health Insurance across state lines: HR371 Health Care Choice Act of 2011; HR1213
"Repeal mandatory funding provided to States in the PPACA to Establish Benefit Exchanges"; HR5 "HEALTH Act of 2011"
Medical Loss Ratios: MLR Broker Fee HR1206 Access to Professional Health Insurance Advisors Act of 2011; State
Innovation Waivers; Quality improvement definition; Consistent reporting requirements for all insurers;
Health Care Quality: Delivery System Incentives to Promote Better Care; Payment Reforms; Patient-centered Primary
Care/Medical Home; Comparative Effectiveness Research; Evidence Based Care; Health Disparities; Wellness; Chronic Care
Management; Childhood Obesity
Insurance Market Reform; Individual Market Reform; Small Group Market Reform; Small Business Healthcare; Guaranteed
Issue; Community Rating; Health Status Rating; Health Savings Accounts/Medical Savings Accounts; Individual Mandate;
MEWAs
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
IRC section 833(b) tax provisions; annual insurer assessments, proposed excise tax on high-value health insurance plans, limitation
of tax deduction for health insurer's executive compensation; Small Employer Tax Credits; Health Savings Accounts; Medical Loss
Ratio definition to qualify for 833(b) tax deduction; MLR Broker Fees HR1206 "Access to Professional Health Insurance Act of
2011"; HR1370 "To Repeal the annual fee on Health Insurance Providers Enacted by PPACA"
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
2nd Quarter, 2011
In Q2, HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY had in-house lobbyists. The report was filed on July 18, 2011.
Original Filing: 300393027.xml
Lobbying Issues
HR371 Health Care Choice Act of 2011; HR1213 "Repeal mandatory funding provided to States in the PPACA to Establish Benefit
Exchanges"; Debt Ceiling; HR1 "Full-Year Continuing Appropriations Act, 2011" Title V and Title VIII
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Please see attached addendum for General Lobbying Issue Area: HCR - Health Issues.Successful Insurance Industry Implementation of Health Reforms: good faith compliance standard, reasonable effective dates
for compliance with PL 111-148
Affordable Private Health Care: Insurer Fees; Realistic Essential Health Benefits; Effective Individual Mandate; Healthcare
Delivery System Reforms; Small Employer Tax Credits; Adequate Insurer Reserve Levels; Most Favored Nation clauses in
provider health contracts; Individual responsibility to obtain and maintain insurance coverage; Health Insurance Excise Tax
State-based regulation: State Oversight of Premium Increases; Creation of State-based Exchanges; Value of properly designed
state health insurance exchanges to improve competition and maximize choice; federal exchanges; federal rate review; existing
state regulatory functions; Selling Health Insurance across state lines: HR371 Health Care Choice Act of 2011; HR1213
"Repeal mandatory funding provided to States in the PPACA to Establish Benefit Exchanges"; HR5 "HEALTH Act of 2011"
Medical Loss Ratios: MLR Broker Fee HR1206 Access to Professional Health Insurance Advisors Act of 2011; State
Innovation Waivers; Quality improvement definition; Consistent reporting requirements for all insurers; Transition for smaller
states and Plans; include benefits for individuals as well as populations
Health Care Quality: Delivery System Incentives to Promote Better Care; Payment Reforms; Patient-centered Primary
Care/Medical Home; Comparative Effectiveness Research; Evidence Based Care; Health Disparities; Wellness; Chronic Care
Management; Childhood Obesity
Health Information Technology Standards; Health Information Privacy; Electronic Health Records; Administrative
Simplification; ICD10 Real time claims adjudication; Data Sharing; Data Aggregation
Insurance Market Reform; Individual Market Reform; Small Group Market Reform; Small Business Healthcare; Guaranteed
Issue; Community Rating; Health Status Rating; Health Savings Accounts/Medical Savings Accounts; Individual Mandate;
MEWAs
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Medicare Advantage; Medicare Fraud; Medicaid; HR1683 and S868 "State Flexibility Act"
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
IRC section 833(b) tax provisions; annual insurer assessments, proposed excise tax on high-value health insurance plans, limitation
of tax deduction for health insurer's executive compensation; Small Employer Tax Credits; Health Savings Accounts; Medical Loss
Ratio definition to qualify for 833(b) tax deduction; MLR Broker Fees HR1206 "Access to Professional Health Insurance Act of
2011"; HR1370 "To Repeal the annual fee on Health Insurance Providers Enacted by PPACA"
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
1st Quarter, 2011
In Q1, HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY had in-house lobbyists. The report was filed on April 15, 2011.
Original Filing: 300365081.xml
Lobbying Issues
See attached addendum for general lobbying issue area: HCR - Health IssuesSuccessful Insurance Industry Implementation of Health Reforms: good faith compliance standard, reasonable effective dates
for compliance with PL 111-148
Affordable Private Health Care: Insurer Fees; Realistic Essential Health Benefits; Effective Individual Mandate; Healthcare
Delivery System Reforms; Small Employer Tax Credits; Adequate Insurer Reserve Levels; Most Favored Nation clauses in
provider health contracts; Individual responsibility to obtain and maintain insurance coverage; Health Insurance Excise Tax
State-based regulation: State Oversight of Premium Increases; Creation of State-based Exchanges; Value of properly designed
state health insurance exchanges to improve competition and maximize choice; federal exchanges; federal rate review; existing
state regulatory functions; Selling Health Insurance across state lines: HR371 Health Care Choice Act of 2011
Medical Loss Ratios: MLR Broker Fee HR1206 Access to Professional Health Insurance Advisors Act of 2011; State
Innovation Waivers; Quality improvement definition; Consistent reporting requirements for all insurers; Transition for smaller
states and Plans; include benefits for individuals as well as populations
Health Care Quality: Delivery System Incentives to Promote Better Care; Payment Reforms; Patient-centered Primary
Care/Medical Home; Comparative Effectiveness Research; Evidence Based Care; Health Disparities; Wellness; Chronic Care
Management; Childhood Obesity
Health Information Technology Standards; Health Information Privacy; Electronic Health Records; Administrative
Simplification; ICD10 Real time claims adjudication; Data Sharing; Data Aggregation
Insurance Market Reform; Individual Market Reform; Small Group Market Reform; Small Business Healthcare; Guaranteed
Issue; Community Rating; Health Status Rating; Health Savings Accounts/Medical Savings Accounts; Individual Mandate;
MEWAs
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Medicare Advantage; Medicare fraud
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
IRC section 833(b) tax provisions; annual insurer assessments, proposed excise tax on high-value health insurance plans, limitation
of tax deduction for health insurer's executive compensation; Small Employer Tax Credits; Medical Loss Ratio definition to qualify
for 833(b) tax deduction; MLR Broker Fees HR1206 "Access to Professional Health Insurance Act of 2011"
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
4th Quarter, 2010
In Q4, HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY had in-house lobbyists. The report was filed on Jan. 19, 2011.
Original Filing: 300345039.xml
Lobbying Issues
See attached addendum for general issue area: HCR: Health IssuesSuccessful Insurance Industry Implementation of Health Reforms: good faith compliance standard, reasonable effective dates
for compliance with PL 111-148
State Oversight of Premium Increases: S 3078 and HR4757 Health Insurance Rate Authority Act of 2010; federal rate
review; HR 4700 Transparency in All Health Care Pricing Act of 2010; existing state regulatory functions; federal exchanges;
state exchanges
Medical Loss Ratios: Quality improvement definition; Consistent reporting requirements for all insurers; Transition for smaller
states and Plans; include benefits for individuals as well as populations
Dependent Health Insurance Coverage: IRS Guidelines on dependent coverage; Pre-existing condition for children; guaranteed
issue for children under the age of 19; Child Only Insurance Policies
Recissions and Routine Administrative Functions; Internal Claims and Appeals/External Review; Open enrollment period;
adverse selection implications
Affordable Private Health Care: Insurer Fees; Realistic Minimum Benefit Values; Effective Individual Mandate; Healthcare
Delivery System Reforms; Small Employer Tax Credits; Adequate Insurer Reserve Levels
Grandfathering Rules: Interim final rule of June 14th; Flexibility to modify items that are not specifically prohibited
Lifetime and Annual Limits: lifetime and annual dollar limits on "essential health benefits"
Health Care Quality; Patient-centered Primary Care/Medical Home; Health Disparities; Wellness; Chronic Care Management;
Comparative Effectiveness Research; Improved Delivery of Health Care; Evidence Based Care; Healthcare Delivery System
Reforms; Childhood Obesity
Health Information Technology Standards; Health Information Privacy; Electronic Health Records; Administrative
Simplification; ICD10 Real time claims adjudication; Data Sharing; Data Aggregation
Insurance Market Reform; Individual Market Reform; Small Group Market Reform; Small Business Healthcare; Guaranteed
Issue; Community Rating; Health Status Rating; Health Savings Accounts/Medical Savings Accounts; Individual Manadate;
MEWAs
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Medicare Advantage; HR 6130 "Strengthening Medicare Anti-Fraud Measures Act of 2010"
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
IRC section 833(b) tax provisions; annual insurer assessments, proposed excise tax on high-value health insurance plans, limitation
of tax deduction for health insurer's executive compensation; Small Employer Tax Credits; IRS Guidelines on dependent coverage;
Medical Loss Ratio definition to qualify for 833(b) tax deduction
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
3rd Quarter, 2010
In Q3, HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY had in-house lobbyists. The report was filed on Oct. 21, 2010.
Original Filing: 300329997.xml
Lobbying Issues
Please see attached addendum for General Lobbying Issue Area: HCR - Health Issues"Good faith compliance standard," reasonable effective dates for compliance with PL 111-148
State oversight of premium increases: S 3708 and HR 4757 "Health Insurance Rate Authority Act of 2010"; federal rate review; HR 4700 "Transparency in All Health Care Pricing Act of 2010"; existing state regulatory functions; federal exchanges; state exchanges
Medical Loss Ratios: Quality improvement definition; consistent reporting requirements for all insurers; include benefits for individuals as well as populations
Dependent health insurance coverage; IRS guidelines on dependent coverage; pre-existing conditions for children; guaranteed issue for children under the age of 19; child-only policies
Rescissions and Routine Administrative Functions; internal claims and appeals/ external review; open enrollment period; adverse selection implications
Affordable private health care; insurer fees; effective individual mandate; healthcare delivery system reforms; small employer tax credits; adequate insurer reserve levels
Grandfathering rules; interim final rule of June 14th; flexibility to modify items that are not specifically prohibited
Lifetime and annual limits; lifetime and annual dollar limits on "essential health benefits"
Health care quality; patient-centered medical home; health disparities; wellness; chronic care management; comparative effectiveness research; improved delivery system of health care; evidence based care; healthcare delivery system reforms; childhood obesity
Health information technology standards; health information privacy; electronic health records; ICD-10 "real time" claims adjudication; data sharing; data aggregation
Insurance market reform; individual market reform; small group market reform; small business healthcare; guaranteed issue; community rating; health status rating; individual mandate
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Medicare Advantage; HR 6130 "Strengthening Medicare Anti-Fraud Measures Act of 2010"
Medicare Advantage funding
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
IRC section 833(b) tax provisions; annual insurer assessments; proposed excise tax on high-value health insurance plans, limitation of tax deduction for health insurers' executive compensation; IRS guidelines on dependent coverage; Medical Loss Ratio definition to qualify for 833(b) tax deduction.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
2nd Quarter, 2010
In Q2, HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY had in-house lobbyists. The report was filed on July 20, 2010.
Original Filing: 300295951.xml
Lobbying Issues
See attached addendum for General Lobbying Issue Area: HCR - Health IssuesSuccessful Insurance Industry Implementation of Health Reforms: "good faith compliance standard," reasonable effective dates for compliance with PL 111-148
State oversight of premium increases: S3078 and HR4757 "Health Insurance Rate Authority Act of 2010;" federal rate review; HR4700 "Transparency in All Health Care Pricing Act of 2010:" existing state regulatory functions; federal exchanges; state exchanges
Grandfathering Rules: Interim final rule of June 14th; Flexibility to modify items that are not specifically prohibited
Medical Loss Ratios: Quality improvement definition; consistent reporting requirements for all insurers; transition for smaller states and Plans; include benefits for individuals as well as populations
Dependent Health Insurance Coverage; IRS Guidelines on dependent coverage; BCBS commitment to cover individuals up to age 26 on their parents' health insuranceHR5200 "FEHBP Dependent Coverage Extension Act"
Pre-existing condition exclusions: pre-existing conditions for children; guaranteed issue for children under age 19
Lifetime and Annual Limits: lifetime and annual dollar limits on "essential health benefits"
Rescissions and Patient Protections; Open enrollment period; adverse selection implications
Affordable Private Health Care: Insurer fees; realistic minimum benefit values; effective individual mandate; health care delivery system reforms; small employer tax credits
Health Care Quality: patient-centered primary care/medical home; health disparities; wellness; chronic care management; comparative effectiveness research; improved delivery of health care; evidence based care; healthcare delivery system reforms
Health Information Technology Standards: health information privacy; electronic health records; administrative simplification; ICD-10 real time claims adjudication
Insurance Market Reform; individual market reform; small group market reform; small business healthcare; guaranteed issue; community rating; health status rating; health savings accounts/medical savings accounts; individual mandate
Agencies Lobbied
U.S. House of Representatives
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
annual insurer assessments; proposed excise tax on high-value health insurance plans; limitation of tax deduction for health insurers' executive compensation; small employer tax credits; IRS guidelines on dependent coverage.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
1st Quarter, 2010
In Q1, HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY had in-house lobbyists. The report was filed on April 19, 2010.
Original Filing: 300263366.xml
Lobbying Issues
Medicare Advantage Funding and Comparative Effectiveness Funding in Health Care Reform legislation
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
See attached addendum for General Issue Area Code: HCRHealth Care Reform Bill HR3590 "Patient Protection and Affordable Care Act" parts pertaining to health care reform; Health Care Reconciliation Bill HR 4872 "The Health Care & Education Affordability Reconciliation Act of 2010" parts pertaining to health care reform; reasonable effective dates for compliance with insurance reforms; affordable premiums (insurer tax, insufficient cost containment, weak mandate, restricted age discounts, insurer fees); federal health insurance rate authority; national insurance exchange; grandfathering
Health Care Reform; Pathway to Covering America; Employer Based Healthcare System; Uninsured/Expanding Coverage; Healthcare Reform Modeling;
Insurance Market Reform; Individual Market Reform; Small Group Market Reform; Small Business Healthcare; Guaranteed Issue; Community Rating; Health Status Rating; Health Savings Accounts/Medical Savings Accounts; Individual Mandate; Medical Loss Ratios; MEWAs;
Government-run health insurance Plan; Government Plan Trigger; negotiated rates; state opt-out; Co-Ops; Medicare Payment Rates; Provider Underpayments; Level Playing Field
Affordable Private Health Care; proposed insurer fees; excise taxes on high value Plans; premium caps; 5 to 1 Age Rating Bands; Realistic Minimum Benefit Values; Effective Individual Mandate; Sherlock Report; Healthcare Delivery System Reforms; malpractice reform; Oliver Wyman actuarial analysis "Impact of the Patient Protection and Affordable Care Act on the Costs in the Individual and Small-Employer Health Insurance Markets"; CBO premium impact analysis
New federal regulatory functions; existing state regulatory functions; Federal Exchanges; Federal Connectors; Virtual Connectors; State Insurance Marts (SIMs); Pooling
Health Care Quality; Patient-centered Primary Care/Medical Home; Health Disparities; Wellness; Chronic Care Management; Comparative Effectiveness Research; Improved Delivery of Health Care; evidence based care; Healthcare Delivery System Reforms;
Health Information Technology Standards; Health Information Privacy; Electronic Health Records; Administrative Simplification
Antitrust and Health Insurance Reform; McCarran-Ferguson antitrust exemption repeal legislation: HR 4626 "Health Insurance Industry Fair Competition Act"
Scope of FEHBP preemption
Agencies Lobbied
U.S. House of Representatives
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
IRC section 833(b) tax provisions
Sections of Health Care Reform legislation pertaining to proposed annual insurer assessments, proposed excise tax on high-value
health insurance plans, and proposed limitation of tax deduction for health insurer's executive compensation
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
4th Quarter, 2009
In Q4, HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY had in-house lobbyists. The report was filed on Jan. 19, 2010.
Original Filing: 300238332.xml
Lobbying Issues
Medicare Advantage Funding and Medicare Advantage Rates; Comparative Effectiveness Funding
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
See attached addendum for General Lobbying Issue Area: HCR - HealthcareHealth Care Reform; Pathway to Covering America; employer-based healthcare system; uninsured/expanding coverage; health care reform modeling;
Insurance market reform; individual market reform; small group market reform; small business healthcare; guaranteed issue; community rating; health status rating; individual mandate; medical loss ratios
HR 3200 "America's Affordable Health Choices Act of 2009"; Senate Finance Committee Chairman's Mark - no bill number "America's Healthy Future Act"; HR 3962 "Affordable Health Care for America Act"; HR 3962 Manager's Amendment; HR 3590 "Patient Protection and Affordable Care Act"; HR 3590 Manager's Amendment
Government-run health insurance plan; government plan trigger; negotiated rates; state opt-out; Co-ops; Medicare payment rates; provider underpayments; level playing field
Affordable Private Health Care; proposed insurer fees; excise tax on high-value plans; premium caps; 5 to 1 age-rating bands; realistic minimum benefit values; effective individual mandate; health care delivery system reforms; malpractice reform; Oliver Wyman actuarial analysis "Impact of the Patient Protection and Affordable Care Act and the Costs in the Individual and Small-Employer Health Insurance Markets"'; CBO premium impact analysis; Price WaterhouseCoopers premium impact analysis
New federal regulatory functions; existing state regulatory functions; federal exchanges; federal connectors; virtual connectors; state insurance marts; pooling
Health care quality; patient centered medical home; chronic care management; comparative effectiveness research; improved delivery of health care; evidence-based medicine;
Health information technology standards; health information privacy; electronic health records; administrative simplification
Antitrust and health insurance reform;
Scope of FEHBP exemption
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Medicare Advantage; Medicaid; Medicare buy-in for those aged 55-64 years of age
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
proposed annual insurer assessments; proposed excise tax on high-value health insurance plans, proposed limitation of tax deduction for health insurer's executive compensation as provided for in healthcare reform proposals
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
3rd Quarter, 2009
In Q3, HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY had in-house lobbyists. The report was filed on Oct. 16, 2009.
Original Filing: 300207101.xml
Lobbying Issues
Medicare Advantage Funding and 2010 Medicare Advantage Rates
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Please see attached addendum for General Lobbying Issue Area: HCR - Health IssuesHealth Care Reform; Pathways to Covering America; Employer-Based Healthcare System; Uninsured/Expanding Coverage; Health Care Reform Modeling;
Insurance Market Reform; Individual Market Reform; Small Group Market Reform; Small Business Healthcare; Guaranteed Issue; Community Rating; Health Status Rating; Health Savings Accounts/Medical Savings Accounts; Individual Mandate;
HR 3200 "America's Affordable Health Choices Act of 2009;" S1679 "Affordable Health Choices Act;" Senate Finance Committee Chairman's Mark - no bill number "America's Healthy Future Act;" HR 1321 and S 391 "Healthy Americans Act"
Government-run Health Insurance Plan; Government Plan Trigger; Co-ops; Medicare Payment Rates; Provider Underpayments; Level Playing Field
Affordable Private Health Care; Proposed Insurer Fee; Excise Taxes on High Value Plans; 5 to 1 Age Rating Bands; Realistic Minimum Benefit Values; Effective Individual Mandate; Healthcare Delivery System Reforms;
Health Care Quality; Patient-centered Primary Care/Medical Home; Health Disparities; Wellness; Chronic Care Management; Comparative Effectiveness Research; Improved Delivery of Health Care; Evidence-based Care; Healthcare Delivery System Reforms;
Pooling; Exchanges; Federal Connectors; Virtual Connectors; State Insurance Marts (SIMs);
Health Information Technology Standards; Health Information Privacy; Electronic Health Records; Administrative Simplification
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Medicare Advantage; Medicaid;
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Proposed Annual Insurer Assessments
Proposed Excise Tax on High-Value Health Insurance Plans
Proposed Limitation on Tax Deduction for Health Insurers Executive Compensation
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
2nd Quarter, 2009
In Q2, HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY had in-house lobbyists. The report was filed on July 27, 2009.
Original Filing: 300195902.xml
Lobbying Issues
Medicare Advantage Funding; 2010 Medicare Advantage Rates
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
See attached addendum for General Lobbying Issue Area: HCR - HealthcareHealth Care Reform: Pathway to Covering America; Employer-Based Healthcare System; Uninsured/Expanding Coverage; Effective Individual mandate; health coverage responsibility; affordable private health care; government plan option; FEHBP; healthcare reform model;
HR 1321 and S391 "Healthy Americans Act," HR 1897 and S 803 "Healthy Workforce Act of 2009," American Health Choices Act
Insurance Market Reform; Individual Market Reform; Small Group Market Reform; Small Business Healthcare; Guaranteed Issue; Community Rating; Health Status Rating;
Patient-centered primary care/Medical Home; Health Care Quality; Comparative Effectiveness Research; Improved Delivery of Health Care; Healthcare System Delivery Reforms
Federal Connectors; Virtual Connectors; State Insurance Marts (SIMs)
Health Information Technology Standards; Health Information Privacy; Electronic Health Records
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Medicare
Medicare Advantage
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2009
In Q1, HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY had in-house lobbyists. The report was filed on April 20, 2009.
Original Filing: 300160847.xml
Lobbying Issues
See attached addendum for General Lobbying Issue Area: BUD - Budget/AppropriationsMedicare Advantage Funding; 2010 Medicare Advantage rates
HR1 "American Recovery and Reinvestment Act of 2009" Section 3001 on COBRA subsidies: Section 5001 on Medicaid funding; Sections 4101 and 4102 on Electronic Health Records; Sections on Health Information Privacy; Section 804 on Comparative Effectiveness Research
CHIP/SCHIP: HR2 and S275 "Children's Health Insurance Program Reauthorization Act of 2009"
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
See attached addendum for general lobbying issue area: HCR - HealthcareHealth Care Reform; Employer Based Healthcare System; Uninsured/Expanding Coverage; Effective Individual Mandate; Affordable Health Care; Government Plan Option
Insurance Market Reform; Individual Market Reform; Small Group Market Reform; Small Business Healthcare; Guaranteed Issue; Community Rating; Health Status Rating
Federal Connectors; Virtual Connectors
Health Care Quality; Wellness; Chronic Care Management; Comparative Effectiveness Research
Health Information Technology Standards; Health Information Privacy; Electronic Health Records; HIPAA Privacy: HR1 "American Recovery and Reinvestment Act of 2009" Sections pertaining to HIPAA Privacy in the HITECH Act
Mental Health Parity
CHIP/SCHIP: HR2 and S275: "Children's Health Insurance Program Reauthorization Act of 2009"
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Medicare Advantage
Medicaid
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2008
In Q4, HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY had in-house lobbyists. The report was filed on Jan. 21, 2009.
Original Filing: 300129792.xml
Lobbying Issues
Medicare Advantage Funding: HR 6331 "Medicare Improvements for Patients and Providers Act of 2008," S3101 medicare Improvements for Patients and Providers Act of 2008," and S3118 "Preserving Access to Medicare Act of 2008" Comparative Effectiveness Funding: HR3162 "Children's Health and Medicare Protection Act of 2007" Section 904 only, HR 2184 "Enhanced Health Care Value for All Act," S 3408 "Comparative Effectiveness Research Act of 2008"
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
See attached addendum for General Lobbying Issue Area: HCR - HealthcareHealth Information Technology Standards; HIT Privacy; Electronic Health Records; ICD-10 Implementation: HR 1368 "Personalized Health Information Act of 2007," S 1783 and S 1693 "Wired for Health Care Quality Act," HR 3800 "Promoting Health Information Technology Act;" HR 2406 "Healthcare Information Technology Enterprise Integration Act;" HR 6357 "Pro(Tech)t Act of 2008"
Healthcare Reform; Insurance Market Reform; Employer-Based Healthcare System; Small Group Market/ Small Business Healthcare; Uninsured; Health Disparities; Connectors/Virtual Connectors; S 1019 "Health Care Choice Act of 2007," S334 and HR 3163 "Healthy Americans Act," S 2795 "Small Business Health Options Program Act of 2008"
Mental Health Parity: S3712 "A Bill to make a technical correction in the Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008"
Comparative Effectiveness Funding: HR 3162 "Children's Health and Medicare Protection Act of 2007" Section 904 only, HR 2184 "Enhanced Health Care Value for All Act," S3408 "Comparative Effectiveness Research Act of 2008"
SCHIP; HR 976 and HR 3963 "SCHIP Extension Bill"
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Medicare; Comparative Effectiveness Funding: HR 3162 "Children's Health and Medicare Protection Act of 2007" Section 904 only, HR 2184 "Enhanced Health Care Value for All Act," S3408 "Comparative Effectiveness Research Act of 2008," Medicare Advantage: HR 6331 "Medicare Improvements for Patients and Providers Act of 2008," S 3101 "Medicare Improvements for Patients and Providers Act of 2008," and S 3118 "Preserving Access to Medicare Act of 2008"
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Comparative Effectiveness Funding: HR 3162 "Children's Health and Medicare Protection Act of 2007" Section 904 only, HR 2184 "Enhanced Health Care Value for All Act;" S 3408 "Comparative Effectiveness Research Act of 2008"
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2008
In Q3, HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY had in-house lobbyists. The report was filed on Oct. 17, 2008.
Original Filing: 300098370.xml
Lobbying Issues
Medicare Advantage Funding: HR 6331/S3101 "Medicare Improvements for Patients and Providers Act of 2008," S3118 "Preserving Access to Medicare of 2008;" Comparative Effectiveness Funding: HR 3162 "Children's Health and Medicare Protection Act of 2007" Section 904 only
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
See attached addendum for General Lobbying Issue Area: HCR - HealthcareHealth Information Technology Standards; HIT Privacy; Electronic Health Records; ICD-10 Implementation; HR 1368 "Personalized Health Information Act of 2007;" S1783 and S1693 "Wired for Health Care Quality Act;" HR3800 "Promoting Health Information Technology Act;" HR6357 "Pro(Tech)t Act of 2008"
Healthcare Reform; Insurance Reform; Employer-Based Healthcare System; Small Group Market/Small Business Healthcare; Uninsured: S1019 "Health Care Choices Act of 2007;" S334 and HR3163 "Healthy Americans Act"
Mental Health Parity: HR 1424 "Paul Wellstone Mental Health and Addiction Equity Act of 2007" and S558 "Mental Health Parity Act of 2007;" HR1424 as passed; sections pertaining to the "Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008"
Comparative Effectiveness Research: HR3162 "Children's Health and Medicare Protection Act of 2007" Section 904 only; HR2184 "Enhanced Health Care Value for All Act"
Health Savings Accounts/Medical Savings Accounts
HR758 "Breast Cancer Patient Protection Act of 2007"
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Medicare; Medicare Part D; Comparative Effectiveness Research: HR3162 "Children's Health and Medicare Protection Act of 2007" Section 904 only; HR2184 "Enhanced Health Care Value for All Act;" Medicare Electronic Health Records; Pay for Performance; Medicare Advantage: HR6331 "Medicare Improvements for Patients and Providers Act of 2008," S3101 "Medicare Improvements for Patients and Providers Act of 2008;" and S3118 "Preserving Access to Medicare Act of 2008"
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
E-prescribing; Comparative Effectiveness Research: HR3162 "Children's Health and Medicare Protection Act of 2007" Section 904 only; HR2184 "Enhanced Health Care Value for All Act"
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2008
In Q2, HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY had in-house lobbyists. The report was filed on July 23, 2008.
Original Filing: 300083620.xml
Lobbying Issues
Medicare Advantage Funding: HR 6331 "Medicare Improvements for Patients and Providers Act of 2008;" S3101 "Medicare Improvements for Patients and Providers Act of 2008;" S3118 "Preserving Access to Medicare Act of 2008;" and Comparative Effectiveness Funding: HR 3162 "Children's Health and Medicare Protection Act of 2007" (Section 904 only).
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
See attached addendum for General Lobbying Issue Area: HCR - HealthcareHealth Information Techonology Standards; Electronic Health Records; ICD-10 Implementation: HR 1368 "Personalized Health Information Act of 2007;" S1783 and S1693 "Wired for Health Care Quality Act;" HR 6357 "Pro(Tech)t Act of 2008"
Healthcare Reform; Insurance Market Reform; Employer-Based Healthcare System; Small Group Market/Small Business Healthcare; Uninsured: S1019 "Health Care Choice Act of 2007;" S334 and HR3163 "Healthy Americans Act;" S2795 "Small Business Health Options Program Act of 2008"
Mental Health Parity: HR 1424 "Paul Wellstone Mental Health and Addiction Equity Act of 2007" and S558 "Mental Health Parity Act of 2007"
Comparative Effectiveness Research: HR3162 "Children's Health and Medicare Protection Act of 2007" (Section 904 only)
Health Savings Accounts/Medical Savings Accounts; SCHIP
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Medicare; Medicare Part D; Comparative Effectiveness Research: HR3162 "Children's Health and Medicare Protection Act of 2007" (Section 904 only); HR2184 "Enhanced Health Care Value For All Act;" Medicare Electronic Health Records; Pay for Performance; Medicare Advantage; HR6331 "Medicare Improvements for Patients and Providers Act of 2008;" S3101 "Medicare Improvements for Patients and Providers Act of 2008;" S3118 "Preserving Access to Medicare Act of 2008"
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
E-prescribing; Comparative Effectiveness Research: HR3162 "Children's Health and Medicare Protection Act of 2007" (Section 904 only); HR2184 "Enhanced Health Care Value for All Act"
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2008
In Q1, HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY had in-house lobbyists. The report was filed on April 17, 2008.
Original Filing: 300040987.xml
Lobbying Issues
Medicare Advantage Funding, Comparative Effectiveness funding - HR 3162 "Children's Health and Medicare Protection Act of 2007" (section 904)
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
See attached addendum for General Lobbying Issue Area: HCR-HealthcareHealth Information Technology Standards; Electronic Health Records; ICD-10 Implementation; HR 1368 "Personalized Health Information Act of 2007"; S 1783 and S 1693 "Wired for Health Care Quality Act"
Healthcare Reform; Insurance Reform; Employer-Based Healthcare System; Uninsured: S 1019 "Health Care Choice Act of 2007"; S 334 and HR 3163 "Healthy Americans Act"
Mental Health Parity: HR 1424 "Paul Wellstone Mental Health and Addiction Equity Act of 2007" and S 558 "Mental Health Parity Act of 2007"
Comparative Effectiveness Research: HR 3162 "Children's Health and Medicare Protection Act of 2007" Section 904 only; HR 2184 "Enhanced Health Care Value for All Act"
SCHIP, Small Group Market/Small Business Healthcare
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Medicare; Medicare Advantage; Medicare Part D; Comparative Effectiveness Research: HR 3162 "Children's Health and Medicare Protection Act of 2007" Section 904 only; HR 2184 "Enhanced Health Care Value for All Act"; Medicare Electronic Health Records; Pay for Performance
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2006
Horizon Blue Cross Blue Shield of New Jersey filed a lobbying registration on March 5, 2006 for in-house lobbying efforts, effective Feb. 21, 2006.
Original Filing: 100022362.xml
Issue(s) they said they’d lobby about: H.R.4157, "Health Information Technology Promotion Act of 2005," Sec. 5 relating to ICD code updates, S.1955, "Health Insurance Marketplace Modernization and Affordability Act of 2005," Titles 1, 2, 3 relating to insurance reform, H.R.2355, "Health Care Choice Act of 2005," all sections relating to state regulation, Medicare Part D, Medicare Advantage, Medicaid. .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...